Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
AC118549.1		ENSG00000036549	"ZZ-type zinc finger-containing protein 3 "	Q8IYH5	1	77562416-77683419	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 2: 19.0;Proximal tubular cells: 15.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053663, HPA054913, HPA066197"	Uncertain		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim"		No	No			"Nucleoplasm, Nucleoli, Nucleoli rim"		"HPA053663: AB_2682222, HPA054913: AB_2682640, HPA066197: AB_2685635"	"unprognostic (1.30e-1)"	"unprognostic (4.78e-2)"	"unprognostic (2.73e-2)"	"unprognostic (2.13e-3)"	"unprognostic (5.38e-3)"	"unprognostic (8.77e-2)"	"prognostic unfavorable (6.96e-5)"	"unprognostic (2.91e-1)"	"unprognostic (9.67e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.43e-1)"	17.8	17.4	20.8	14.1	23.6	11.6	21.6	20.4	20.3	18.1	16.2	16.1	18.3	12.1	18.3	14.3	14.5	15.3	12.1	13.7	16.9	11.7	18.8	20.0	12.3	15.8	24.1	17.8	24.1	14.5	19.0	28.2	13.9	14.4	16.0	13.0	10.5	15.2	16.8	19.0	16.9	12.4	17.0	16.2	11.5	13.5	9.9	23.6	17.9	26.5	8.6	16.0	20.1	14.9	7.9	7.4	5.6	5.1	7.4	10.4	5.0	13.4	6.9	12.7	9.7	11.1	17.7	13.4	17.2	15.9	15.9	17.5	7.7	7.2	17.6	15.5	14.4	18.0	12.4	16.7	11.1	24.1	13.8	13.2	21.8	13.9	9.5	17.1	22.5	6.2	13.5	17.2	17.6	34.4	15.4	16.1	12.2	21.1	13.7	15.4	6.3	11.2	7.0	18.8	7.4	15.7	13.2	21.7	9.0	11.1	14.3	15.9	13.4	10.3	11.8	30.3	9.1	7.1	12.4	13.2	13.8	17.0	22.3	22.1	10.3	14.4	18.7	13.6	19.7	10.5	0.1	4.6	5.6	6.9	5.1	10.4	7.9	8.2	8.1	7.4	7.9	10.2	9.2	0.9	7.4	4.7	5.0	10.4	5.0	20.8	23.6	20.4	20.3	16.9	11.7	24.1	17.8	14.4	23.6	11.9	19.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	12.5	10.4	0.0	11.4	10.0	13.1	0.0	0.0	0.0	0.0	11.1	10.1	0.0	0.0	5.8	0.0	12.3	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	13.6	0.0	0.0	11.8	0.0	0.0	15.7	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0
ADAR	"ADAR1, G1P1, IFI4"	ENSG00000160710	"Adenosine deaminase, RNA specific"	P55265	1	154582062-154627999	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity, mRNA processing, RNA-mediated gene silencing"	"DNA-binding, Hydrolase, RNA-binding"	"Aicardi-Goutieres syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003890, HPA051519, CAB056157"	Enhanced		Enhanced	Nucleoplasm,Nucleoli		No	No			Nucleoli	Nucleoplasm	"CAB056157: AB_2665578, HPA003890: AB_1078103, HPA051519: AB_2681520"	"unprognostic (3.46e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.83e-2)"	"unprognostic (2.38e-1)"	"unprognostic (9.37e-2)"	"unprognostic (2.07e-2)"	"unprognostic (6.97e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.90e-1)"	"unprognostic (4.13e-2)"	"unprognostic (7.16e-2)"	"prognostic unfavorable (7.30e-5)"	"unprognostic (3.44e-1)"	"unprognostic (1.49e-1)"	"unprognostic (9.00e-2)"	"unprognostic (3.94e-2)"	36.1	33.1	30.3	36.6	44.4	43.1	29.7	41.4	50.8	30.7	28.2	33.3	19.9	31.4	38.0	26.5	27.7	32.9	28.9	24.0	25.7	38.1	31.5	36.0	34.7	41.3	27.3	32.6	39.2	29.5	46.2	38.4	33.9	39.8	28.8	31.1	32.2	36.7	30.2	14.0	27.0	40.6	36.3	24.4	47.7	29.1	21.9	26.9	57.6	32.8	16.7	41.9	29.7	27.6	7.8	6.1	25.1	8.6	6.4	9.7	5.6	26.6	30.9	26.5	32.6	26.8	27.8	31.5	18.4	36.9	61.6	53.5	26.6	26.2	48.0	29.7	29.3	34.2	25.9	33.8	34.9	31.4	46.6	16.9	25.0	21.9	15.0	29.2	35.3	27.8	27.0	25.5	31.5	32.3	25.2	31.5	34.7	23.6	37.0	21.5	32.5	42.6	18.2	43.7	35.7	23.3	40.8	21.8	38.6	21.1	29.7	26.4	31.5	31.7	51.3	37.6	41.3	34.5	43.5	28.7	22.1	21.8	18.2	21.2	43.8	48.0	51.6	21.5	23.3	24.9	6.9	6.6	12.0	9.4	8.3	8.8	7.8	9.4	9.7	6.1	6.2	8.8	8.6	25.1	6.4	8.6	5.5	7.1	5.6	30.3	44.4	41.4	50.8	25.7	38.1	27.3	32.6	39.8	26.9	77.4	46.4	72.2	33.2	29.7	90.3	15.5	33.1	41.5	43.3	45.4	90.3	33.7	8.3	43.8	3.6	83.1	68.1	23.3	58.0	42.0	39.5	47.9	61.1	78.8	46.9	158.9	60.6	78.0	80.2	9.5	68.1	57.4	18.6	68.5	54.5	46.8	58.0	53.7	55.5	36.0	81.7	51.8	36.9	11.7	23.2	35.3	26.3	58.3	48.2	41.3
ANAPC11	"APC11, Apc11p, HSPC214, MGC882"	ENSG00000141552	"Anaphase promoting complex subunit 11"	Q9NYG5	17	81890790-81900991	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Late spermatids: 944.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA021989, HPA027838"	Approved		Enhanced	Nucleoplasm,Nucleoli		Yes	No			Nucleoplasm	Nucleoli	"HPA021989: AB_1844915, HPA027838: AB_10600978"	"unprognostic (9.00e-3)"	"unprognostic (1.24e-2)"	"unprognostic (3.76e-1)"	"unprognostic (4.93e-2)"	"unprognostic (8.76e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.13e-2)"	"unprognostic (8.20e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.17e-3)"	"unprognostic (2.22e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.76e-2)"	"unprognostic (8.07e-2)"	"unprognostic (9.08e-2)"	"unprognostic (2.51e-2)"	"unprognostic (3.16e-1)"	29.3	26.1	44.9	21.9	34.1	39.6	27.2	19.5	31.8	19.4	26.3	14.8	30.3	26.1	19.2	27.5	31.7	24.6	26.0	63.6	32.9	26.7	25.9	38.4	18.5	26.7	35.2	31.8	17.2	40.3	12.6	20.6	25.7	29.8	25.4	12.2	18.1	48.8	24.0	94.2	21.6	24.8	25.4	27.6	18.9	25.9	42.2	27.3	18.5	32.5	45.7	17.0	23.5	25.5	54.9	107.5	74.0	80.1	43.1	52.8	80.4	41.4	97.5	23.2	34.3	18.5	21.1	26.6	20.1	15.8	18.3	20.9	40.0	36.6	13.1	22.5	17.7	20.2	24.2	9.3	25.7	6.6	19.2	70.6	19.6	43.3	60.3	20.8	14.6	17.4	23.4	23.5	18.7	15.3	11.9	29.3	17.9	26.7	38.2	18.9	74.7	35.5	24.2	21.9	40.3	72.8	14.8	22.1	26.3	16.7	37.3	29.2	47.4	21.7	34.3	39.4	16.7	41.9	35.6	17.4	35.6	28.5	38.1	37.7	18.7	7.8	16.5	37.4	22.3	28.4	70.1	80.1	74.0	45.3	63.7	42.8	54.9	46.4	49.5	64.6	51.6	45.2	43.5	40.5	43.1	59.3	107.5	52.8	80.4	44.9	34.1	19.5	31.8	32.9	26.7	35.2	31.8	29.8	27.3	119.1	121.6	108.7	168.5	132.0	55.6	277.3	203.8	155.2	153.6	188.5	19.6	436.4	442.7	236.1	329.1	152.3	247.2	186.9	293.4	435.1	217.2	291.4	105.2	427.2	386.6	31.8	182.7	139.3	155.4	944.1	168.2	179.2	248.0	315.6	205.6	112.3	274.1	235.0	154.9	400.2	53.7	103.5	220.7	379.1	245.5	163.2	425.4	121.6	237.2	254.5
AP002495.1		ENSG00000254469	"Putative short transient receptor potential channel 2-like protein "	Q6ZNB5	11	71865509-71928654	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	16	"Ciliated cells: 2.7;Cytotrophoblasts: 4.7;Extravillous trophoblasts: 2.1;Hofbauer cells: 1.8;Syncytiotrophoblasts: 2.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA051121, HPA051124"	Uncertain		Enhanced	"Nucleoli,Mitotic chromosome"		NA	NA			Nucleoli	"Mitotic chromosome"	"HPA051121: AB_2681349, HPA051124: "	"unprognostic (1.66e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.32e-3)"	"unprognostic (9.79e-4)"	"unprognostic (5.91e-3)"	"unprognostic (5.04e-3)"	"unprognostic (7.21e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.60e-1)"	"unprognostic (3.12e-3)"	5.8	6.9	8.2	7.7	7.3	9.1	7.3	7.4	8.7	7.5	6.3	11.6	21.7	6.1	9.2	13.2	6.2	7.2	5.0	4.8	6.4	4.9	7.6	5.1	5.4	8.9	6.8	5.4	12.1	7.2	7.4	12.7	4.8	6.6	7.2	8.5	10.4	7.9	15.7	5.9	8.8	7.5	6.4	6.5	7.9	6.9	9.7	11.9	11.6	8.7	3.6	12.2	7.1	6.8	6.0	7.5	3.4	4.5	1.8	8.5	3.2	2.8	6.4	5.1	4.8	1.9	2.0	3.2	3.3	2.5	3.5	3.3	7.6	7.3	6.2	3.0	2.1	4.2	9.2	5.4	3.4	3.9	9.0	4.7	10.0	7.2	4.5	1.4	4.8	3.4	2.6	1.6	5.7	4.6	2.8	5.2	8.8	6.7	9.2	3.5	5.8	4.8	3.5	5.6	9.8	4.7	4.0	18.7	4.3	3.7	3.6	7.6	7.8	4.8	4.5	10.1	3.9	6.5	2.4	4.9	2.7	4.8	5.2	2.0	5.7	9.1	7.7	4.7	5.1	4.4	3.4	3.0	2.5	4.6	4.5	2.9	4.2	8.5	6.3	3.5	6.0	8.2	6.8	2.6	1.8	2.7	7.5	7.1	3.2	8.2	7.3	7.4	8.7	6.4	4.9	6.8	5.4	6.6	11.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	2.7	1.2	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0
ASNA1	"ARSA-I, GET3, TRC40"	ENSG00000198356	"ArsA arsenite transporter, ATP-binding, homolog 1 (bacterial)"	O43681	19	12737139-12748323	"Predicted intracellular proteins, Transporters"	Transport	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045951, HPA048087"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA		52000	Nucleoli	Nucleoplasm	"HPA045951: AB_2679511, HPA048087: AB_2680258"	"unprognostic (2.87e-1)"	"prognostic favorable (9.53e-4)"	"unprognostic (1.01e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.05e-2)"	"unprognostic (5.70e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.33e-2)"	"unprognostic (3.34e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.39e-2)"	"prognostic favorable (4.27e-5)"	"unprognostic (6.11e-2)"	"unprognostic (5.77e-2)"	"unprognostic (2.32e-3)"	"prognostic unfavorable (8.47e-4)"	22.3	33.9	32.3	23.1	32.8	35.1	22.2	28.2	51.9	23.5	27.2	26.1	23.6	24.7	24.8	30.3	33.3	30.7	28.9	48.0	30.5	27.9	46.9	28.5	21.2	26.6	29.2	26.5	24.2	30.3	23.8	25.2	32.0	27.3	21.8	18.3	30.9	26.7	21.5	35.7	28.9	24.7	21.3	24.5	26.5	24.2	30.9	18.5	25.8	40.7	28.0	23.5	28.7	20.6	12.5	27.1	16.0	26.9	9.3	20.2	19.4	33.6	27.8	14.9	32.1	29.7	18.3	18.4	17.5	24.2	34.0	26.8	21.7	16.8	15.5	27.4	22.7	39.0	18.1	20.6	23.4	16.3	23.8	32.3	13.4	21.0	24.6	31.8	19.8	26.1	21.1	20.6	27.4	16.3	22.0	24.0	18.4	16.6	21.1	26.5	75.3	26.1	15.9	37.7	21.7	52.4	19.4	23.2	30.3	31.7	28.8	27.7	23.5	23.7	31.9	28.0	13.3	26.3	19.1	20.4	48.1	16.3	53.2	40.6	38.0	63.9	14.3	33.7	32.4	26.4	16.0	26.9	15.0	16.1	20.4	13.7	12.5	14.4	14.2	27.1	10.6	10.4	12.8	9.6	9.3	23.7	17.8	20.2	19.4	32.3	32.8	28.2	51.9	30.5	27.9	29.2	26.5	27.3	18.5	3.0	6.5	44.7	52.5	61.4	33.5	7.4	66.2	9.4	5.7	52.4	15.7	89.1	112.7	135.7	88.0	42.9	87.6	46.7	116.1	66.8	58.1	46.3	34.5	24.5	125.2	27.0	53.9	36.8	50.0	143.9	44.5	54.1	77.6	138.9	56.6	59.9	93.6	94.7	53.0	177.7	23.1	32.3	54.5	52.9	128.0	69.5	92.6	59.8	57.4	54.0
BMS1	"BMS1L, KIAA0187"	ENSG00000165733	"BMS1, ribosome biogenesis factor"	Q14692	10	42782801-42834937	"Disease related genes, Predicted intracellular proteins"	"Ribosome biogenesis"		"Disease mutation, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036589, HPA043081"	Uncertain		Enhanced	"Nucleoplasm,Nucleoli,Mitotic chromosome"		Yes	No			"Nucleoplasm, Nucleoli, Mitotic chromosome"		"HPA036589: AB_10601460, HPA043081: AB_2678305"	"unprognostic (1.46e-2)"	"unprognostic (4.31e-1)"	"unprognostic (7.09e-2)"	"unprognostic (3.56e-2)"	"unprognostic (3.11e-2)"	"unprognostic (7.25e-3)"	"prognostic unfavorable (1.06e-6)"	"unprognostic (1.47e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.89e-2)"	"unprognostic (3.81e-3)"	"unprognostic (1.32e-2)"	"unprognostic (2.16e-3)"	"unprognostic (7.03e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.43e-1)"	"unprognostic (4.82e-2)"	17.8	15.3	10.4	15.8	19.7	17.4	16.2	22.5	20.6	15.5	12.9	13.7	11.2	11.8	23.1	13.4	17.8	14.0	10.0	14.4	10.8	13.3	17.8	16.8	14.1	17.2	12.6	15.4	17.5	16.2	24.7	28.0	15.3	22.8	14.1	15.4	12.3	18.8	14.0	29.9	18.1	13.8	14.7	15.0	18.3	13.5	14.8	13.4	20.7	14.0	17.2	19.2	14.4	15.9	9.8	8.4	3.4	9.1	6.2	11.6	5.6	16.8	14.4	14.0	15.9	10.6	8.8	13.6	14.2	15.0	16.8	14.5	19.8	13.3	9.0	10.1	12.2	9.4	14.8	22.8	18.3	22.1	13.1	16.0	12.0	11.2	16.8	9.2	32.4	11.4	7.9	9.4	18.1	17.6	9.4	12.7	10.5	21.0	9.7	11.9	14.2	18.0	10.7	17.7	11.7	15.3	16.6	14.7	9.6	9.3	14.9	10.7	11.4	12.3	13.8	11.7	15.3	16.7	9.4	15.3	7.9	28.3	15.7	23.0	7.8	9.6	26.3	11.5	24.0	6.0	3.4	5.1	2.9	8.6	9.1	10.2	9.8	10.6	9.3	8.4	7.4	11.6	10.0	0.7	6.2	7.4	4.4	7.5	5.6	10.4	19.7	22.5	20.6	10.8	13.3	12.6	15.4	22.8	13.4	29.8	24.9	24.6	24.5	20.4	21.0	41.4	22.9	68.3	44.3	22.7	9.8	24.5	18.3	25.0	12.0	26.4	7.9	0.0	30.5	25.1	21.9	17.4	20.9	17.1	17.5	20.6	16.1	23.9	18.6	8.1	21.9	21.0	32.1	41.5	10.4	11.4	29.2	7.0	15.6	23.2	25.6	19.4	20.3	35.2	53.5	22.2	20.8	20.0	16.8	36.0
BOP1	KIAA0124	ENSG00000261236	"Block of proliferation 1"	Q14137	8	144262102-144291370	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatogonia: 60.5"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 67.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047869, HPA066764"	Approved		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Nucleoli, Nucleoli rim"	"Nucleoplasm, Mitotic chromosome"	"HPA047869: AB_2680193, HPA066764: AB_2685716"	"unprognostic (6.92e-2)"	"unprognostic (5.03e-3)"	"unprognostic (6.78e-2)"	"unprognostic (2.06e-3)"	"unprognostic (3.32e-1)"	"unprognostic (2.16e-2)"	"prognostic unfavorable (3.35e-5)"	"unprognostic (2.25e-2)"	"unprognostic (4.14e-1)"	"unprognostic (3.31e-1)"	"unprognostic (2.26e-2)"	"unprognostic (7.00e-2)"	"prognostic unfavorable (2.23e-7)"	"unprognostic (7.83e-2)"	"unprognostic (4.33e-1)"	"unprognostic (8.49e-2)"	"unprognostic (4.06e-3)"	4.8	4.3	5.7	7.7	5.9	7.8	6.4	6.3	6.9	2.0	3.9	1.6	2.0	5.1	2.7	1.5	6.8	2.6	4.8	5.1	5.5		2.8	6.2	2.3	6.6	4.1	6.7	2.7	17.5	5.1	2.2	3.2	4.3	2.9	1.5	1.5	5.8	3.0	19.0	7.4	4.5	4.9	2.0	4.8	4.4	8.3	3.3	6.3	3.9	6.7	4.5	3.5	6.9	5.2	6.4	2.5	4.7	3.5	5.7	2.5	12.5	24.6	3.4	14.5	2.0	2.3	12.6	8.7	1.8	8.8	5.5	18.6	7.3	15.3	14.9	3.3	3.3	10.1	6.2	10.3	2.0	13.4	24.8	19.2	14.9	14.1	4.6	8.5	10.6	4.5	5.1	7.4	6.7	1.7	5.5	14.2	19.3	5.1	3.4	32.0	22.8	10.9	8.3	12.9	67.8	17.5	5.1	23.3	3.6	8.4	19.1	7.6	9.3	12.1	5.9	1.7	8.9	8.1	10.3	8.1	25.0	10.9	24.9	4.9	3.1	12.8	6.0	13.8	10.6	0.0	4.7	2.5	4.4	4.7	4.8	5.2	4.9	5.7	6.4	4.5	4.4	4.1	0.2	3.5	4.0	4.1	4.2	2.5											8.9	6.1	13.4	13.8	0.5	10.2	6.7	10.2	2.7	6.8	10.4	0.0	21.5	5.0	24.4	8.9	8.7	7.0	0.0	18.7	35.1	9.3	10.0	10.3	13.1	19.1	14.3	25.8	3.7	6.4	15.5	9.8	7.5	0.0	11.8	9.2	13.7	20.3	8.6	9.2	13.6	4.2	12.9	4.3	10.4	60.5	0.1	14.9	8.7	21.6	11.6
BRIX1	"BRIX, BXDC2, FLJ11100"	ENSG00000113460	"BRX1, biogenesis of ribosomes"	Q8TDN6	5	34915376-34925996	"Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039614			Enhanced	"Nucleoli,Mitotic chromosome"		Yes	No			"Nucleoli, Mitotic chromosome"		"HPA039614: AB_10963698"	"prognostic unfavorable (2.18e-4)"	"unprognostic (2.60e-1)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (1.10e-5)"	"unprognostic (1.82e-1)"	"unprognostic (5.85e-3)"	"prognostic unfavorable (4.11e-8)"	"unprognostic (3.37e-2)"	"unprognostic (3.84e-3)"	"prognostic favorable (6.34e-4)"	"unprognostic (1.24e-1)"	"unprognostic (2.54e-2)"	"prognostic unfavorable (3.07e-9)"	"unprognostic (1.95e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.09e-2)"	18.9	18.4	20.4	15.6	24.0	30.6	23.7	24.9	24.1	16.4	14.4	10.7	18.9	11.9	18.1	18.2	23.4	17.6	11.9	16.4	15.8	15.2	17.0	18.6	14.0	22.2	21.1	15.6	19.4	13.4	15.6	19.1	24.5	20.9	15.9	16.5	7.7	15.7	14.5	19.7	15.9	13.3	22.9	18.6	17.0	14.7	13.4	21.9	17.0	16.6	14.2	23.1	21.6	21.7	22.9	14.0	4.1	10.4	15.0	22.1	16.2	14.8	14.7	15.0	20.7	6.5	9.3	29.6	18.4	13.0	24.9	15.9	20.0	19.7	32.8	9.5	10.9	27.7	12.4	26.2	18.9	28.3	17.6	25.9	21.9	35.2	17.8	17.9	34.8	15.2	11.2	12.3	22.9	20.7	7.6	11.4	17.2	38.3	10.0	16.2	16.1	24.1	38.1	24.2	17.6	21.6	21.6	27.2	14.1	14.3	17.3	18.2	16.3	38.0	26.7	17.1	12.4	16.7	21.5	6.8	19.1	20.9	13.7	35.1	9.1	19.4	41.6	16.5	40.1	23.7	4.1	8.5	4.0	14.4	7.9	20.4	22.9	17.7	18.1	10.7	18.0	22.1	19.6	0.5	15.0	10.4	14.0	16.4	16.2	20.4	24.0	24.9	24.1	15.8	15.2	21.1	15.6	20.9	21.9	26.8	30.7	36.9	76.5	96.6	20.2	18.6	15.3	46.8	48.9	22.7	11.8	108.4	41.4	38.0	10.5	32.1	8.4	23.3	37.3	80.2	49.4	31.2	18.6	11.5	37.1	20.6	20.2	16.5	12.9	6.8	36.5	20.6	30.4	33.3	17.8	15.1	37.9	10.5	27.3	26.6	34.1	6.5	35.4	54.6	70.7	83.7	105.5	31.6	29.0	66.5
BYSL	Enp1	ENSG00000112578	"Bystin like"	Q13895	6	41921188-41933046	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031217, HPA031219"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Nucleoli, Nucleoli rim, Mitotic chromosome"	Nucleoplasm	"HPA031217: AB_10599488, HPA031219: AB_10601989"	"unprognostic (6.12e-3)"	"unprognostic (6.97e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.33e-3)"	"unprognostic (4.38e-2)"	"unprognostic (2.73e-3)"	"prognostic unfavorable (6.43e-4)"	"unprognostic (2.09e-2)"	"unprognostic (2.51e-1)"	"unprognostic (6.38e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (2.15e-8)"	"unprognostic (4.39e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.79e-3)"	"unprognostic (5.99e-2)"	11.5	13.4	6.0	11.5	7.2	6.0	17.5	5.0	8.9	7.8	7.9	4.6	5.3	4.0	11.0	5.4	11.7	9.3	10.0	17.6	5.9	6.8	8.0	18.6	7.1	7.4	5.8	6.5	11.8	15.9	10.6	5.4	11.3	7.4	8.0	6.8	4.8	9.6	7.9	31.7	9.2	5.0	12.6	6.3	9.9	7.3	8.9	4.6	20.1	7.1	11.9	12.9	7.3	10.1	4.0	9.3	0.9	3.4	4.5	5.5	2.2	11.9	14.8	8.2	11.6	6.1	6.9	16.8	12.2	6.4	19.3	14.1	20.4	3.1	22.0	11.1	9.1	13.2	7.9	24.9	17.8	15.2	7.9	27.1	20.5	10.4	22.9	10.6	14.6	9.0	8.9	11.6	18.0	16.4	4.2	13.2	12.9	26.0	4.9	12.7	20.4	15.3	14.7	6.4	37.3	15.6	18.3	11.2	14.0	10.7	10.2	16.5	10.0	8.1	7.4	14.2	6.6	8.6	12.9	10.2	11.2	13.3	7.6	17.7	5.7	7.4	47.6	3.8	14.8	11.7	0.0	3.4	0.9	3.9	3.4	5.5	3.8	2.5	3.1	5.4	4.0	1.3	3.0	0.3	4.5	3.1	9.3	3.1	2.2	6.0	7.2	5.0	8.9	5.9	6.8	5.8	6.5	7.4	4.6	0.0	3.8	8.9	21.5	27.5	2.5	2.5	5.1	4.0	5.7	1.8	3.9	19.5	3.3	20.9	6.2	7.1	1.4	0.0	14.8	19.5	10.6	9.6	2.3	6.6	10.6	0.0	5.2	4.3	1.0	3.4	7.5	5.3	8.5	7.2	5.5	3.4	18.6	0.0	6.7	8.4	2.8	6.5	17.3	6.5	26.9	22.1	24.4	5.0	9.9	23.5
C12orf43	FLJ12448	ENSG00000157895	"Chromosome 12 open reading frame 43"	Q96C57	12	121000486-121016502	"Predicted intracellular proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046148, HPA061739"	Uncertain		Supported	"Nucleoli,Golgi apparatus"		NA	NA			Nucleoli	"Golgi apparatus"	"HPA046148: AB_10965169, HPA061739: AB_2684597"	"unprognostic (1.51e-1)"	"unprognostic (5.75e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.24e-2)"	"prognostic unfavorable (1.29e-6)"	"prognostic unfavorable (6.44e-4)"	"unprognostic (3.53e-1)"	"unprognostic (5.02e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.45e-3)"	"unprognostic (9.70e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.36e-1)"	10.0	8.6	12.1	7.5	12.9	7.5	8.7	15.2	19.6	7.4	10.2	8.5	3.1	5.7	11.4	5.3	7.2	11.2	5.8	8.7	8.4	8.5	7.2	12.0	7.8	9.2	8.3	11.1	14.3	8.8	9.3	6.8	8.3	13.1	7.3	6.4	8.0	10.0	8.0	7.2	6.4	5.8	10.0	7.1	7.3	7.2	7.1	6.7	7.5	7.6	4.0	8.4	9.6	6.9	16.2	10.7	5.8	13.7	11.0	19.9	13.4	9.8	22.3	11.7	9.1	10.4	8.2	12.9	12.2	12.6	20.6	13.0	16.0	9.3	18.3	12.6	11.8	10.9	11.2	13.7	18.7	12.4	21.9	15.3	14.6	9.5	11.8	12.3	19.3	11.8	9.6	9.9	18.9	12.0	13.1	11.8	19.3	17.3	4.9	10.8	16.2	21.1	15.2	20.8	7.7	16.7	19.0	13.8	13.8	12.6	14.8	16.0	10.2	16.4	7.2	13.2	10.2	19.4	9.1	11.2	11.4	13.7	9.2	12.8	8.9	12.8	14.3	15.0	11.6	16.8	3.7	10.3	5.8	16.9	13.7	15.4	16.2	16.7	16.4	10.7	13.0	19.9	16.9	1.6	11.0	11.4	8.6	15.1	13.4	12.1	12.9	15.2	19.6	8.4	8.5	8.3	11.1	13.1	6.7	23.8	17.8	18.3	14.4	7.8	17.3	5.9	7.6	22.7	7.9	17.4	19.6	19.3	19.9	13.9	4.8	14.4	4.9	0.0	15.9	18.1	10.8	10.6	13.9	10.2	14.6	15.9	2.4	11.1	11.0	8.2	12.7	8.1	13.5	25.2	7.7	15.4	13.1	8.6	12.0	12.9	13.6	19.4	14.4	12.6	12.8	6.8	11.4	16.6	9.5	10.6
C8orf59		ENSG00000176731	"Chromosome 8 open reading frame 59"	Q8N0T1	8	85214076-85220421	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA044805, HPA071903"			Enhanced	Nucleoplasm,Nucleoli,Cytosol		No	No			"Nucleoplasm, Nucleoli"	Cytosol	"HPA044805: AB_2679095, HPA071903: AB_2686469"	"unprognostic (1.61e-2)"	"unprognostic (2.98e-1)"	"unprognostic (4.51e-1)"	"unprognostic (1.63e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.22e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.82e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.03e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.84e-3)"	28.1	28.2	25.3	25.3	21.9	33.0	46.1	18.9	26.5	33.0	38.4	12.6	36.3	28.1	32.0	45.5	44.8	28.7	25.8	41.5	20.6	24.1	32.3	47.1	20.8	30.7	26.3	27.2	45.1	35.1	19.5	36.0	27.7	24.4	35.5	27.7	14.7	37.8	36.2	43.9	24.8	37.1	33.7	27.0	32.2	36.9	16.7	25.7	39.1	43.5	53.6	32.0	39.1	35.2	33.3	42.7	21.3	25.3	36.5	38.0	23.9	38.9	19.9	29.6	19.2	18.4	35.7	23.2	26.0	25.0	30.4	30.0	23.2	33.8	9.7	21.5	17.2	28.5	27.2	20.5	28.5	34.3	27.4	22.4	57.6	18.8	34.2	21.8	21.6	26.1	30.2	33.9	19.6	24.8	33.1	25.8	35.0	25.8	24.0	25.2	30.7	47.7	40.6	8.5	88.2	34.8	20.4	24.8	44.2	29.5	25.0	10.0	21.5	19.7	32.4	35.7	37.3	37.3	32.3	19.7	19.4	40.7	21.5	24.6	27.9	32.7	45.8	38.7	27.7	21.5	21.3	20.5	13.4	24.7	25.3	29.5	33.3	32.7	30.1	34.8	29.9	38.0	36.3	5.1	36.5	21.5	42.7	32.1	23.9	25.3	21.9	18.9	26.5	20.6	24.1	26.3	27.2	24.4	25.7	80.4	65.2	124.2	47.1	48.2	25.9	26.3	86.6	147.2	103.5	34.9	9.8	86.5	56.3	152.0	93.6	67.1	76.6	46.7	240.4	102.1	84.3	40.2	75.1	136.0	90.6	22.3	36.9	108.6	132.2	20.6	173.2	92.3	54.0	180.3	112.7	58.4	213.9	84.2	122.0	90.6	33.5	155.2	88.6	128.1	91.8	40.0	64.3	104.7	101.8	39.3
CCDC137	MGC16597	ENSG00000185298	"Coiled-coil domain containing 137"	Q6PK04	17	81666364-81673904	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052637, HPA053914"	Uncertain		Enhanced	"Nucleoli,Mitotic chromosome"		Yes	No			"Nucleoli, Mitotic chromosome"		"HPA052637: AB_2681894, HPA053914: AB_2682306"	"unprognostic (3.04e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.24e-1)"	"prognostic unfavorable (1.35e-7)"	"prognostic unfavorable (8.32e-4)"	"unprognostic (2.21e-2)"	"unprognostic (8.33e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (1.16e-7)"	"unprognostic (4.26e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.93e-1)"	"unprognostic (1.39e-1)"	11.3	10.9	10.9	16.0	14.1	20.2	10.2	11.3	17.0	10.3	11.5	8.0	8.9	16.2	9.1	6.4	25.2	9.2	9.1	9.1	12.1	9.0	10.6	12.1	8.7	18.8	12.4	11.9	8.4	12.0	9.4	8.4	11.2	11.8	13.1	6.4	5.7	13.0	9.9	12.7	29.8	11.8	10.3	9.1	17.7	11.4	13.4	12.4	9.8	9.2	13.1	16.6	10.6	14.7	12.8	12.6	10.2	9.2	11.9	11.2	5.9	12.4	24.7	6.7	12.0	4.9	4.9	13.5	14.3	6.8	20.6	11.4	21.8	7.5	12.9	7.6	8.5	11.6	16.4	13.9	16.1	7.7	6.6	21.4	20.0	11.0	17.3	7.5	15.3	13.1	7.2	8.7	18.9	8.5	4.5	14.5	14.0	19.0	6.9	9.6	13.6	15.2	16.6	16.1	9.5	25.0	18.2	12.7	8.3	6.5	11.4	16.5	21.3	13.1	27.0	11.7	7.9	19.5	12.7	9.9	29.8	17.4	11.9	19.7	18.2	10.5	13.0	10.7	15.0	16.9	1.9	7.8	10.2	11.2	8.4	7.0	10.3	9.7	9.6	7.4	12.8	10.7	9.6	3.5	11.9	9.2	12.6	9.5	5.9	10.9	14.1	11.3	17.0	12.1	9.0	12.4	11.9	11.8	12.4	20.8	13.4	25.0	19.6	28.2	5.7	6.2	10.2	26.8	25.0	12.2	2.0	19.0	16.6	24.5	1.0	19.6	12.7	23.3	18.6	32.2	11.4	18.3	18.5	10.9	21.5	17.5	6.9	14.1	11.0	0.9	12.7	18.2	15.1	33.3	13.4	12.9	26.4	13.6	12.7	10.2	7.1	6.5	15.6	31.2	46.5	30.1	17.4	29.9	17.0	18.6
CCDC86	MGC2574	ENSG00000110104	"Coiled-coil domain containing 86"	Q9H6F5	11	60842071-60851081	"Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"parathyroid gland: 200.8"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041117, HPA041540"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Nucleoli, Nucleoli rim, Mitotic chromosome"	Nucleoplasm	"HPA041117: AB_10794984, HPA041540: AB_10794299"	"unprognostic (2.93e-1)"	"unprognostic (6.59e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.47e-3)"	"unprognostic (3.64e-1)"	"prognostic unfavorable (7.36e-5)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (1.65e-3)"	"unprognostic (9.52e-2)"	"unprognostic (1.25e-2)"	"unprognostic (6.12e-2)"	"unprognostic (4.47e-1)"	"unprognostic (3.76e-2)"	"unprognostic (7.54e-3)"	"unprognostic (2.90e-1)"	"unprognostic (2.16e-1)"	"unprognostic (6.25e-2)"	13.5	12.4	7.3	8.6	11.0	6.1	11.2	3.3	11.2	5.8	6.7	7.9	3.4	7.4	8.4	5.0	9.3	7.4	8.3	9.3	6.7	6.4	8.1	11.4	5.4	8.2	10.0	6.0	11.3	13.6	200.8	12.7	7.3	8.5	11.9	4.7	6.7	6.4	6.2	20.2	10.4	6.2	7.3	6.7	9.3	7.7	47.8	8.7	10.2	7.9	12.6	6.5	8.6	6.5	6.9	20.0	5.0	19.5	4.2	8.5	6.7	21.0	28.7	7.1	20.5	5.8	9.6	9.7	14.2	11.1	26.1	14.0	24.4	14.2	25.8	27.2	7.7	18.6	19.8	24.0	17.1	12.0	9.1	26.6	13.1	12.7	34.0	19.2	20.5	22.5	10.9	13.0	24.1	15.3	3.8	19.3	14.2	41.9	13.3	12.7	24.9	30.8	31.3	28.7	12.5	41.3	21.0	10.7	64.9	9.1	9.0	16.1	10.4	9.1	21.1	16.6	4.7	21.3	8.2	12.6	26.0	16.0	35.3	30.7	11.2	16.5	27.9	21.3	22.2	31.4	2.6	9.1	5.0	6.5	19.5	6.9	6.9	6.9	6.0	20.0	6.5	8.5	7.4	0.7	4.2	6.3	11.2	6.2	6.7	7.3	11.0	3.3	11.2	6.7	6.4	10.0	6.0	8.5	8.7	0.0	2.1	3.0	15.4	32.7	9.3	0.4	2.5	0.0	4.5	1.8	7.9	15.9	6.6	20.4	19.7	6.8	2.6	0.0	10.4	14.1	9.5	18.2	4.7	2.4	16.0	3.2	6.9	3.7	2.8	10.6	10.6	7.9	15.1	4.6	4.9	3.6	13.7	3.5	5.6	5.4	7.9	19.4	20.2	37.1	19.1	27.0	6.9	6.1	9.7	15.5
CDV3	H41	ENSG00000091527	"CDV3 homolog"	Q9UKY7	3	133573730-133590261	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Late spermatids: 485.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 153.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029761, HPA029762, HPA029763"	Enhanced		Enhanced	"Nucleoli,Plasma membrane,Cytosol"		NA	NA		220000	Cytosol	"Nucleoli, Plasma membrane"	"HPA029761: AB_10600193, HPA029762: AB_10611247, HPA029763: AB_10601679"	"unprognostic (1.17e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.06e-2)"	"unprognostic (4.56e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (5.21e-6)"	"unprognostic (1.20e-1)"	"unprognostic (3.30e-1)"	"unprognostic (8.45e-3)"	"unprognostic (3.29e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.36e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.48e-2)"	"unprognostic (9.87e-2)"	"unprognostic (7.59e-3)"	46.4	26.5	20.7	45.7	22.4	44.9	38.1	13.2	22.3	25.6	29.5	20.2	16.2	18.5	27.0	26.1	34.1	22.0	25.4	50.5	19.0	18.3	26.2	40.2	34.3	47.6	22.5	20.6	32.8	34.4	25.6	22.5	34.8	24.4	24.6	23.9	18.7	24.6	16.7	106.6	23.1	27.7	33.1	25.4	56.6	31.4	38.2	21.5	61.1	33.9	32.5	52.1	43.8	37.2	10.6	14.2	14.7	11.1	5.3	20.8	4.5	50.8	11.8	20.9	13.8	24.2	29.9	24.8	28.1	36.6	28.2	28.0	29.3	20.5	65.0	42.7	31.4	32.6	22.0	29.9	28.1	52.8	41.5	11.3	38.4	13.0	17.9	37.7	42.7	24.7	28.3	29.5	25.1	67.9	20.0	35.5	19.3	27.6	43.7	40.7	14.6	34.9	24.7	21.1	22.1	15.2	21.3	27.8	52.1	29.6	20.7	16.6	12.5	26.7	19.9	33.4	31.3	64.3	26.2	43.9	30.1	28.4	23.8	27.8	63.8	47.8	153.1	16.8	25.9	17.4	11.5	9.6	14.7	12.2	10.7	12.8	10.6	11.7	12.4	8.5	6.5	9.4	14.4	8.7	5.3	11.1	14.2	20.8	4.5	20.7	22.4	13.2	22.3	19.0	18.3	22.5	20.6	24.4	21.5	53.6	71.1	101.7	142.6	129.7	20.9	78.7	53.5	28.1	42.1	80.3	9.8	43.1	31.5	38.9	281.1	76.6	64.9	0.0	75.3	62.7	68.5	184.4	43.9	86.4	99.8	22.3	45.3	81.0	95.3	485.8	31.7	84.0	52.3	32.5	44.7	88.5	74.6	39.3	33.6	39.1	27.1	25.8	54.6	20.4	24.7	112.0	29.4	62.3	47.8	220.3
CUTC	CGI-32	ENSG00000119929	"CutC copper transporter"	Q9NTM9	10	99702558-99756134	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 122.1"	"Cell type enhanced"	"Detected in many"	6	"Spermatocytes: 105.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038619, HPA058231"	Enhanced		Enhanced	Nucleoplasm,Nucleoli,Cytosol		No	No			"Nucleoplasm, Cytosol"	Nucleoli	"HPA038619: AB_10672649, HPA058231: "	"unprognostic (1.25e-2)"	"unprognostic (5.92e-2)"	"unprognostic (2.70e-1)"	"unprognostic (8.66e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.55e-3)"	"unprognostic (8.67e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (3.81e-7)"	"unprognostic (1.00e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.97e-1)"	11.6	4.9	5.7	9.8	8.7	7.9	9.8	3.5	6.5	5.3	5.9	7.2	3.5	4.4	4.9	8.0	6.2	5.1	5.8	13.2	5.9	4.7	5.3	11.0	5.1	7.9	8.6	6.6	4.6	4.5	3.5	3.6	4.5	5.5	6.0	6.4	6.9	5.7	5.4	122.1	5.8	6.2	11.6	7.4	9.2	6.0	14.1	8.3	9.2	4.3	25.1	7.3	13.5	11.4	32.8	24.2	47.1	19.4	25.5	36.3	19.3	9.5	20.5	7.2	21.9	26.8	12.3	3.9	7.8	10.1	7.9	8.9	9.4	7.3	34.7	7.0	13.3	3.9	8.2	14.7	13.0	8.8	10.2	14.0	11.5	9.2	14.8	12.4	21.3	5.6	12.7	8.1	12.6	26.2	9.8	13.5	20.2	10.1	7.7	5.9	6.6	19.1	22.0	7.2	9.7	7.7	13.0	8.5	13.3	8.3	3.9	2.4	5.4	3.6	5.7	9.8	10.4	9.1	12.2	7.5	3.3	4.4	3.6	10.3	12.7	16.5	24.3	10.8	45.8	2.9	26.5	19.4	47.1	27.2	15.2	28.3	32.8	25.9	25.9	21.0	29.0	36.3	27.8	30.8	25.5	18.5	24.2	24.7	19.3	5.7	8.7	3.5	6.5	5.9	4.7	8.6	6.6	5.5	8.3	8.9	12.2	21.9	13.0	10.8	16.5	35.8	10.2	20.1	10.3	5.2	7.9	15.9	18.3	14.6	8.1	21.5	4.9	0.0	15.0	10.7	15.3	11.4	30.0	20.2	18.3	11.1	11.6	22.7	17.8	6.8	12.0	15.9	28.7	27.9	7.8	17.8	10.1	10.1	15.2	24.5	27.1	19.4	15.6	105.8	35.1	9.5	11.3	20.1	9.7	10.7
DDX18	"Has1, MrDb"	ENSG00000088205	"DEAD-box helicase 18"	Q9NVP1	2	117814650-117832379	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 90.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035400, HPA041056"	Approved		Enhanced	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Nucleoli, Nucleoli rim, Mitotic chromosome"		"HPA035400: AB_10672091, HPA041056: AB_2677277"	"unprognostic (1.44e-1)"	"unprognostic (2.22e-2)"	"unprognostic (5.63e-2)"	"prognostic unfavorable (2.64e-4)"	"unprognostic (2.06e-1)"	"unprognostic (1.77e-3)"	"prognostic unfavorable (3.07e-4)"	"unprognostic (8.80e-2)"	"unprognostic (1.66e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.42e-2)"	"unprognostic (4.94e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.53e-1)"	"unprognostic (7.28e-2)"	"unprognostic (5.65e-2)"	35.3	21.3	20.5	28.7	26.0	17.4	31.2	27.1	25.6	31.2	27.9	16.7	21.6	20.9	32.0	22.9	27.8	28.5	21.3	22.9	19.6	19.1	32.0	40.3	24.1	35.0	25.5	22.9	36.3	29.5	21.0	25.9	25.0	25.0	25.0	30.3	11.5	24.2	26.6	37.0	24.9	26.3	28.3	30.8	46.5	26.2	22.9	31.1	40.7	31.3	23.9	37.6	37.6	23.7	22.2	20.5	9.4	18.5	17.2	23.6	16.3	22.0	10.0	15.0	13.5	8.9	8.0	24.8	13.1	10.4	18.1	16.0	24.6	14.6	32.5	21.5	10.8	16.8	17.1	29.0	16.9	26.8	16.5	20.3	31.0	9.4	24.7	12.4	41.4	16.2	8.3	15.7	23.0	23.3	9.2	10.8	16.9	33.8	14.1	13.8	13.7	22.6	21.6	37.6	18.7	15.2	19.7	23.4	28.4	12.0	13.1	14.4	24.5	15.2	16.8	17.0	15.9	10.6	22.9	8.3	16.2	23.9	11.4	23.5	16.3	20.2	90.0	11.9	19.6	7.2	6.2	13.8	9.4	16.2	17.3	20.6	22.2	19.3	18.5	12.5	19.1	23.6	20.7	3.6	17.2	18.5	20.5	15.0	16.3	20.5	26.0	27.1	25.6	19.6	19.1	25.5	22.9	25.0	31.1	89.3	53.4	123.6	65.7	171.3	131.1	44.8	122.3	89.7	94.4	115.1	78.5	95.4	99.5	87.4	10.8	105.7	49.3	23.3	99.4	101.8	89.3	52.4	108.5	162.0	78.1	77.9	54.6	103.7	79.2	10.1	98.7	99.7	87.7	93.8	85.3	76.8	106.8	59.6	97.6	93.5	118.7	64.7	108.2	111.4	127.7	140.4	74.3	107.1	93.0	50.8
DDX50	"GU2, GUB, MGC3199, RH-II/GuB"	ENSG00000107625	"DExD-box helicase 50"	Q9BQ39	10	68901278-68946847	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037388, HPA037389, HPA058196"	Approved		Enhanced	Nucleoli		NA	NA			Nucleoli		"HPA037388: AB_10671752, HPA037389: AB_2675450, HPA058196: AB_2683635"	"unprognostic (2.05e-1)"	"unprognostic (3.36e-1)"	"unprognostic (9.90e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.47e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.97e-1)"	"unprognostic (8.78e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.22e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.38e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.02e-1)"	25.0	17.8	16.7	25.5	19.2	14.7	24.8	20.8	17.0	26.5	25.3	13.1	24.0	12.9	30.0	22.6	24.0	23.0	17.5	20.3	15.7	15.0	18.6	16.1	16.4	24.5	17.6	15.0	35.3	24.1	24.9	35.2	23.0	16.1	30.0	18.1	12.6	19.5	25.0	26.6	18.3	17.4	31.9	18.3	22.0	19.9	25.6	17.3	33.0	26.1	21.5	25.7	35.4	27.2	14.2	10.3	10.7	12.2	13.8	20.2	10.9	19.3	12.5	22.2	27.5	18.9	24.8	14.2	20.7	22.8	18.7	17.7	28.0	16.9	25.2	12.5	18.2	11.7	17.4	21.5	15.2	23.5	22.1	16.3	13.5	12.4	12.2	19.1	28.1	16.9	19.0	15.9	17.8	49.8	33.6	15.0	22.0	24.1	15.4	23.0	15.5	26.9	27.0	12.9	18.6	28.1	23.3	25.3	4.6	14.7	11.6	15.5	21.4	15.2	17.8	22.8	21.6	20.7	18.3	13.0	14.6	17.1	16.5	28.1	20.9	18.8	21.4	15.7	29.4	8.5	5.5	7.8	10.7	15.0	12.2	18.3	13.6	18.5	15.4	10.3	14.2	20.2	17.7	2.7	13.8	9.6	10.2	16.1	10.9	16.7	19.2	20.8	17.0	15.7	15.0	17.6	15.0	16.1	17.3	17.9	17.1	30.4	30.5	10.5	42.7	23.6	20.4	29.4	34.2	19.2	37.3	35.2	48.0	24.1	57.6	24.3	8.9	0.0	21.8	33.0	25.7	18.5	40.6	13.5	20.5	35.0	15.5	22.1	18.1	12.1	33.6	21.7	11.8	39.7	18.2	20.9	20.8	18.4	36.7	25.1	51.1	19.4	28.1	54.0	56.0	12.5	34.4	41.5	21.3	16.8
DDX55	KIAA1595	ENSG00000111364	"DEAD-box helicase 55"	Q8NHQ9	12	123602077-123620941	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039962, HPA044101"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA039962: AB_2676774, HPA044101: AB_2678810"	"unprognostic (1.14e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (2.11e-9)"	"unprognostic (1.60e-1)"	"unprognostic (4.49e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.67e-3)"	"prognostic unfavorable (8.97e-12)"	"unprognostic (9.15e-3)"	"unprognostic (2.94e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.23e-3)"	15.0	13.5	12.3	16.4	14.0	27.7	16.3	21.4	13.9	13.0	13.2	15.7	16.2	12.0	14.7	13.2	14.2	15.0	11.8	8.8	11.4	10.9	10.2	17.8	11.2	19.9	15.6	10.3	17.5	25.9	13.8	20.3	12.3	14.4	14.4	14.5	11.9	15.2	12.6	12.6	21.4	12.9	11.9	10.5	18.8	11.6	11.2	14.8	16.9	12.2	12.5	16.5	11.9	23.1	13.4	12.8	7.3	10.0	12.2	15.7	8.5	10.1	14.5	11.1	11.2	9.6	7.6	16.8	12.6	4.6	11.3	7.8	16.4	7.5	15.1	10.1	5.5	10.2	12.6	16.9	9.4	13.2	11.3	15.3	20.4	16.0	12.1	7.3	25.0	16.1	6.4	10.0	13.4	15.5	8.8	8.1	12.3	20.8	8.0	7.9	10.5	24.5	34.1	17.2	11.8	14.4	18.5	11.9	9.8	7.9	17.7	13.2	11.0	10.3	13.4	17.2	9.7	23.8	16.2	8.3	9.8	12.9	15.9	15.6	14.8	18.3	27.4	9.3	18.0	16.6	2.8	9.2	7.3	12.0	10.0	12.7	13.4	11.6	12.5	7.5	11.3	15.7	14.7	5.6	12.2	5.9	12.8	9.1	8.5	12.3	14.0	21.4	13.9	11.4	10.9	15.6	10.3	14.4	14.8	20.8	11.5	9.0	8.3	9.7	18.5	2.2	7.6	13.4	10.3	7.0	21.6	11.2	6.6	9.6	42.5	10.5	5.1	46.7	10.4	13.9	10.1	8.4	24.3	8.5	12.6	14.3	6.9	6.2	6.6	50.7	15.8	7.9	6.8	4.6	10.5	15.6	11.6	7.0	13.8	5.4	25.4	6.5	8.5	17.9	19.6	14.8	6.4	10.2	8.3	7.8
DNTTIP2	"ERBP, HSU15552, TdIF2"	ENSG00000067334	"Deoxynucleotidyltransferase terminal interacting protein 2"	Q5QJE6	1	93866283-93879918	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044502, HPA053707"	Supported		Enhanced	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Nucleoli, Nucleoli rim, Mitotic chromosome"		"HPA044502: AB_10960277, HPA053707: AB_2682236"	"unprognostic (2.95e-3)"	"unprognostic (3.84e-2)"	"unprognostic (6.21e-3)"	"unprognostic (1.12e-2)"	"unprognostic (2.41e-1)"	"unprognostic (8.92e-2)"	"prognostic unfavorable (1.90e-6)"	"unprognostic (7.94e-2)"	"unprognostic (5.57e-3)"	"unprognostic (2.69e-2)"	"unprognostic (2.02e-3)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (7.80e-5)"	"unprognostic (2.59e-1)"	"unprognostic (8.41e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.06e-2)"	14.0	8.5	10.7	7.3	11.4	27.6	10.9	12.0	12.5	12.4	9.4	5.8	7.9	6.1	9.4	14.1	15.1	9.7	9.7	11.4	9.4	10.3	14.5	15.1	12.1	10.7	10.4	10.5	15.9	8.3	9.9	12.1	15.5	17.7	13.0	8.1	4.6	9.0	7.3	24.6	11.7	11.7	11.0	13.2	16.2	9.0	12.0	10.9	15.9	16.2	12.6	10.7	17.3	15.5	11.1	7.2	15.8	11.6	11.9	11.6	8.0	12.4	6.0	6.8	7.1	6.5	5.8	10.3	8.4	6.0	10.1	8.7	6.6	5.6	16.7	11.3	8.8	12.7	7.1	10.8	10.1	14.4	10.1	6.1	13.7	9.9	9.6	6.8	15.3	4.9	6.4	11.0	10.8	9.1	5.1	7.2	5.5	16.1	5.8	13.7	5.4	10.7	10.0	13.0	5.6	9.7	6.2	14.4	6.4	10.3	9.7	8.1	7.3	8.8	13.2	9.2	9.0	5.7	11.1	6.8	8.2	8.6	9.4	14.1	6.1	8.1	13.7	4.8	12.1	5.4	10.9	7.9	15.8	9.6	11.6	11.6	11.1	8.9	8.7	7.2	10.5	8.2	10.4	12.1	11.9	10.7	5.0	8.8	8.0	10.7	11.4	12.0	12.5	9.4	10.3	10.4	10.5	17.7	10.9	53.6	74.1	43.3	98.3	48.3	31.6	69.0	10.2	117.8	117.2	12.2	55.0	44.4	18.3	60.2	28.9	60.6	13.1	23.3	52.7	36.6	31.7	61.4	112.5	16.6	33.8	19.1	8.1	20.9	24.1	7.4	23.9	59.5	21.9	64.1	12.1	30.7	68.6	15.3	24.4	14.7	29.6	19.4	106.0	54.0	70.5	44.3	46.7	46.5	19.7	80.3
DPH6	"ATPBD4, MGC14798"	ENSG00000134146	"Diphthamine biosynthesis 6"	Q7L8W6	15	35217345-35546193	"Enzymes, Predicted intracellular proteins"		Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042976, HPA055496"	Approved		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA042976: AB_10964890, HPA055496: AB_2682835"	"unprognostic (9.78e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.60e-1)"	"unprognostic (9.94e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.49e-3)"	"unprognostic (7.92e-3)"	"unprognostic (1.13e-1)"	"unprognostic (4.65e-6)"	"unprognostic (9.70e-2)"	"unprognostic (5.61e-2)"	"unprognostic (2.18e-2)"	"unprognostic (7.44e-2)"	13.3	12.7	8.0	6.8	16.1	6.4	15.3	11.6	15.8	14.7	9.2	15.5	10.8	8.5	23.9	17.1	14.7	11.5	10.5	14.4	7.8	7.2	14.7	11.2	8.7	9.3	9.7	12.0	16.7	19.5	15.8	31.7	11.1	13.4	8.5	10.2	14.6	11.5	14.7	24.9	15.2	8.7	16.8	11.1	8.3	9.6	11.3	10.6	7.1	15.3	16.5	10.0	11.0	11.3	8.4	6.3	0.3	6.5	13.2	10.8	4.4	10.5	5.7	9.6	8.1	1.7	7.9	9.4	4.0	7.0	9.7	5.1	7.6	9.9	3.3	9.8	3.7	11.8	12.2	11.1	11.5	11.6	2.6	7.0	12.3	6.5	12.0	10.3	6.5	8.0	6.6	14.6	3.9	18.9	6.0	9.3	7.1	13.5	13.4	8.9	4.1	8.0	6.1	8.5	16.1	5.3	10.0	9.0	4.5	8.4	13.5	7.0	6.9	7.5	8.4	6.4	5.9	29.0	9.1	2.8	9.5	9.2	9.4	6.3	12.0	19.0	8.3	8.2	11.3	9.0	0.0	6.5	0.3	6.2	6.0	7.7	8.4	8.3	8.6	6.3	6.5	10.8	9.5	0.3	13.2	5.6	5.4	5.4	4.4	8.0	16.1	11.6	15.8	7.8	7.2	9.7	12.0	13.4	10.6	14.9	6.9	12.6	16.6	27.5	31.5	11.0	17.8	5.3	17.0	8.7	37.3	22.9	11.6	12.0	2.1	9.5	10.1	23.3	21.1	18.8	11.6	7.6	3.5	7.3	15.0	17.5	5.2	6.7	10.0	1.6	13.0	10.9	15.1	15.4	6.0	16.6	15.1	7.0	6.3	16.4	22.2	0.0	11.3	8.3	15.1	20.3	18.9	5.0	9.2	11.1
EBNA1BP2	"EBP2, NOBP, P40"	ENSG00000117395	"EBNA1 binding protein 2"	Q99848	1	43164175-43270936	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026512, HPA028277"	Approved		Enhanced	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Nucleoli, Nucleoli rim"	"Mitotic chromosome"	"HPA026512: AB_1847954, HPA028277: AB_10603664"	"unprognostic (9.30e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.05e-3)"	"unprognostic (2.03e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (4.22e-4)"	"unprognostic (7.64e-3)"	"unprognostic (2.89e-2)"	"unprognostic (1.24e-3)"	"unprognostic (7.11e-2)"	"unprognostic (1.64e-3)"	"unprognostic (4.10e-3)"	"unprognostic (3.04e-3)"	"unprognostic (1.69e-1)"	"unprognostic (3.22e-2)"	"unprognostic (1.33e-2)"	18.9	24.8	30.2	22.8	41.1	19.3	27.6	17.7	35.7	18.1	23.6	19.0	15.6	15.4	22.4	40.6	27.8	30.4	15.6	24.9	26.3	25.2	34.0	66.0	18.5	21.9	25.1	29.8	21.8	30.7	24.5	30.0	26.0	29.2	20.3	26.0	16.6	22.3	22.3	28.4	22.8	16.9	24.3	21.6	18.4	19.7	24.8	27.4	18.2	28.8	31.3	25.8	21.5	19.8	26.9	29.6	10.2	22.8	24.1	25.1	17.8	61.7	36.1	13.5	39.1	10.9	12.3	28.0	43.1	21.6	68.9	43.4	40.3	38.6	41.1	34.2	31.3	32.5	44.0	29.2	39.9	75.4	19.4	28.8	28.0	32.5	35.4	19.8	48.5	21.6	9.8	40.4	50.6	41.0	13.2	37.7	28.3	42.3	13.9	33.5	34.0	36.8	29.0	58.7	41.5	33.5	27.0	30.7	46.3	25.3	27.0	26.9	28.9	24.9	46.6	43.2	22.9	19.1	26.5	29.0	26.7	50.3	42.6	70.0	20.6	40.6	50.8	22.1	50.3	53.6	7.5	20.1	10.2	24.0	22.8	25.1	26.9	24.5	24.9	29.6	26.7	22.8	22.8	1.8	24.1	21.6	28.3	24.6	17.8	30.2	41.1	17.7	35.7	26.3	25.2	25.1	29.8	29.2	27.4	32.8	33.2	26.8	68.9	109.3	25.1	28.5	56.0	87.0	48.9	29.6	5.9	95.0	76.3	100.0	109.6	36.8	23.0	70.0	107.4	112.0	52.9	58.1	49.7	127.1	57.6	14.3	23.2	32.5	23.4	70.9	30.8	30.6	52.3	54.1	37.8	44.2	101.2	11.5	36.0	100.9	22.3	38.8	54.7	79.6	103.6	86.9	70.5	23.5	59.7	77.3
EXOSC5	"hRrp46p, MGC12901, p12B, RRP41B, RRP46, Rrp46p"	ENSG00000077348	"Exosome component 5"	Q9NQT4	19	41386374-41397479	"Predicted intracellular proteins"	"rRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Extravillous trophoblasts: 115.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053150, HPA055677"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA053150: AB_2682058, HPA055677: AB_2682882"	"unprognostic (1.24e-1)"	"unprognostic (5.68e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.53e-3)"	"unprognostic (7.50e-3)"	"unprognostic (5.74e-2)"	"unprognostic (3.83e-3)"	"unprognostic (9.23e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.54e-1)"	"unprognostic (9.39e-2)"	"unprognostic (2.35e-2)"	"prognostic unfavorable (3.45e-7)"	"unprognostic (6.84e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.79e-2)"	"unprognostic (7.82e-2)"	9.1	14.3	12.6	12.3	16.6	13.1	11.1	7.6	21.3	8.8	12.1	10.8	9.0	10.0	8.1	6.0	14.6	13.6	6.4	11.6	12.0	10.3	7.9	25.1	5.7	17.0	13.4	9.9	13.2	46.9	3.2	4.9	6.5	10.3	9.5	6.6	6.3	14.0	8.1	30.9	18.5	9.5	6.6	14.0	12.7	9.8	7.5	11.8	16.8	15.1	15.7	12.2	11.3	8.6	22.9	36.8	3.3	23.7	17.1	21.1	13.5	17.9	33.5	4.7	13.8	3.0	3.8	11.0	7.6	3.6	12.5	10.3	19.5	13.3	28.0	19.8	3.7	6.4	6.8	9.3	8.5	3.9	17.8	32.1	12.5	12.7	14.9	9.6	22.4	12.4	4.7	19.1	10.0	9.6	3.4	5.8	16.0	16.6	20.1	4.1	23.4	19.3	15.8	16.6	25.4	16.6	18.3	12.9	25.2	5.0	12.8	18.2	13.6	11.0	18.3	18.6	3.2	8.5	27.7	4.6	13.1	11.0	8.3	23.3	31.7	40.5	30.4	10.2	32.4	11.1	3.3	21.7	0.6	13.2	23.7	15.8	21.1	14.4	13.3	34.1	22.9	21.1	18.5	1.5	17.1	14.0	36.8	11.1	13.5	12.6	16.6	7.6	21.3	12.0	10.3	13.4	9.9	10.3	11.8	3.0	3.7	19.5	26.4	27.1	5.6	8.1	17.8	18.7	11.4	17.4	3.9	24.0	31.5	14.5	7.3	9.0	5.1	23.3	18.3	115.4	11.0	15.5	4.7	17.9	26.6	6.4	8.2	4.3	13.8	5.6	15.5	19.8	13.5	14.4	16.8	4.8	20.0	5.8	11.7	19.5	2.1	6.5	18.4	11.9	27.2	29.1	17.7	11.7	30.9	22.0
EXOSC9	"p5, p6, PM/Scl-75, PMSCL1, RRP45, Rrp45p"	ENSG00000123737	"Exosome component 9"	Q06265	4	121801317-121817021	"Predicted intracellular proteins"	"rRNA processing"	RNA-binding	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 108.4;Spermatocytes: 107.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041838, HPA048257, CAB070171"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"CAB070171: AB_11026964, HPA041838: AB_10794492, HPA048257: AB_2680331"	"unprognostic (7.36e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.36e-2)"	"prognostic unfavorable (1.04e-4)"	"unprognostic (7.89e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.66e-2)"	"unprognostic (9.25e-2)"	"unprognostic (9.85e-3)"	"prognostic unfavorable (6.49e-4)"	"unprognostic (3.28e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.21e-2)"	12.5	12.7	10.1	18.9	14.7	29.7	13.9	16.8	18.6	11.2	9.7	8.1	12.5	7.5	12.5	12.4	13.3	11.8	7.8	13.1	13.5	11.3	11.3	14.0	11.9	19.8	11.3	12.2	12.6	10.4	14.2	15.5	12.1	12.9	10.3	12.0	9.6	10.9	8.9	17.6	12.1	10.3	10.6	11.7	14.2	10.4	36.7	10.0	33.7	9.2	15.4	18.9	12.2	10.5	19.9	15.9	20.1	17.7	11.6	23.6	14.0	19.5	9.2	24.9	14.8	3.9	8.0	12.1	25.4	14.7	36.4	28.2	9.9	16.4	34.3	6.3	15.8	11.0	7.0	26.9	11.8	32.5	15.2	12.3	17.2	14.2	12.8	8.2	29.1	16.0	6.0	6.1	25.4	7.3	7.5	17.9	22.1	29.4	13.6	34.0	11.4	44.6	22.5	13.1	7.6	10.8	24.9	41.7	15.4	12.4	6.4	15.9	16.7	9.3	13.9	15.4	13.2	11.8	18.8	10.8	16.3	24.1	13.7	24.4	19.8	15.0	41.2	16.9	20.3	10.7	12.0	13.3	20.1	18.7	17.7	18.4	19.9	20.5	23.6	15.9	19.9	23.3	20.7	3.3	11.6	17.0	15.7	21.6	14.0	10.1	14.7	16.8	18.6	13.5	11.3	11.3	12.2	12.9	10.0	41.7	15.5	16.4	12.6	11.3	10.7	11.1	7.6	18.7	26.1	3.5	9.8	24.1	1.7	17.1	108.4	14.2	4.5	0.0	26.6	25.0	13.6	7.6	30.1	4.9	21.1	15.9	5.8	12.3	10.3	9.2	12.0	18.0	8.5	20.8	7.9	13.8	16.5	8.7	10.3	7.1	16.3	6.5	11.3	107.2	58.5	12.9	9.2	19.2	10.5	12.9
FAM133B	MGC40405	ENSG00000234545	"Family with sequence similarity 133 member B"	Q5BKY9	7	92560793-92590394	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA066175, HPA069513"			Enhanced	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA066175: AB_2685629, HPA069513: AB_2686143"	"unprognostic (5.54e-2)"	"unprognostic (4.42e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.61e-1)"	"unprognostic (6.70e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.87e-3)"	"unprognostic (8.56e-3)"	"unprognostic (1.11e-1)"	"unprognostic (8.85e-2)"	"unprognostic (2.73e-3)"	"unprognostic (9.01e-3)"	"unprognostic (3.16e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.38e-2)"	10.5	11.7	18.5	11.1	23.6	32.1	15.1	25.7	23.3	13.6	10.4	8.2	12.0	11.9	13.0	22.5	11.4	10.4	9.2	9.2	13.8	9.1	11.2	14.3	11.2	14.1	15.3	13.2	15.1	13.6	13.4	21.3	12.9	18.0	12.0	11.7	7.5	11.4	10.5	17.1	12.8	10.8	15.7	18.5	12.1	10.6	7.3	17.3	15.9	12.5	7.5	12.8	10.6	12.0	22.5	23.2	9.8	11.7	10.7	17.0	5.9	13.1	6.8	19.2	29.4	11.3	12.0	11.5	14.9	16.1	14.6	17.8	10.9	14.6	21.5	14.5	10.1	12.7	10.6	15.1	9.4	22.4	12.1	19.7	17.4	10.0	21.8	11.8	19.1	15.1	8.0	9.9	11.2	14.0	11.5	8.6	16.8	22.9	27.3	15.6	16.0	30.0	29.9	26.2	12.0	8.8	21.8	19.3	17.8	14.5	14.1	18.6	18.0	12.8	16.3	17.3	18.8	15.1	14.1	9.9	16.8	26.7	19.5	16.7	7.1	7.5	38.5	10.1	25.2	21.6	9.5	11.7	9.8	10.7	10.5	13.9	22.5	13.6	13.2	9.6	18.8	17.0	14.4	4.9	10.7	7.8	23.2	14.3	5.9	18.5	23.6	25.7	23.3	13.8	9.1	15.3	13.2	18.0	17.3	53.6	65.5	102.1	185.5	101.5	81.2	25.7	180.9	38.8	62.6	83.7	70.7	55.8	84.6	78.1	31.4	87.5	92.6	163.5	75.9	52.0	92.4	103.6	86.4	97.3	62.9	52.4	131.6	108.1	107.2	13.2	95.0	114.5	72.6	69.5	83.4	83.5	72.6	112.3	83.4	48.4	75.1	51.8	103.0	97.0	117.4	91.7	59.0	97.2	97.8	127.1
FAM193B	"FLJ10404, IRIZIO, KIAA1931"	ENSG00000146067	"Family with sequence similarity 193 member B"	Q96PV7	5	177519788-177554541	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035847, HPA035848"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA035847: , HPA035848: AB_10601320"	"unprognostic (6.58e-3)"	"unprognostic (1.07e-1)"	"unprognostic (8.95e-3)"	"unprognostic (2.94e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.15e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.71e-3)"	"unprognostic (2.78e-2)"	"prognostic unfavorable (3.71e-8)"	"unprognostic (1.08e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.15e-1)"	"prognostic favorable (1.30e-5)"	13.5	9.5	18.5	16.5	17.2	35.6	15.8	37.9	20.4	18.1	13.5	13.6	17.2	15.4	19.8	11.6	13.8	13.3	12.3	9.1	18.4	8.0	16.3	18.5	17.0	20.5	17.3	18.3	22.1	22.1	10.3	15.2	15.2	17.0	19.0	11.6	17.1	14.3	14.6	11.6	34.9	18.7	12.7	10.9	27.8	14.9	14.0	16.2	11.7	16.9	9.5	15.3	13.7	23.1	1.3	1.6	2.9	1.8	2.0	2.8	0.9	5.3	7.1	15.8	13.8	7.8	7.6	34.3	4.9	5.2	8.1	7.7	19.1	10.4	10.2	7.5	4.7	10.2	9.3	7.2	10.2	6.0	22.4	7.5	7.2	11.2	9.1	4.6	7.0	14.8	7.5	11.4	6.8	7.5	14.5	8.1	16.2	6.9	10.1	5.7	17.9	12.7	20.4	11.0	4.7	5.7	20.8	3.5	8.6	7.7	15.3	14.7	9.4	5.6	16.3	4.8	12.5	15.9	9.7	10.0	9.0	7.4	5.8	5.7	11.1	4.6	8.2	7.2	11.4	7.4	0.0	1.8	0.7	2.8	0.2	1.8	0.7	1.4	2.0	1.1	1.3	0.7	1.0	2.9	2.0	1.1	1.6	0.9	0.9	18.5	17.2	37.9	20.4	18.4	8.0	17.3	18.3	17.0	16.2	17.9	29.0	6.0	5.1	7.7	10.9	6.4	22.9	8.1	13.6	10.4	17.7	4.3	0.0	5.4	5.1	9.2	9.1	0.0	7.6	6.8	7.8	7.9	4.7	10.4	4.2	11.1	8.1	14.1	7.6	7.4	9.2	7.8	8.5	3.6	13.9	9.1	5.5	5.8	4.9	2.2	12.4	6.5	9.9	10.6	12.9	11.3	3.8	7.9	10.3	5.4
FAU	"asr1, FLJ22986, Fub1, Fubi, MNSFbeta, RPS30, S30"	ENSG00000149806	"FAU, ubiquitin like and ribosomal protein S30 fusion"	"P35544, P62861"	11	65120628-65122473	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA059015	Supported		Enhanced	"Nucleoli,Endoplasmic reticulum,Cytosol"		No	No			"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA059015: AB_2683881"	"unprognostic (1.81e-3)"	"unprognostic (3.47e-2)"	"unprognostic (2.89e-1)"	"unprognostic (2.91e-1)"	"unprognostic (5.73e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.97e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.26e-1)"	"unprognostic (7.06e-3)"	"unprognostic (7.77e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.45e-2)"	79.7	95.0	90.6	84.9	76.2	186.7	95.4	50.9	80.9	103.6	134.8	77.6	63.4	77.8	84.0	80.5	115.2	100.0	87.2	133.9	70.0	58.9	88.0	162.9	77.5	182.6	78.9	40.8	176.0	202.8	27.5	56.1	73.2	46.6	123.5	53.0	67.8	97.3	76.7	190.8	86.8	93.8	97.5	72.4	130.9	79.2	53.6	53.2	126.8	121.5	83.6	149.5	122.0	136.6	291.3	169.7	90.9	119.0	116.3	253.8	346.5	78.9	52.0	46.0	72.8	45.0	67.3	63.0	45.1	43.9	63.2	40.1	58.8	79.3	94.1	122.5	38.7	42.6	69.8	42.6	60.1	26.3	69.0	65.3	75.8	54.7	80.7	82.8	89.8	83.6	82.9	100.1	54.3	73.9	60.2	48.7	91.0	70.7	111.5	33.4	98.7	103.8	181.4	126.5	59.2	86.7	101.0	36.8	184.5	58.2	44.7	64.0	64.3	35.0	101.3	140.8	28.6	90.5	124.6	46.0	57.2	66.0	88.2	72.0	121.3	115.2	160.1	69.3	70.0	64.7	90.9	119.0	70.6	128.9	107.0	176.1	291.3	212.1	165.5	132.1	281.7	253.8	198.1	78.9	116.3	92.8	169.7	153.8	346.5	90.6	76.2	50.9	80.9	70.0	58.9	78.9	40.8	46.6	53.2	595.5	951.7	2941.4	2547.1	3351.7	327.7	460.8	1579.6	745.5	1039.6	909.0	184.6	1889.5	1737.5	1225.7	710.1	1573.3	1664.2	1027.9	2337.8	2188.3	1714.1	2189.0	1307.1	1658.9	1928.3	179.6	1179.1	1412.4	2371.4	1489.6	2116.5	2866.9	2014.3	2418.4	1788.3	428.5	1806.3	2457.4	1155.5	1844.9	362.4	1099.5	2206.1	745.0	649.0	3667.7	2335.8	2033.7	2040.2	2956.6
FEN1	"FEN-1, MF1, RAD2"	ENSG00000168496	"Flap structure-specific endonuclease 1"	P39748	11	61792637-61797244	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication"	"Endonuclease, Exonuclease, Hydrolase, Nuclease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 36.3"	"Cell type enhanced"	"Detected in many"	5	"Extravillous trophoblasts: 61.7;Spermatogonia: 63.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002262, HPA006748"	Enhanced		Enhanced	Nucleoplasm,Nucleoli		NA	Yes		38000	Nucleoplasm	Nucleoli	"CAB002262: AB_563729, HPA006748: AB_1848494"	"unprognostic (1.82e-1)"	"unprognostic (2.71e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.45e-2)"	"prognostic unfavorable (3.39e-6)"	"unprognostic (1.50e-2)"	"unprognostic (9.82e-2)"	"prognostic favorable (7.85e-4)"	"unprognostic (2.82e-3)"	"unprognostic (5.86e-2)"	"prognostic unfavorable (5.73e-6)"	"prognostic favorable (9.46e-4)"	"unprognostic (1.10e-1)"	"unprognostic (4.49e-3)"	"unprognostic (4.04e-2)"	4.8	9.6	7.9	14.6	8.5	23.9	7.4	16.9	14.9	4.9	11.0	8.5	5.0	8.1	5.0	6.6	13.3	4.2	7.0	4.6	8.6	8.5	4.9	9.3	5.0	22.5	8.3	9.8	3.9	6.3	5.2	7.9	11.2	12.6	4.7	12.0	7.3	9.3	4.6	11.2	6.8	8.2	6.4	7.1	12.3	7.2	16.2	5.9	36.3	3.5	10.6	25.5	6.1	4.2	11.5	18.1	14.5	9.4	13.3	18.0	7.3	31.2	28.8	31.6	17.0	3.1	3.9	20.1	27.7	15.8	33.9	38.6	25.1	23.6	45.1	21.6	11.7	32.0	33.1	44.4	24.2	34.8	23.7	24.5	23.8	39.3	25.6	2.4	37.0	24.7	2.7	3.3	31.3	8.3	5.0	13.2	25.5	36.0	32.7	28.1	39.4	51.6	33.3	34.7	24.6	28.2	35.4	36.6	46.6	13.5	29.6	36.0	29.9	18.5	24.2	15.9	15.5	35.1	26.0	8.8	30.2	38.2	38.4	27.8	25.9	40.2	46.9	21.1	24.8	26.0	14.5	5.0	10.2	12.4	9.4	13.1	11.5	10.0	11.8	5.8	11.5	11.2	11.3	2.1	13.3	8.8	18.1	18.0	7.3	7.9	8.5	16.9	14.9	8.6	8.5	8.3	9.8	12.6	5.9	0.0	2.1	12.6	4.8	9.2	21.1	4.0	5.1	6.7	3.4	0.0	11.8	28.6	6.6	11.6	16.8	2.7	3.1	23.3	10.5	61.7	7.6	4.4	0.0	6.8	21.8	14.3	4.6	1.3	5.1	9.8	5.2	7.1	5.0	19.0	5.3	29.9	9.3	6.0	6.7	4.7	20.5	0.0	4.2	33.0	63.4	5.4	25.9	14.1	13.0	3.7
FTSJ3	SPB1	ENSG00000108592	"FtsJ RNA methyltransferase homolog 3"	Q8IY81	17	63819433-63830012	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055544, HPA062628"	Supported		Enhanced	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Nucleoli, Nucleoli rim"	"Mitotic chromosome"	"HPA055544: AB_2682843, HPA062628: AB_2684813"	"unprognostic (1.33e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.60e-2)"	"unprognostic (7.82e-2)"	"unprognostic (6.45e-2)"	"unprognostic (2.92e-1)"	"prognostic unfavorable (1.44e-5)"	"unprognostic (1.27e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.41e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.99e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.10e-1)"	"unprognostic (3.43e-1)"	20.1	19.9	14.2	15.8	18.2	12.5	16.4	13.6	15.2	17.5	17.4	22.4	25.0	12.9	22.7	19.4	17.6	17.3	16.8	19.2	14.8	9.2	24.4	24.9	13.9	17.5	18.9	9.5	22.3	14.6	30.6	13.3	15.4	16.2	19.3	17.1	17.4	16.5	18.1	25.1	21.2	16.2	21.5	17.7	19.8	16.5	13.0	17.8	31.1	22.4	19.7	26.0	18.0	16.8	9.8	13.3	6.5	12.8	12.3	15.1	9.0	20.6	32.6	12.6	17.9	20.4	17.6	19.6	20.7	15.2	23.7	18.9	27.1	13.9	27.6	8.5	12.1	12.5	14.3	23.5	19.7	30.6	4.7	23.5	24.8	23.2	25.2	14.9	31.3	18.1	12.4	15.6	36.8	17.8	12.1	19.7	17.0	24.6	11.3	15.8	34.8	27.5	10.2	34.0	23.3	33.3	24.6	34.7	19.4	15.5	18.9	11.7	45.9	24.4	20.8	14.1	26.3	19.8	10.5	17.7	17.7	24.9	19.7	38.2	27.4	38.5	27.5	15.8	20.9	17.1	4.5	10.8	6.5	11.4	12.8	15.1	9.8	12.2	14.9	13.3	9.8	9.8	12.0	2.4	12.3	9.2	10.1	14.2	9.0	14.2	18.2	13.6	15.2	14.8	9.2	18.9	9.5	16.2	17.8	29.8	23.8	10.4	12.4	12.2	6.9	26.9	20.4	29.4	30.7	14.0	9.8	13.8	11.6	21.2	6.1	18.5	13.1	0.0	29.2	13.7	11.6	9.0	24.2	17.1	12.5	3.2	12.2	9.2	15.2	11.9	22.5	14.0	8.5	20.8	11.2	13.8	23.1	13.6	18.0	21.6	8.6	45.3	17.9	10.4	12.8	11.2	13.6	10.0	16.4	9.1
GET4	"C7orf20, CEE, CGI-20, H_NH1244M04.5, TRC35"	ENSG00000239857	"Golgi to ER traffic protein 4"	Q7L5D6	7	876552-896436	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	8	"Cone photoreceptor cells: 3.9;Horizontal cells: 7.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019765	Uncertain		Enhanced	"Nucleoplasm,Nucleoli,Mitotic chromosome,Cytosol"		Yes	No			"Nucleoplasm, Cytosol"	"Nucleoli, Mitotic chromosome"	"HPA019765: AB_1845750"	"unprognostic (2.80e-2)"	"unprognostic (2.40e-2)"	"unprognostic (2.10e-2)"	"unprognostic (9.66e-4)"	"unprognostic (9.86e-2)"	"unprognostic (8.64e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.59e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.21e-1)"	"unprognostic (7.65e-2)"	"unprognostic (8.18e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.93e-2)"	"unprognostic (9.47e-2)"	13.7	39.8	22.4	14.8	21.4	28.5	15.3	22.1	23.5	10.3	15.5	20.9	19.0	21.8	12.3	23.8	18.8	14.6	12.8	18.7	16.4	15.4	27.8	37.5	12.2	15.1	22.9	21.5	16.5	32.6	11.3	32.9	21.7	18.9	16.8	9.9	15.2	25.0	21.9	53.7	29.7	20.9	12.6	18.9	16.9	22.2	32.0	22.7	12.5	16.0	21.8	12.5	14.3	17.3	23.3	31.5	28.9	30.7	24.9	27.3	21.9	26.3	13.0	9.1	13.4	4.7	3.3	28.9	7.3	5.2	9.4	9.4	35.3	33.0	9.7	7.7	4.2	26.2	16.8	10.2	8.0	4.1	3.9	17.5	5.3	10.2	19.9	10.4	9.1	9.9	4.9	9.7	8.2	5.4	7.1	7.4	11.3	34.5	9.0	5.2	20.0	6.9	21.9	32.7	15.6	19.5	14.5	1.6	10.4	8.3	15.6	16.5	17.8	6.7	24.9	10.6	11.6	18.9	16.2	7.4	6.9	15.6	16.0	10.0	13.6	8.5	12.5	7.1	15.7	17.5	16.8	27.4	28.9	24.2	24.7	23.7	23.3	26.5	24.0	27.7	23.2	26.0	27.3	21.1	24.9	30.7	31.5	24.5	21.9	22.4	21.4	22.1	23.5	16.4	15.4	22.9	21.5	18.9	22.7	0.0	1.9	0.0	0.2	0.9	0.8	0.4	0.0	2.7	3.4	0.0	3.9	0.9	0.0	0.6	3.6	0.1	1.6	0.0	0.6	0.6	0.3	0.4	1.1	0.0	0.6	7.9	0.0	0.0	0.3	1.5	0.0	2.5	0.0	0.0	1.9	0.2	0.8	0.0	0.0	0.6	1.1	0.0	0.2	0.5	1.0	0.9	1.4	0.9	1.7	0.8
GNL2	"HUMAUANTIG, Ngp-1, Nog2, Nug2"	ENSG00000134697	"G protein nucleolar 2"	Q13823	1	37566816-37595935	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027163, HPA060026"	Approved		Enhanced	"Nucleoli,Nucleoli rim"		NA	NA			"Nucleoli, Nucleoli rim"		"HPA027163: AB_10601655, HPA060026: AB_2684191"	"unprognostic (1.38e-2)"	"unprognostic (5.23e-2)"	"unprognostic (2.61e-1)"	"unprognostic (9.49e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (5.86e-9)"	"unprognostic (2.28e-1)"	"unprognostic (7.80e-2)"	"prognostic favorable (7.89e-4)"	"unprognostic (1.01e-2)"	"unprognostic (8.19e-2)"	"prognostic unfavorable (2.90e-11)"	"unprognostic (3.36e-2)"	"unprognostic (7.33e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.87e-1)"	24.1	17.4	13.8	24.1	15.0	30.7	21.9	11.2	14.2	15.9	15.7	11.7	16.8	12.4	20.2	18.3	21.8	16.4	14.8	17.9	12.5	11.3	18.0	26.9	18.7	19.6	21.2	11.5	19.6	17.4	15.2	21.6	24.5	15.8	16.4	18.7	10.1	19.4	18.9	40.3	22.2	16.3	17.4	15.0	21.8	17.8	21.4	15.2	24.3	17.1	27.5	22.2	20.5	19.8	18.4	25.2	14.4	22.7	20.7	17.4	12.2	19.3	10.0	19.4	20.3	15.6	18.0	31.6	29.5	20.5	27.3	27.9	27.3	22.9	31.8	19.3	21.7	15.4	18.3	31.7	24.0	37.7	18.0	24.8	31.9	20.1	21.9	20.9	41.8	22.9	11.3	22.1	37.2	44.6	13.0	19.6	13.9	42.3	22.9	26.4	17.1	22.5	25.3	50.9	14.0	19.6	24.1	35.3	36.1	22.8	21.2	23.8	21.9	22.3	22.5	21.9	30.2	16.1	24.4	15.7	18.5	26.1	39.1	40.9	21.5	19.3	55.3	21.3	33.7	23.5	10.3	17.1	14.4	15.3	22.7	17.4	18.4	14.3	16.5	25.2	13.5	15.1	14.5	1.8	20.7	20.7	18.5	16.9	12.2	13.8	15.0	11.2	14.2	12.5	11.3	21.2	11.5	15.8	15.2	14.9	47.4	26.7	52.5	56.2	7.6	18.2	5.1	73.6	79.6	7.0	9.8	32.5	23.2	37.6	45.3	20.2	13.4	0.0	54.2	43.6	26.3	29.5	46.2	16.2	28.9	6.4	16.6	11.6	17.1	7.8	22.2	29.8	8.5	36.1	16.0	19.1	39.6	17.8	18.0	12.9	8.6	0.0	33.0	50.5	54.9	46.2	38.6	26.7	19.7	42.6
GORAB	"FLJ11752, GO, NTKL-BP1, SCYL1BP1"	ENSG00000120370	"Golgin, RAB6 interacting"	Q5T7V8	1	170532129-170553446	"Disease related genes, Predicted intracellular proteins"			Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027208, HPA027250, HPA027746"	Approved		Enhanced	"Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol"	"Intracellular and membrane"	NA	NA			"Golgi apparatus, Cytosol"	"Nucleoplasm, Nucleoli"	"HPA027208: AB_10599622, HPA027250: AB_10611253, HPA027746: "	"unprognostic (1.59e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.75e-3)"	"prognostic favorable (1.39e-4)"	"prognostic unfavorable (5.26e-4)"	"unprognostic (8.48e-3)"	"unprognostic (2.94e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.77e-2)"	"prognostic unfavorable (7.83e-12)"	"unprognostic (2.52e-2)"	"unprognostic (2.83e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.70e-1)"	7.7	14.7	8.4	9.4	9.2	0.5	10.6	8.7	9.5	10.7	9.4	4.8	7.0	4.8	8.8	10.5	6.3	6.8	6.7	8.2	7.4	7.8	7.2	11.1	6.8	9.6	6.3	8.1	12.6	9.7	6.5	20.6	9.4	8.7	11.1	10.4	6.3	8.8	13.1	3.3	6.5	7.0	6.4	11.1	10.4	5.6	8.6	7.3	8.7	10.5	4.2	9.7	10.4	10.0	6.2	7.3	1.2	7.4	7.9	9.4	5.5	5.1	5.0	9.6	3.6	12.9	9.6	6.3	7.8	12.1	6.9	7.2	3.2	8.8	7.5	9.0	7.9	4.5	6.5	9.5	4.6	9.2	8.0	2.9	5.0	6.5	4.0	8.7	6.6	5.1	8.3	4.5	7.4	6.9	8.6	5.4	4.3	6.8	3.7	7.3	1.2	9.5	6.0	8.5	11.6	6.3	5.7	6.4	10.0	6.2	3.8	2.5	5.3	6.5	7.9	18.2	6.4	5.0	11.7	6.9	11.0	5.8	4.3	10.8	6.7	7.3	6.6	9.2	6.0	9.8	1.0	7.4	0.0	4.7	7.4	7.4	6.1	8.3	7.2	7.3	6.2	7.3	6.2	1.2	7.9	5.7	4.6	9.4	5.5	8.4	9.2	8.7	9.5	7.4	7.8	6.3	8.1	8.7	7.3	0.0	10.7	6.0	2.9	2.5	3.9	6.7	7.6	1.4	6.8	5.2	2.0	5.2	3.3	9.4	1.6	7.4	5.1	0.0	5.3	5.6	10.4	4.1	12.8	5.8	6.3	4.8	0.0	3.7	6.3	2.6	13.0	3.9	3.3	10.0	6.4	3.4	5.8	7.0	6.0	4.4	7.2	6.5	8.5	13.1	7.7	1.4	4.7	5.7	6.0	2.7
GPATCH4	"DKFZP434F1735, FLJ20249, GPATC4"	ENSG00000160818	"G-patch domain containing 4"		1	156594487-156601496	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028323, HPA054319"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA028323: AB_10601017, HPA054319: AB_2682447"	"unprognostic (2.80e-2)"	"unprognostic (4.61e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.89e-2)"	"prognostic unfavorable (3.17e-5)"	"unprognostic (2.40e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.33e-3)"	"unprognostic (9.60e-2)"	"unprognostic (6.39e-3)"	"prognostic unfavorable (3.70e-4)"	"unprognostic (1.07e-1)"	"unprognostic (1.71e-1)"	"unprognostic (6.03e-2)"	"unprognostic (6.80e-2)"	18.2	13.3	14.7	16.9	27.7	9.4	15.1	6.9	22.5	10.0	12.1	8.3	3.9	9.7	13.8	10.0	14.0	11.6	7.2	11.9	12.6	12.1	18.0	23.1	10.0	15.7	15.3	12.4	15.3	12.9	19.6	16.2	10.0	24.2	12.6	14.6	5.7	11.5	11.9	47.1	10.9	10.0	15.1	10.2	16.6	12.5	8.8	13.2	8.0	10.3	19.0	19.1	12.5	10.1	16.6	10.1	0.3	11.2	10.7	15.9	7.6	17.1	23.7	10.0	14.4	9.2	7.1	13.0	21.3	8.5	16.7	9.8	24.2	13.0	41.4	17.7	14.9	10.8	12.0	22.7	18.8	18.5	12.3	22.5	24.7	23.2	18.5	8.3	55.1	16.0	8.0	15.9	31.6	28.0	4.7	11.7	13.5	40.4	10.4	13.5	32.0	22.6	13.3	43.8	29.9	25.0	22.6	17.1	28.7	11.5	20.4	15.8	23.8	20.4	44.9	13.1	11.4	14.7	26.8	17.8	15.9	21.7	16.5	38.1	19.1	21.0	53.4	14.4	28.6	24.0	0.0	5.4	0.1	13.3	10.5	13.4	16.6	13.5	14.7	10.1	16.6	15.4	15.9	0.3	10.7	11.2	6.4	8.5	7.6	14.7	27.7	6.9	22.5	12.6	12.1	15.3	12.4	24.2	13.2	29.8	34.7	41.0	38.8	65.5	7.1	24.8	28.1	16.0	40.9	15.7	7.9	31.9	21.6	38.5	7.6	30.2	8.5	23.3	48.9	40.5	22.6	43.6	56.6	37.8	33.7	7.9	35.5	14.7	10.7	7.4	24.7	22.6	21.9	19.8	19.7	4.3	44.1	14.0	25.1	25.9	5.9	32.3	59.0	37.1	39.9	54.7	12.9	29.7	28.3	36.6
GRWD1	"GRWD, RRB1, WDR28"	ENSG00000105447	"Glutamate rich WD repeat containing 1"	Q9BQ67	19	48445773-48457022	"Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042643, HPA055680"	Approved		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim"		No	No			"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA042643: AB_10795510, HPA055680: AB_2682884"	"unprognostic (1.19e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.99e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.46e-1)"	"unprognostic (7.77e-2)"	"prognostic unfavorable (2.16e-4)"	"unprognostic (1.71e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.69e-2)"	"unprognostic (7.70e-2)"	"unprognostic (2.83e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.02e-1)"	"unprognostic (5.07e-2)"	16.9	15.5	9.2	15.7	11.1	14.8	15.5	12.9	14.1	13.6	14.1	10.4	11.9	15.6	18.7	12.8	20.0	15.0	16.2	16.9	7.8	8.6	13.0	26.3	12.5	17.5	11.0	10.3	19.3	35.5	16.5	10.3	14.7	9.5	13.8	8.0	12.0	18.6	14.4	29.1	18.3	11.5	13.3	8.2	19.4	14.7	13.1	10.9	18.6	17.3	19.0	17.3	14.1	18.0	21.1	18.4	1.4	17.8	17.4	22.6	16.5	17.0	45.1	7.7	14.4	6.3	6.2	6.6	13.3	6.4	19.2	16.1	25.3	12.7	24.4	11.6	8.3	10.8	14.6	19.1	20.6	7.6	18.2	25.8	22.2	15.3	18.0	7.3	20.9	14.3	7.4	11.4	18.1	9.2	4.3	9.5	13.4	31.0	15.4	8.0	17.7	22.0	52.6	20.9	18.2	13.2	27.4	8.6	17.5	8.0	21.1	17.3	9.6	15.0	21.3	6.6	4.8	10.5	10.6	10.1	17.9	15.1	7.8	31.6	15.7	35.9	22.8	6.0	18.9	20.8	0.1	11.0	1.4	19.6	17.8	22.6	21.1	18.1	19.5	18.4	20.4	21.3	19.7	0.8	17.4	13.5	13.6	15.6	16.5	9.2	11.1	12.9	14.1	7.8	8.6	11.0	10.3	9.5	10.9	3.0	17.4	22.9	20.9	41.1	12.6	6.5	15.3	18.7	14.8	12.2	0.0	35.6	19.9	28.0	1.7	18.0	7.3	0.0	15.7	30.6	18.6	13.5	19.6	14.7	21.5	20.6	18.4	11.6	10.7	14.6	15.8	12.4	27.0	35.1	9.0	5.3	18.5	7.0	11.7	15.3	13.0	19.4	20.2	6.1	34.7	35.5	29.3	20.0	13.4	17.6
GTPBP4	"CRFG, FLJ10686, FLJ10690, NGB, NOG1"	ENSG00000107937	"GTP binding protein 4"	Q9BZE4	10	988019-1019936	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039618, HPA056468"	Uncertain		Supported	"Nuclear membrane,Nucleoli,Nucleoli rim"		No	No			"Nucleoli, Nucleoli rim"	"Nuclear membrane"	"HPA039618: AB_10795292, HPA056468: AB_2683141"	"unprognostic (2.11e-3)"	"unprognostic (3.10e-3)"	"unprognostic (7.77e-3)"	"prognostic unfavorable (4.57e-4)"	"unprognostic (3.72e-2)"	"unprognostic (8.91e-3)"	"prognostic unfavorable (8.85e-12)"	"unprognostic (9.06e-2)"	"unprognostic (1.72e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (2.38e-5)"	"unprognostic (7.90e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.67e-2)"	19.0	24.6	11.3	13.9	14.9	24.8	14.2	11.6	15.0	11.0	10.5	12.2	10.3	9.6	14.8	10.1	12.2	15.8	8.9	11.9	14.1	11.8	11.8	14.0	9.5	13.8	14.0	10.1	16.3	22.8	12.7	18.3	13.8	15.3	11.1	12.2	8.9	10.3	9.9	24.8	11.4	11.0	14.4	18.1	13.5	12.7	22.9	12.2	14.2	11.9	16.3	16.3	11.6	10.4	10.5	11.3	10.7	14.2	15.8	14.2	7.7	21.0	17.2	14.5	12.7	10.3	12.3	10.4	19.8	6.9	24.3	20.7	25.4	16.4	30.6	6.0	15.7	8.4	16.7	28.6	18.1	28.4	15.1	17.9	33.5	12.4	15.5	16.3	14.5	18.1	15.9	15.4	26.7	18.6	9.9	13.2	23.8	34.3	12.7	22.2	19.4	22.2	13.7	21.1	28.0	11.9	22.1	12.7	21.1	14.4	13.4	7.3	22.0	13.0	16.7	22.9	14.9	23.9	14.5	11.4	11.6	6.4	27.8	24.0	16.5	31.5	38.5	13.0	15.4	9.5	10.7	8.4	3.0	11.6	14.2	13.6	10.5	11.0	11.7	11.3	9.9	12.2	11.8	1.4	15.8	10.8	7.4	14.2	7.7	11.3	14.9	11.6	15.0	14.1	11.8	14.0	10.1	15.3	12.2	53.6	69.5	32.8	58.3	55.6	25.5	29.7	22.9	66.9	108.1	27.9	17.7	41.8	28.2	54.3	49.0	30.8	10.0	23.3	37.9	45.9	31.1	41.3	62.7	24.3	30.8	22.3	21.2	20.9	25.9	13.8	23.0	29.0	21.9	38.7	24.5	27.3	52.1	17.5	27.6	24.0	31.8	19.4	25.8	86.5	85.2	58.7	79.8	24.5	28.6	76.5
H1FX	"H1X, MGC15959, MGC8350"	ENSG00000184897	"H1 histone family member X"	Q92522	3	129314771-129316277	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	8	"bone marrow: 381.6;lymphoid tissue: 238.6"	"Cell type enhanced"	"Detected in all"	6	"Basal glandular cells: 485.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 139.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB012235, HPA040099, HPA068431"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Nucleoplasm, Nucleoli, Nucleoli rim"		"CAB012235: , HPA040099: AB_2676846, HPA068431: "	"unprognostic (1.01e-2)"	"unprognostic (1.12e-2)"	"unprognostic (4.13e-2)"	"unprognostic (8.48e-2)"	"unprognostic (6.94e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.51e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.85e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.50e-2)"	23.1	13.1	11.9	19.0	14.5	381.6	33.7	29.0	22.9	30.9	21.0	9.6	13.4	21.1	26.0	19.6	34.5	25.1	24.0	27.5	11.3	11.2	12.9	24.9	30.9	44.2	6.7	16.3	39.0	22.4	18.4	20.5	15.0	6.9	26.2	7.8	18.4	32.3	16.3	30.8	40.5	26.0	19.1	9.6	29.9	29.0	14.2	6.3	238.6	21.9	18.1	20.5	35.6	25.0	5.7	10.8	15.9	5.3	4.8	8.3	2.2	19.9	10.6	20.1	8.7	2.0	2.4	19.1	8.8	6.4	10.5	11.1	6.3	11.0	2.5	9.7	3.1	7.0	20.1	8.4	5.6	1.6	18.3	16.3	7.6	8.2	8.6	8.7	8.8	2.0	4.9	7.7	4.2	9.7	4.7	6.0	35.4	11.7	45.5	1.4	20.9	40.7	17.5	18.8	3.6	12.0	29.4	8.6	23.7	3.2	4.2	32.1	37.2	9.3	4.6	26.6	4.0	18.2	17.8	5.9	8.1	42.6	7.9	7.3	139.5	53.3	21.5	6.6	8.4	8.9	0.4	5.3	15.9	4.3	3.7	4.0	4.4	6.7	5.1	7.4	5.7	8.3	4.3	1.2	4.8	3.3	10.8	5.1	2.2	11.9	14.5	29.0	22.9	11.3	11.2	6.7	16.3	6.9	6.3	14.9	12.8	95.3	485.3	89.5	119.1	25.5	63.7	2.7	3.4	89.0	29.5	60.0	94.5	42.6	7.4	89.9	34.4	70.0	71.0	93.0	97.3	173.5	5.7	38.5	77.7	138.2	153.1	85.3	93.5	8.0	92.0	75.7	118.1	25.2	86.3	209.9	59.2	48.9	48.8	25.1	84.3	122.9	82.1	13.2	36.5	96.0	57.2	72.6	52.5	312.3
HDHD3	"C9orf158, MGC12904"	ENSG00000119431	"Haloacid dehalogenase like hydrolase domain containing 3"	Q9BSH5	9	113373419-113376999	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 54.7"	"Cell type enhanced"	"Detected in many"	6	"Enterocytes: 204.4;Paneth cells: 171.9;Proximal tubular cells: 218.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 34.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020427, HPA024158, HPA024585"	Enhanced		Enhanced	Nucleoli,Vesicles		NA	NA			Nucleoli	Vesicles	"HPA020427: AB_1850561, HPA024158: AB_1850563, HPA024585: AB_1850565"	"unprognostic (1.30e-1)"	"prognostic favorable (2.72e-4)"	"unprognostic (3.01e-2)"	"unprognostic (1.31e-2)"	"unprognostic (8.24e-3)"	"unprognostic (1.57e-2)"	"unprognostic (6.66e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.92e-2)"	"unprognostic (5.87e-2)"	"prognostic favorable (3.54e-7)"	"unprognostic (2.16e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.68e-1)"	"unprognostic (1.19e-3)"	4.9	54.7	5.1	10.1	8.4	3.3	12.7	6.2	8.5	6.0	29.8	5.6	10.6	38.2	6.4	15.5	13.8	5.8	18.1	9.1	4.6	5.3	17.7	36.6	4.4	6.3	4.5	9.4	7.2	23.7	20.5	9.1	6.5	7.3	10.6	16.8	8.3	24.4	12.5	2.8	11.4	47.1	8.0	4.8	6.0	17.7	4.5	4.0	8.0	18.2	6.1	6.8	7.0	6.9	12.1	10.6	5.9	2.9	5.6	12.3	5.8	3.4	9.7	2.1	5.8	5.2	2.3	17.7	2.5	4.8	4.1	4.5	17.8	17.0	7.5	3.2	1.4	8.2	13.3	3.3	3.9	1.4	10.4	7.6	10.3	5.3	11.0	6.1	0.6	8.0	3.6	8.3	3.3	9.5	4.8	2.1	7.0	8.1	1.9	1.9	22.1	4.7	3.0	4.7	34.0	7.6	3.9	0.0	6.0	5.2	7.1	5.3	3.4	4.3	18.8	6.3	4.8	11.8	2.1	2.1	0.8	0.0	0.7	0.8	4.6	9.0	3.1	1.0	0.0	0.6	0.1	2.9	5.9	9.9	1.6	11.2	11.3	11.5	9.0	4.5	12.1	12.0	8.9	1.9	5.6	0.2	10.6	12.3	5.8	5.1	8.4	6.2	8.5	4.6	5.3	4.5	9.4	7.3	4.0	8.9	8.5	18.1	18.5	8.9	9.4	12.0	73.9	22.7	11.4	22.7	9.8	23.7	72.9	66.3	0.1	8.9	204.4	23.3	138.2	16.2	7.5	24.3	7.0	74.9	17.6	1.6	38.8	8.6	5.1	0.9	13.3	6.7	10.1	19.8	61.9	10.8	96.2	171.9	8.5	218.3	12.1	6.5	7.5	0.2	6.1	12.8	26.4	17.3	72.5	40.4
HECTD1	KIAA1131	ENSG00000092148	"HECT domain E3 ubiquitin protein ligase 1"	Q9ULT8	14	31100112-31207804	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Urothelial cells: 267.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002929, HPA054461"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA002929: AB_1850574, HPA054461: AB_2682496"	"unprognostic (6.71e-2)"	"unprognostic (4.86e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.64e-1)"	"unprognostic (6.99e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.03e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.13e-2)"	"unprognostic (3.60e-3)"	"unprognostic (1.51e-1)"	"prognostic favorable (1.20e-6)"	"unprognostic (6.53e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.91e-3)"	22.0	22.3	14.2	21.0	16.8	22.0	18.5	22.3	18.9	19.4	17.9	15.2	20.2	11.5	17.6	15.7	30.4	16.1	15.2	26.2	13.5	14.3	18.0	35.2	15.0	14.1	14.5	14.5	18.2	15.1	34.8	20.5	27.0	18.8	16.8	15.5	16.8	18.9	16.4	88.5	24.3	16.3	15.6	13.7	16.4	18.8	18.9	14.4	16.7	24.8	23.0	18.6	18.6	22.3	10.6	9.3	12.6	8.6	8.9	8.1	3.3	28.8	18.1	15.9	9.9	50.4	26.4	15.2	17.7	17.9	15.8	13.7	13.5	15.7	22.7	18.8	32.3	11.3	19.6	21.2	16.0	24.1	13.9	8.7	23.2	14.9	54.0	23.5	24.1	17.0	23.2	22.1	17.8	28.0	22.0	29.1	13.5	16.6	10.5	24.6	23.7	9.3	10.3	12.1	25.3	16.5	17.3	18.4	9.9	24.7	30.0	11.8	13.9	25.9	18.0	15.7	20.2	18.9	15.6	29.1	18.4	14.4	13.2	15.0	11.5	16.4	25.6	8.7	12.2	15.5	12.6	8.6	11.3	7.1	7.1	8.1	7.2	8.0	6.3	9.3	10.6	6.7	6.6	4.4	8.9	5.3	7.8	8.0	3.3	14.2	16.8	22.3	18.9	13.5	14.3	14.5	14.5	18.8	14.4	44.7	63.3	37.1	68.0	76.9	78.2	103.0	22.9	155.2	84.2	68.0	92.3	53.4	10.0	37.6	2.9	56.2	38.8	23.3	31.4	36.2	49.1	82.9	31.3	79.7	25.8	62.0	46.8	39.9	39.7	6.7	63.9	34.4	32.1	29.7	30.4	36.8	41.9	28.1	70.0	20.0	175.8	45.3	41.2	53.4	107.2	100.5	117.1	37.4	37.3	267.3
HJURP	"DKFZp762E1312, FAKTS, hFLEG1, URLC9"	ENSG00000123485	"Holliday junction recognition protein"	Q8NCD3	2	233833416-233854566	"Predicted intracellular proteins"	"Cell cycle"	"Chaperone, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 27.4;lymphoid tissue: 51.1;testis: 20.9"	"Cell type enhanced"	"Detected in many"	17	"Early spermatids: 12.4;Erythroid cells: 46.7;Extravillous trophoblasts: 13.7;Spermatocytes: 18.4;Spermatogonia: 12.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"T-reg: 4.2"	"Group enriched"	"Detected in many"	4	"granulocytes: 1.2;monocytes: 1.3;T-cells: 4.2"	"Low cell line specificity"	"Detected in many"							"Not detected"	"Not detected"			"HPA008436, HPA027261"	Uncertain		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitochondria"		Yes	Yes			"Nucleoplasm, Nucleoli, Nucleoli rim"	Mitochondria	"HPA008436: AB_1850757, HPA027261: AB_2672184"	"unprognostic (5.63e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.44e-3)"	"unprognostic (3.62e-1)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (3.37e-5)"	"prognostic unfavorable (2.46e-4)"	"prognostic unfavorable (6.49e-4)"	"unprognostic (9.48e-2)"	"prognostic unfavorable (7.72e-5)"	"unprognostic (7.60e-2)"	"unprognostic (0.00e+0)"	"unprognostic (7.42e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.74e-2)"	1.4	0.9	0.1	12.2	0.4	27.4	2.2	0.1	0.7	1.1	3.7	0.3	0.1	2.6	0.6	1.8	8.0	0.3	0.7	1.1	0.1	0.2	1.0	1.2	2.0	8.1	0.2	0.1	0.6	0.4	0.0	0.2	3.1	0.2	0.7	3.6	0.3	1.5	1.0	0.2	2.6	4.8	1.1	0.4	5.8	2.4	20.9	0.1	51.1	0.4	3.0	11.6	1.0	2.8	0.5	0.3	1.2	1.3	0.5	4.2	1.7	17.0	23.1	22.6	10.6	0.8	1.8	14.1	25.6	12.3	18.3	20.0	16.2	18.7	5.3	2.9	10.1	32.6	20.0	18.0	13.3	24.4	12.5	6.8	20.6	18.6	15.7	0.1	16.9	14.2	0.6	0.5	14.9	10.3	5.2	11.4	16.5	17.4	13.3	33.6	17.2	23.7	18.7	19.3	13.4	16.0	18.4	33.9	9.5	9.4	10.3	13.0	8.1	14.8	11.2	10.5	10.8	8.4	13.1	8.3	19.8	21.6	14.5	27.7	12.7	10.0	21.4	11.9	12.5	49.3	0.6	0.2	0.2	0.3	0.2	0.2	0.4	0.7	0.6	0.3	0.5	0.3	0.5	1.2	0.5	1.3	0.2	4.2	1.7	0.1	0.4	0.1	0.7	0.1	0.2	0.2	0.1	0.2	0.1	0.0	0.3	0.8	0.4	1.1	0.0	0.8	0.0	0.0	3.4	0.0	0.0	1.1	0.0	0.0	12.4	0.1	0.9	46.7	0.0	13.7	0.3	0.4	0.0	0.0	5.7	0.0	0.0	2.5	2.4	7.4	0.6	2.1	0.0	0.0	0.7	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.3	18.4	12.9	0.6	1.3	1.3	1.2	0.6
IMP3	"BRMS2, C15orf12, FLJ10968, MRPS4"	ENSG00000177971	"IMP3, U3 small nucleolar ribonucleoprotein"	Q9NV31	15	75639085-75648706	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	"Ribosome biogenesis, rRNA processing"	"Ribonucleoprotein, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA060955, HPA061177"			Enhanced	Nucleoplasm,Nucleoli		No	No			"Nucleoplasm, Nucleoli"		"HPA060955: AB_2684397, HPA061177: AB_2684445"	"unprognostic (6.01e-2)"	"unprognostic (5.40e-3)"	"unprognostic (7.04e-2)"	"unprognostic (7.64e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.44e-2)"	"unprognostic (4.51e-2)"	"unprognostic (2.69e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.22e-2)"	21.2	28.4	21.9	23.0	24.0	18.9	34.3	20.1	28.8	19.4	31.0	15.4	17.5	27.5	14.7	24.5	35.6	20.1	25.2	21.7	21.1	19.7	28.2	49.7	21.1	28.5	17.6	19.6	23.0	29.1	12.6	17.3	16.9	16.7	23.3	19.2	17.5	28.3	25.4	37.6	29.3	31.5	11.0	15.5	28.5	25.9	12.4	13.3	33.7	30.0	37.5	27.9	19.6	21.8	40.7	34.0	23.0	31.1	33.3	47.2	48.1	20.4	23.2	11.3	19.5	20.1	11.5	16.7	17.3	13.8	14.2	16.4	17.8	18.1	24.5	18.9	9.0	15.7	34.0	37.1	28.0	12.6	18.4	44.5	25.7	19.1	30.8	14.8	26.0	17.9	10.5	23.2	11.4	14.1	10.6	9.3	20.1	33.1	20.0	12.8	24.6	20.6	63.7	30.3	20.9	24.5	22.5	13.8	26.9	19.2	27.9	19.3	19.9	14.6	25.6	31.4	17.1	22.3	24.3	10.5	18.5	14.9	13.2	23.3	27.4	50.4	27.5	20.4	42.3	12.1	18.5	31.1	23.0	42.0	23.9	45.1	40.7	40.5	40.4	33.4	38.7	47.2	44.5	4.0	33.3	23.0	34.0	38.7	48.1	21.9	24.0	20.1	28.8	21.1	19.7	17.6	19.6	16.7	13.3	35.7	34.5	89.1	67.5	203.1	22.0	11.4	66.2	52.2	52.4	38.4	13.7	88.6	122.7	81.1	1.3	74.4	52.6	23.3	93.2	83.2	66.4	58.7	46.3	101.8	81.8	20.6	42.2	68.2	45.6	4.1	56.4	60.5	92.8	116.4	61.3	53.7	92.0	59.6	41.4	158.4	20.3	25.8	71.8	14.0	43.8	207.5	45.9	74.0	84.6	70.1
IMP4	"BXDC4, MGC19606"	ENSG00000136718	"IMP4, U3 small nucleolar ribonucleoprotein"	Q96G21	2	130342225-130347810	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	Ribonucleoprotein		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066222, HPA066673"			Enhanced	Nucleoli		NA	NA			Nucleoli		"HPA066222: AB_2685638, HPA066673: AB_2685701"	"unprognostic (8.26e-2)"	"unprognostic (5.10e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.70e-3)"	"unprognostic (2.18e-3)"	"prognostic unfavorable (4.72e-4)"	"unprognostic (1.33e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.28e-2)"	"unprognostic (5.08e-2)"	"unprognostic (4.47e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.10e-2)"	19.0	15.7	13.1	19.5	15.7	17.9	14.2	6.6	25.1	9.4	12.2	11.7	9.2	15.6	11.1	7.4	20.1	9.2	12.7	30.5	11.8	10.1	13.5	29.1	10.6	22.2	14.9	12.7	9.0	36.3	2.6	7.4	10.5	15.4	9.5	3.4	7.1	26.0	12.5	52.3	10.8	15.5	12.5	8.5	11.2	16.4	9.1	13.7	8.5	12.0	10.9	11.5	17.1	9.7	34.8	31.6	7.0	26.8	26.6	25.4	26.7	19.4	17.8	0.8	15.0	2.9	3.5	13.9	11.9	5.7	8.5	8.8	38.4	12.4	52.2	18.7	5.7	8.4	11.8	1.6	12.5	0.3	11.9	13.4	16.0	5.0	32.3	15.8	15.0	11.5	5.8	7.7	15.2	6.8	1.2	8.5	12.4	17.9	16.1	2.2	36.2	11.2	6.3	13.5	9.1	23.6	15.7	6.3	26.7	3.7	13.8	9.2	10.3	9.1	27.7	9.9	0.2	10.6	10.8	9.4	16.0	15.3	16.9	24.6	16.3	20.1	43.3	12.3	9.6	22.5	2.4	25.5	7.0	25.4	26.8	22.6	34.8	22.4	21.9	29.3	30.7	22.4	22.2	2.9	26.6	25.1	31.6	21.5	26.7	13.1	15.7	6.6	25.1	11.8	10.1	14.9	12.7	15.4	13.7	14.9	22.7	67.7	56.9	94.6	23.3	49.6	61.1	13.4	33.0	41.8	3.9	56.3	86.2	67.2	18.1	38.3	44.6	23.3	95.4	82.6	49.8	54.8	46.1	77.4	68.9	15.9	52.4	25.8	29.9	46.7	28.4	45.9	74.2	73.1	42.6	14.0	74.6	45.6	24.1	115.0	21.1	25.8	72.6	26.3	45.4	96.5	41.2	37.4	60.5	76.3
KIF2A	"HK2, KIF2"	ENSG00000068796	"Kinesin family member 2A"	O00139	5	62306162-62537249	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis"	"Developmental protein, Motor protein"	"Cancer-related genes, Disease mutation, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"monocytes: 152.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004715, HPA004716"	Approved		Enhanced	Nucleoplasm,Nucleoli,Centrosome		Yes	No		2100000	"Nucleoplasm, Nucleoli, Centrosome"		"HPA004715: AB_2667215, HPA004716: AB_1079211"	"unprognostic (2.40e-2)"	"unprognostic (3.43e-1)"	"prognostic favorable (1.70e-4)"	"unprognostic (2.74e-2)"	"unprognostic (1.43e-1)"	"prognostic favorable (5.45e-4)"	"prognostic unfavorable (3.17e-6)"	"unprognostic (8.77e-3)"	"unprognostic (4.69e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (3.81e-5)"	"unprognostic (3.53e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.58e-1)"	11.3	9.3	25.4	21.9	26.4	12.4	15.5	15.4	40.1	19.7	13.5	19.4	8.0	10.3	12.9	7.6	14.3	17.5	13.7	7.2	26.2	24.1	8.2	5.8	10.6	29.4	24.9	24.6	13.0	12.3	15.2	14.3	27.8	37.0	10.2	14.5	6.8	10.7	11.9	7.4	7.9	15.8	13.5	34.3	17.4	9.6	39.2	26.4	28.7	13.0	5.6	26.7	17.4	14.8	9.0	8.4	7.1	3.0	15.8	25.4	9.7	17.3	17.4	29.1	25.8	11.0	15.5	23.8	18.6	15.4	20.3	25.8	18.7	19.1	43.1	20.6	16.4	24.0	11.0	22.0	14.9	27.1	43.2	15.4	43.2	16.3	10.2	13.0	23.5	16.5	12.8	9.9	19.7	17.9	11.9	18.5	24.9	30.6	26.3	16.9	13.1	39.4	11.7	16.9	4.2	11.0	29.0	23.0	23.8	9.1	21.1	26.1	21.7	25.3	10.6	13.1	22.5	13.9	13.3	16.0	12.1	20.0	14.0	18.5	24.9	35.9	45.5	14.0	28.4	14.8	7.1	3.0	3.4	20.2	2.6	22.8	9.0	20.3	20.6	4.0	7.8	17.9	18.4	5.3	15.8	1.8	8.4	25.4	9.7	25.4	26.4	15.4	31.2	26.2	24.1	24.9	24.6	37.0	26.4	14.9	13.1	22.3	22.3	14.9	41.8	7.0	7.6	71.0	25.0	19.2	98.2	16.2	11.6	30.0	88.3	17.5	11.4	0.0	27.0	18.7	10.4	29.9	16.3	3.4	13.1	49.3	20.2	14.7	10.2	90.3	12.0	18.7	11.8	152.3	5.1	22.4	23.3	7.4	12.4	13.5	88.2	25.8	13.3	80.2	42.1	8.3	36.7	39.6	9.5	40.0
KNOP1	"101F10.1, C16orf88, FAM191A, TSG118"	ENSG00000103550	"Lysine rich nucleolar protein 1"	Q1ED39	16	19701934-19718235	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatogonia: 132.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA041079, HPA066169"	Uncertain		Enhanced	"Nucleoli,Nucleoli rim,Cytosol"		NA	NA			"Nucleoli, Nucleoli rim"	Cytosol	"HPA041079: AB_10962350, HPA066169: AB_2685628"	"unprognostic (6.55e-3)"	"unprognostic (3.96e-1)"	"unprognostic (2.16e-2)"	"unprognostic (2.42e-2)"	"unprognostic (8.57e-3)"	"unprognostic (2.35e-1)"	"prognostic unfavorable (3.75e-6)"	"unprognostic (2.50e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.18e-3)"	"unprognostic (5.84e-2)"	"unprognostic (2.14e-2)"	"unprognostic (7.91e-2)"	"unprognostic (3.75e-2)"	"unprognostic (3.62e-1)"	"unprognostic (1.34e-3)"	"unprognostic (1.08e-1)"	6.9	7.1	13.9	7.6	34.7	3.9	13.8	11.1	23.7	7.1	9.5	20.9	8.5	8.2	8.5	10.9	10.1	8.1	7.3	6.9	17.0	10.5	6.2	7.6	5.5	9.4	33.1	9.1	12.8	19.6	17.2	6.4	10.3	18.1	8.1	11.1	4.9	13.9	9.8	15.2	15.0	8.2	5.8	21.2	6.4	9.3	10.0	33.2	4.9	7.3	5.8	7.5	8.4	7.7	7.0	5.2	1.6	8.0	4.5	12.8	4.4	12.4	19.2	21.4	16.2	5.3	5.0	11.0	7.7	4.2	7.4	7.5	13.5	10.9	14.9	31.7	4.7	6.5	11.6	16.6	10.6	7.2	10.0	11.6	8.8	10.9	17.7	9.7	13.7	6.9	3.2	15.2	9.7	8.0	6.5	7.8	10.6	26.9	6.7	6.9	16.3	12.1	11.4	41.7	12.4	7.7	26.1	11.5	17.3	7.8	11.9	19.3	16.3	9.6	12.4	12.6	12.8	14.5	9.3	9.0	11.7	12.0	7.1	10.2	9.9	20.5	18.7	6.3	10.5	11.3	0.4	3.5	1.6	4.8	8.0	7.2	6.6	6.9	4.8	4.2	7.0	12.8	7.2	1.0	4.5	7.0	5.2	4.4	4.4	13.9	34.7	11.1	23.7	17.0	10.5	33.1	9.1	18.1	33.2	6.0	16.2	27.4	24.0	10.9	38.4	6.5	40.8	17.4	12.5	36.6	82.5	46.7	39.7	78.4	1.8	39.8	26.2	0.0	57.5	34.0	26.3	21.6	5.8	47.9	31.3	33.4	14.5	23.4	23.1	5.2	56.1	24.0	11.8	27.1	35.8	17.1	64.2	10.5	50.5	25.8	56.7	45.3	37.1	37.0	132.6	14.1	20.6	20.0	51.0	21.1
KRI1	FLJ12949	ENSG00000129347	"KRI1 homolog"	Q8N9T8	19	10553078-10566037	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Rod photoreceptor cells: 51.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 57.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043110, HPA043574"	Approved		Enhanced	Nucleoli		Yes	No			Nucleoli		"HPA043110: AB_2678321, HPA043574: AB_2678561"	"unprognostic (6.38e-2)"	"unprognostic (2.34e-3)"	"prognostic unfavorable (9.37e-4)"	"unprognostic (6.70e-2)"	"unprognostic (2.35e-2)"	"unprognostic (5.10e-3)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (3.46e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.43e-2)"	"prognostic unfavorable (4.89e-10)"	"unprognostic (2.99e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.02e-1)"	14.7	12.5	10.4	23.6	20.6	19.1	14.3	27.8	19.6	14.5	13.4	16.6	12.4	12.7	15.9	17.6	17.2	14.3	15.0	12.1	13.1	10.3	11.9	13.3	12.4	25.2	16.7	9.8	17.2	19.5	21.0	18.3	10.9	14.9	15.6	9.8	20.3	14.7	18.2	23.0	25.3	16.8	15.0	17.2	23.0	12.7	14.6	18.6	46.8	15.6	10.9	21.3	15.8	15.9	8.5	14.1	2.5	4.9	8.5	11.2	3.9	12.3	6.3	8.1	11.7	4.4	4.9	5.6	11.4	5.4	7.2	6.7	9.1	4.5	18.2	13.5	4.6	6.3	9.7	9.9	8.9	8.2	19.8	22.5	57.8	12.2	5.9	8.1	22.6	21.0	6.0	7.3	10.4	10.7	6.3	4.6	11.1	16.1	18.6	6.2	11.0	23.2	33.7	13.0	10.0	15.1	9.8	10.6	9.0	6.1	11.0	13.4	6.3	13.4	7.9	8.4	7.5	9.9	16.6	5.5	9.4	7.9	25.2	23.8	13.2	15.3	13.1	7.9	18.4	14.0	1.3	4.5	2.5	11.2	4.9	10.3	7.1	7.5	9.0	5.8	8.5	8.4	9.0	0.8	8.5	2.5	14.1	5.4	3.9	10.4	20.6	27.8	19.6	13.1	10.3	16.7	9.8	14.9	18.6	14.9	23.8	9.3	12.1	11.9	14.0	6.1	7.6	22.7	22.7	14.0	37.3	9.8	1.7	6.5	3.2	7.3	6.7	0.0	6.4	7.3	8.2	6.6	18.5	7.4	6.8	11.1	9.2	9.8	10.2	5.0	7.8	8.2	8.5	1.8	7.8	8.9	5.0	7.0	8.5	3.9	51.4	0.0	7.3	28.7	15.0	12.0	3.8	15.3	9.5	5.9
KRR1	"HRB2, RIP-1"	ENSG00000111615	"KRR1, small subunit processome component homolog"	Q13601	12	75490861-75511636	"Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043433, HPA051690"	Approved		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Nucleoli, Nucleoli rim"	"Nucleoplasm, Mitotic chromosome"	"HPA043433: AB_10960988, HPA051690: AB_2681574"	"unprognostic (2.77e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.71e-2)"	"unprognostic (6.01e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.12e-2)"	22.5	18.4	14.2	15.1	22.0	38.0	17.8	29.1	23.3	21.2	14.3	6.7	14.6	12.6	18.3	15.2	24.2	14.7	10.5	12.5	12.6	10.8	23.7	25.0	13.5	18.2	12.8	16.4	21.7	15.0	17.8	33.5	21.4	19.8	20.9	11.8	6.3	20.7	14.2	28.8	16.6	15.2	15.7	16.1	19.8	15.1	12.3	17.3	24.3	20.5	22.4	18.1	19.6	16.4	15.8	10.8	8.9	4.6	8.6	14.7	5.6	25.4	21.1	13.3	11.8	10.5	9.6	24.3	22.3	14.2	17.6	11.3	15.4	13.4	27.1	18.2	11.0	17.6	13.4	17.8	19.6	19.9	22.3	18.1	26.2	11.7	17.9	12.7	46.1	16.6	9.9	16.8	20.2	19.3	17.8	12.0	25.9	28.9	8.7	17.2	16.8	26.8	13.1	19.6	14.1	19.3	21.3	25.6	16.3	19.6	32.2	16.0	13.3	21.1	15.0	26.3	13.3	24.9	18.8	14.9	16.3	10.8	16.8	23.1	17.4	21.8	17.0	8.8	16.3	29.3	7.7	2.4	8.9	10.1	4.6	12.4	15.8	14.1	11.4	3.9	14.4	14.7	13.8	1.1	8.6	3.7	10.8	12.5	5.6	14.2	22.0	29.1	23.3	12.6	10.8	12.8	16.4	19.8	17.3	65.5	42.2	31.8	91.0	43.6	53.3	22.4	15.3	48.2	54.6	38.4	31.4	56.6	49.7	37.5	4.0	32.2	15.1	0.0	42.7	45.8	41.4	40.8	36.9	36.7	26.1	69.9	17.2	22.1	18.8	5.3	48.6	29.3	11.8	32.5	23.2	65.0	33.7	27.9	50.2	37.3	53.6	12.9	36.3	55.6	54.8	38.8	58.9	48.4	29.3	62.9
LLPH	"C12orf31, hLLP, MGC14817"	ENSG00000139233	"LLP homolog, long-term synaptic facilitation"	Q9BRT6	12	66116555-66130768	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA048920, HPA058786"			Enhanced	"Nucleoli,Mitotic chromosome"		Yes	No			Nucleoli	"Mitotic chromosome"	"HPA048920: AB_2680556, HPA058786: AB_2683820"	"unprognostic (3.60e-3)"	"unprognostic (4.94e-2)"	"unprognostic (4.07e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.31e-2)"	"prognostic unfavorable (6.44e-7)"	"unprognostic (7.15e-2)"	"unprognostic (1.30e-2)"	"unprognostic (8.49e-3)"	"unprognostic (2.15e-2)"	"unprognostic (1.07e-2)"	"unprognostic (3.87e-2)"	"unprognostic (9.65e-3)"	"unprognostic (2.49e-2)"	"unprognostic (3.37e-1)"	"unprognostic (2.94e-2)"	20.4	38.1	16.4	20.4	16.9	40.9	17.9	10.9	20.0	16.4	20.2	11.2	19.7	16.4	17.2	17.1	21.3	14.4	13.4	19.9	15.7	13.9	27.8	31.3	14.5	21.4	20.6	16.7	18.2	16.2	11.1	18.0	24.3	17.3	18.1	18.6	9.9	15.9	14.5	47.3	13.9	27.9	21.0	26.7	29.7	18.6	20.0	17.6	23.8	22.9	23.5	21.6	23.6	22.4	23.6	24.6	34.9	34.7	20.0	29.4	21.1	27.2	22.1	13.6	16.8	15.9	15.7	16.8	32.0	20.7	23.8	20.2	19.1	11.6	31.7	26.4	21.2	18.8	23.4	21.2	19.4	32.3	27.7	18.2	33.5	16.0	17.0	19.2	58.2	23.6	15.8	20.1	20.2	21.8	18.7	20.5	16.1	28.9	22.8	27.8	29.3	26.0	39.2	29.2	22.3	23.5	22.1	25.1	22.8	23.3	33.0	13.7	16.9	20.7	22.1	33.7	15.0	28.4	31.8	22.1	18.7	26.8	22.7	29.0	17.7	27.4	46.9	24.4	27.4	28.3	22.2	25.6	26.4	23.7	29.0	27.0	23.6	27.6	25.5	24.6	21.7	23.9	25.2	34.9	20.0	34.7	21.2	29.4	21.1	16.4	16.9	10.9	20.0	15.7	13.9	20.6	16.7	17.3	17.6	11.9	36.4	61.0	44.6	24.2	16.2	20.7	50.9	30.8	53.4	29.6	3.9	54.4	56.3	64.5	29.5	27.6	32.9	0.0	61.6	55.9	32.7	30.8	87.7	53.9	56.6	20.6	13.3	33.2	50.4	10.0	40.6	51.5	33.7	79.4	24.4	25.7	76.7	34.5	28.3	61.5	14.5	25.8	23.6	77.7	46.2	26.7	60.8	41.5	28.5	46.2
LYAR	"ZC2HC2, ZLYAR"	ENSG00000145220	"Ly1 antibody reactive"	Q9NX58	4	4267701-4290169	"Predicted intracellular proteins, Transcription factors"	"Immunity, Innate immunity, rRNA processing, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 60.2"	"Cell type enhanced"	"Detected in many"	12	"Spermatocytes: 435.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035880, HPA035881"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA035880: , HPA035881: AB_10669980"	"unprognostic (2.81e-1)"	"unprognostic (3.79e-1)"	"unprognostic (2.64e-2)"	"unprognostic (6.22e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.97e-2)"	"prognostic unfavorable (3.20e-5)"	"unprognostic (1.08e-3)"	"unprognostic (2.92e-2)"	"prognostic favorable (8.82e-4)"	"unprognostic (5.05e-2)"	"unprognostic (1.59e-2)"	"prognostic unfavorable (4.36e-10)"	"unprognostic (4.94e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.90e-2)"	"unprognostic (2.72e-1)"	11.1	5.7	6.8	11.9	10.1	10.9	8.2	7.3	8.0	6.6	6.9	4.3	4.1	5.7	6.9	5.5	11.2	7.1	5.4	10.1	7.0	4.6	5.0	9.9	7.7	13.8	10.9	4.5	11.1	6.3	4.4	15.6	7.1	8.4	7.8	6.8	3.7	5.4	6.4	15.1	5.9	6.2	9.1	7.9	18.2	5.8	60.2	12.0	10.0	6.3	11.9	10.9	10.1	10.4	7.3	7.1	8.9	12.9	10.7	32.8	10.3	13.3	7.0	6.3	9.2	5.5	6.3	10.8	12.2	4.2	12.7	8.8	22.0	17.6	35.9	8.8	5.2	20.5	8.5	23.5	12.7	16.7	6.4	17.3	36.0	6.7	24.6	9.4	41.5	9.8	4.9	8.1	14.6	24.9	3.3	10.9	20.5	48.1	12.0	8.8	13.5	14.1	53.5	31.3	14.2	23.0	21.7	11.5	17.3	5.7	9.3	15.0	6.4	6.6	7.3	12.4	8.4	7.5	12.4	10.2	12.7	10.1	16.5	38.4	8.5	12.8	57.4	8.6	35.1	10.2	8.9	9.7	8.5	28.6	9.6	32.8	7.3	18.9	30.8	7.1	5.7	8.9	19.0	2.8	10.7	12.9	5.3	8.8	10.3	6.8	10.1	7.3	8.0	7.0	4.6	10.9	4.5	8.4	12.0	14.9	30.0	19.7	34.4	106.7	9.4	21.6	12.7	26.8	36.4	1.8	7.9	43.0	8.3	15.1	74.2	29.5	2.8	0.0	17.0	43.6	29.4	25.4	20.8	10.6	32.5	14.3	10.3	8.6	30.8	61.9	31.7	32.1	20.3	19.0	16.0	9.6	22.6	13.9	25.1	5.1	28.7	38.8	35.0	435.9	39.2	101.3	16.9	130.7	24.0	62.3
MAGED2	"11B6, BCG1, HCA10, JCL-1, MAGE-D2, MAGED, MGC8386"	ENSG00000102316	"MAGE family member D2"	Q9UNF1	X	54807599-54816012	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Tumor antigen"	"Bartter syndrome, Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Peritubular cells: 301.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA031572, HPA031573"	Approved		Enhanced	Nucleoplasm,Nucleoli,Cytosol		No	No			"Nucleoplasm, Nucleoli, Cytosol"		"HPA031572: AB_10599819, HPA031573: AB_10602181"	"unprognostic (1.33e-1)"	"unprognostic (8.60e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.69e-3)"	"unprognostic (4.79e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.41e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.97e-1)"	"prognostic favorable (2.88e-4)"	"prognostic favorable (2.82e-4)"	"unprognostic (6.34e-2)"	"unprognostic (3.55e-3)"	"prognostic unfavorable (9.43e-4)"	"unprognostic (1.58e-1)"	"unprognostic (9.77e-2)"	"unprognostic (3.58e-1)"	22.1	38.4	26.9	14.8	26.5	8.2	50.2	24.4	43.0	55.7	27.3	27.8	21.4	16.2	41.1	31.8	21.9	45.9	28.5	40.7	23.8	38.2	42.7	17.3	24.0	13.5	30.3	36.0	79.7	23.5	34.5	57.6	58.6	57.1	63.9	16.4	43.1	32.0	53.7	25.6	16.5	17.6	41.6	24.7	17.5	22.5	21.8	18.3	23.4	45.1	17.3	22.0	31.9	29.2	17.1	11.7	43.1	37.0	28.5	35.5	32.5	5.4	10.0	60.2	18.3	28.7	39.1	11.1	22.5	40.2	17.9	31.8	10.0	13.9	7.6	59.1	45.3	14.7	7.4	17.1	17.0	12.9	13.5	14.2	15.7	11.9	19.5	24.6	4.0	12.1	51.1	7.1	18.1	9.2	36.9	33.9	8.9	3.8	9.3	34.1	15.0	8.9	6.7	22.2	9.5	12.0	5.9	21.6	10.8	24.5	4.1	9.5	24.5	8.9	10.4	52.0	73.5	42.9	6.8	29.2	15.3	23.8	22.7	6.3	6.0	5.0	5.4	22.3	10.6	77.7	43.1	9.1	35.5	35.5	22.4	27.3	16.3	29.4	33.1	11.7	17.1	29.7	34.1	3.4	28.5	37.0	7.2	29.2	32.5	26.9	26.5	24.4	43.0	23.8	38.2	30.3	36.0	57.1	18.3	41.7	33.9	29.8	80.0	37.7	72.3	51.6	53.5	66.9	30.7	73.3	27.5	185.2	208.9	88.2	2.4	76.6	14.7	0.0	47.8	117.1	94.0	95.1	100.4	13.2	60.7	130.3	56.0	66.9	12.9	8.5	216.0	36.3	150.1	64.9	42.6	178.6	48.5	32.3	301.2	111.7	49.9	155.2	150.8	13.5	12.4	30.6	141.5	45.4	24.9	55.9
MPHOSPH10	"CT90, MPP10, MPP10P, PPP1R106"	ENSG00000124383	"M-phase phosphoprotein 10"	O00566	2	71130314-71150101	"Predicted intracellular proteins, Predicted membrane proteins"	"Ribosome biogenesis, rRNA processing"	Ribonucleoprotein		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035059, HPA035060, HPA049907"	Enhanced		Enhanced	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Nucleoli, Nucleoli rim"	"Mitotic chromosome"	"HPA035059: AB_2674436, HPA035060: AB_10601875, HPA049907: AB_2680947"	"unprognostic (3.20e-3)"	"unprognostic (1.59e-1)"	"unprognostic (8.51e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.41e-3)"	"unprognostic (6.13e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (3.89e-7)"	"unprognostic (1.24e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.23e-2)"	20.5	17.6	21.8	20.2	28.0	21.2	23.7	26.7	25.7	23.5	17.6	12.6	22.0	16.5	22.3	26.7	30.6	19.4	17.1	20.4	21.6	20.3	22.2	27.5	15.5	21.9	30.4	22.7	25.4	20.7	20.0	36.7	18.5	26.3	24.0	18.4	8.1	21.8	28.8	48.4	24.4	16.8	25.0	25.0	22.0	17.6	13.7	29.8	22.3	20.4	26.3	24.4	22.2	22.2	13.5	12.8	8.7	17.3	12.4	17.4	8.4	15.0	11.4	14.7	17.5	13.7	13.0	20.1	16.8	13.4	13.9	10.3	20.4	11.1	21.2	10.6	11.7	10.8	14.1	18.4	11.9	18.6	14.6	14.7	25.4	9.0	46.4	12.0	32.8	20.4	11.1	15.3	11.4	15.3	9.5	11.7	13.3	36.7	16.9	13.8	16.1	26.4	33.3	24.4	21.0	13.0	22.0	23.0	25.0	11.2	16.4	17.9	13.8	11.2	26.1	16.1	13.0	13.2	14.6	12.2	16.5	17.7	15.7	21.2	14.4	16.2	34.7	14.2	27.5	16.5	8.7	9.9	7.2	12.4	13.6	16.0	13.5	15.7	14.8	11.7	12.3	17.4	15.3	1.4	12.4	17.3	12.8	13.2	8.4	21.8	28.0	26.7	25.7	21.6	20.3	30.4	22.7	26.3	29.8	32.8	49.8	36.5	30.0	29.8	35.6	38.2	17.8	38.8	66.0	17.4	3.9	41.6	21.6	35.8	4.3	33.7	11.5	23.3	36.1	40.3	37.1	24.7	46.2	28.1	23.8	17.5	17.2	20.3	16.4	5.3	45.1	24.7	11.8	28.9	19.6	22.1	29.5	10.5	41.1	21.9	47.2	38.8	34.8	57.9	88.6	29.4	27.1	34.8	22.9	28.6
NAT10	"FLJ10774, FLJ12179, hALP, KIAA1709, Kre33, NET43"	ENSG00000135372	"N-acetyltransferase 10"	Q9H0A0	11	34105602-34147670	"Plasma proteins, Predicted intracellular proteins"	"rRNA processing, tRNA processing"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB035546, HPA057576, HPA071628"	Approved		Enhanced	Nucleoli,Midbody		Yes	No			Nucleoli	Midbody	"CAB035546: , HPA057576: AB_2683475, HPA071628: AB_2686426"	"unprognostic (3.04e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.92e-2)"	"prognostic unfavorable (1.07e-4)"	"prognostic unfavorable (9.61e-8)"	"unprognostic (1.15e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (8.83e-5)"	"unprognostic (1.24e-1)"	"unprognostic (7.18e-2)"	"unprognostic (9.55e-2)"	"unprognostic (8.69e-2)"	18.5	22.8	20.5	21.9	27.5	23.6	20.8	21.9	29.9	18.1	17.6	24.3	16.4	13.7	30.6	19.8	25.2	21.7	14.7	16.4	17.2	18.6	15.9	21.8	15.1	28.7	16.9	19.8	26.4	24.9	31.5	23.1	20.1	23.4	19.5	21.7	23.0	22.5	17.8	23.4	31.0	16.6	21.5	15.1	23.6	18.0	30.9	16.9	31.2	18.3	19.4	35.3	17.8	19.7	10.4	12.8	2.2	11.1	11.8	13.7	6.9	12.4	17.6	9.4	20.0	11.4	10.1	10.9	12.4	9.1	15.8	12.6	19.7	7.2	40.0	9.2	10.4	13.6	18.9	35.4	18.9	20.2	11.1	22.7	18.1	14.4	18.4	10.3	45.3	13.2	10.3	13.0	10.3	29.0	7.4	12.0	19.3	39.5	14.0	13.1	23.6	36.9	20.6	13.5	21.6	21.2	27.8	31.9	16.7	9.1	21.8	14.0	10.6	16.7	17.7	7.4	9.5	17.7	12.5	9.6	14.1	11.2	20.6	22.9	15.3	18.3	38.1	14.2	18.8	13.9	0.5	6.6	2.2	10.3	11.1	13.7	10.4	11.1	11.7	12.8	9.6	11.5	11.2	0.8	11.8	9.7	9.7	9.6	6.9	20.5	27.5	21.9	29.9	17.2	18.6	16.9	19.8	23.4	16.9	6.0	16.5	12.0	9.6	10.9	11.2	9.8	10.2	14.7	22.7	14.0	11.8	15.4	5.0	6.8	3.8	7.8	3.5	23.3	8.3	9.9	7.4	6.4	4.7	7.2	10.5	11.1	6.9	6.7	4.0	2.1	8.6	6.0	1.7	11.8	8.5	7.7	6.9	2.9	12.4	5.0	10.1	12.9	8.1	17.9	25.4	12.0	12.0	10.2	12.4	6.3
NCL	"C23, Nsr1"	ENSG00000115053	Nucleolin	P19338	2	231453531-231483641	"Plasma proteins, Predicted intracellular proteins"		"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004210, HPA023981, HPA071110"	Supported		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	Yes		600000	"Nucleoplasm, Nucleoli, Nucleoli rim"	"Mitotic chromosome"	"CAB004210: AB_670270, HPA023981: AB_1854688, HPA071110: "	"unprognostic (1.91e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (2.28e-4)"	"unprognostic (1.63e-2)"	"unprognostic (2.72e-3)"	"prognostic unfavorable (1.41e-6)"	"unprognostic (3.74e-2)"	"unprognostic (4.31e-3)"	"unprognostic (9.78e-2)"	"unprognostic (6.70e-3)"	"unprognostic (6.07e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.57e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.42e-2)"	71.2	68.2	59.6	67.7	77.0	96.6	71.0	72.8	69.2	72.1	63.0	79.2	46.0	48.1	80.3	63.7	85.2	65.7	45.9	55.9	57.7	53.3	66.7	94.7	55.6	78.4	67.4	51.8	93.9	77.5	94.8	83.4	69.5	79.8	64.6	75.4	47.1	58.1	51.8	120.6	70.3	56.9	70.9	88.4	80.2	59.4	41.7	76.4	118.9	67.8	82.6	105.5	79.9	60.6	40.8	41.3	20.4	36.4	52.6	53.9	40.8	63.3	59.3	71.9	52.7	42.5	46.2	74.0	71.7	48.7	67.7	60.0	97.9	45.6	84.2	61.8	55.3	90.9	62.2	143.9	96.3	116.1	49.2	60.3	140.5	56.3	131.9	46.6	160.1	53.3	43.8	55.9	84.5	89.0	38.9	71.0	76.8	125.1	28.9	59.5	86.2	140.1	99.4	107.1	66.9	42.6	104.6	129.7	73.9	49.7	84.2	62.3	44.4	48.0	55.1	63.3	61.3	41.4	81.1	60.3	54.3	56.2	63.4	94.2	54.8	53.8	181.3	39.5	104.5	56.2	9.5	27.9	20.4	47.4	33.2	53.9	40.8	41.7	42.6	41.3	38.9	46.6	42.1	6.0	52.6	36.4	35.5	34.4	40.8	59.6	77.0	72.8	69.2	57.7	53.3	67.4	51.8	79.8	76.4	271.0	357.6	280.1	370.4	408.5	137.1	290.7	137.6	385.4	589.2	184.9	45.2	333.3	195.6	173.5	15.4	228.8	106.1	210.2	218.7	336.0	249.6	218.4	431.8	217.9	213.5	76.3	191.8	122.8	135.8	18.9	201.0	194.7	156.9	238.1	192.5	194.0	213.8	138.2	150.3	209.2	125.5	148.8	282.2	390.1	563.8	385.9	316.9	226.1	268.8	321.5
NIFK	"hNIFK, MKI67IP, Nopp34"	ENSG00000155438	"Nucleolar protein interacting with the FHA domain of MKI67"	Q9BYG3	2	121726945-121736923	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015382, HPA035735, HPA035736, CAB075728, CAB075729"	Supported		Enhanced	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Nucleoli, Nucleoli rim"	"Mitotic chromosome"	"CAB015382: AB_2142390, CAB075728: AB_2665734, CAB075729: AB_2665735, HPA035735: AB_2674758, HPA035736: AB_2674759"	"unprognostic (3.53e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.49e-1)"	"prognostic unfavorable (5.57e-4)"	"unprognostic (1.21e-1)"	"unprognostic (4.15e-3)"	"prognostic unfavorable (2.92e-6)"	"unprognostic (7.74e-3)"	"unprognostic (4.63e-2)"	"unprognostic (3.21e-2)"	"unprognostic (6.02e-3)"	"unprognostic (9.50e-2)"	"prognostic unfavorable (5.01e-11)"	"unprognostic (1.72e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.28e-1)"	25.1	18.7	18.4	22.1	19.0	19.9	28.1	14.3	20.8	24.0	17.3	14.8	9.8	16.5	21.4	17.4	28.2	20.3	16.6	15.4	16.1	15.1	24.2	40.1	14.7	30.8	15.8	15.2	32.8	33.7	12.9	28.9	19.8	18.5	21.2	19.7	10.2	16.5	14.2	35.5	22.8	17.9	20.9	18.3	28.1	19.2	18.7	18.0	31.3	23.6	21.3	29.5	26.1	21.0	28.1	25.9	12.5	23.5	27.1	32.9	24.6	28.8	8.7	18.9	18.5	16.6	23.0	22.7	22.7	20.4	28.6	31.3	25.5	14.7	39.7	28.4	17.7	24.8	18.7	40.6	30.7	42.9	24.1	21.5	39.0	12.3	23.8	23.3	35.9	21.6	23.1	35.4	37.8	50.7	13.3	20.5	15.8	43.8	19.8	24.7	14.2	27.5	35.7	46.3	34.5	31.5	26.4	21.2	48.6	25.4	18.1	23.6	24.4	14.3	28.6	49.6	17.9	13.7	30.9	11.8	19.7	32.2	22.2	32.3	23.2	34.9	44.1	15.3	35.5	27.4	12.5	19.8	9.3	22.9	23.5	32.1	27.0	28.2	26.2	25.9	28.1	32.9	30.8	1.3	27.1	20.9	22.6	23.5	24.6	18.4	19.0	14.3	20.8	16.1	15.1	15.8	15.2	18.5	18.0	41.7	23.4	49.1	90.7	87.3	25.6	18.3	15.3	44.2	64.8	14.0	11.8	63.5	39.7	65.3	10.4	41.8	15.2	23.3	39.1	70.0	52.4	39.8	53.1	31.1	49.2	12.7	27.0	22.7	32.3	3.8	53.2	41.0	21.9	45.1	37.8	44.7	45.9	21.0	42.5	40.0	38.4	38.8	44.3	54.8	72.2	88.7	40.8	39.4	44.3	93.5
NIN		ENSG00000100503	Ninein	Q8N4C6	14	50719763-50831121	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Muller glia cells: 87.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA005939, HPA070691"	Approved		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Centrosome"		NA	NA			Centrosome	"Nucleoplasm, Nucleoli, Nucleoli rim"	"HPA005939: AB_2667474, HPA070691: AB_2686296"	"unprognostic (1.98e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.43e-2)"	"unprognostic (3.41e-2)"	"unprognostic (3.31e-1)"	"unprognostic (5.81e-3)"	"unprognostic (1.78e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.06e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.58e-2)"	"unprognostic (7.66e-3)"	13.0	6.1	15.1	24.9	10.3	34.8	9.7	12.6	14.0	8.0	9.2	7.6	4.5	5.0	11.8	6.1	11.8	8.2	7.6	16.4	11.7	4.9	6.7	5.2	10.7	30.2	7.6	10.0	11.0	5.4	9.1	12.3	20.2	7.1	6.5	7.7	6.2	8.2	5.1	16.9	10.9	8.3	12.0	7.1	18.2	9.3	4.6	9.0	16.4	7.8	5.1	25.8	11.7	10.3	6.8	6.3	18.4	2.3	1.5	6.0	1.3	12.3	8.7	18.3	15.5	7.0	11.4	7.6	10.6	9.1	8.9	7.5	5.6	6.6	29.1	7.3	14.3	8.5	13.0	14.7	6.7	18.9	14.0	4.5	10.7	5.4	5.3	4.1	18.6	30.9	7.8	5.4	15.7	6.4	5.3	14.2	15.1	2.6	11.9	13.5	13.5	14.1	7.5	2.5	3.9	9.7	16.0	33.8	2.1	8.0	14.0	8.5	9.6	13.3	4.0	11.4	4.2	7.6	16.6	20.7	22.8	31.7	8.7	11.7	9.6	4.8	20.1	5.9	15.2	12.3	12.6	2.3	18.4	3.3	1.7	3.5	6.8	2.2	6.0	1.5	5.5	4.4	3.8	8.3	1.5	1.5	6.3	1.9	1.3	15.1	10.3	12.6	14.0	11.7	4.9	7.6	10.0	7.1	9.0	6.0	7.7	41.0	7.0	16.4	7.5	37.9	12.7	26.8	36.4	10.4	58.9	9.2	3.3	6.9	22.3	24.1	4.1	0.0	3.5	8.9	27.9	13.0	30.1	3.9	20.1	6.4	12.1	27.0	40.6	7.8	7.8	47.2	21.9	12.6	3.9	87.7	4.7	5.8	8.9	5.1	18.0	32.3	20.8	0.0	0.4	18.3	8.1	37.4	4.6	14.5
NOC2L	"DKFZP564C186, NET15, NET7, NIR, PPP1R112"	ENSG00000188976	"NOC2 like nucleolar associated transcriptional repressor"	Q9Y3T9	1	944204-959309	"Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044258, HPA062195"	Approved		Enhanced	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No		420000	"Nucleoli, Nucleoli rim, Mitotic chromosome"		"HPA044258: AB_10961284, HPA062195: AB_2684707"	"unprognostic (3.18e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.59e-1)"	"unprognostic (9.54e-3)"	"unprognostic (6.75e-2)"	"unprognostic (2.31e-3)"	"unprognostic (1.94e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.20e-3)"	"unprognostic (8.62e-2)"	"unprognostic (6.25e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.52e-1)"	17.7	15.6	13.4	20.5	17.8	23.8	18.2	23.7	27.4	15.0	15.3	15.6	13.5	16.8	19.0	13.5	27.7	18.3	21.8	23.0	15.3	15.3	15.2	36.6	14.0	19.3	18.7	19.0	16.9	26.8	20.8	15.3	15.9	16.7	16.6	11.1	14.0	22.0	16.5	40.0	32.4	14.6	14.7	13.6	17.5	16.4	21.1	18.0	22.7	19.8	29.5	21.8	17.5	18.0	14.3	20.2	11.3	29.0	18.8	18.4	16.0	27.6	27.6	4.9	32.1	9.0	8.0	18.1	20.7	9.7	29.0	15.9	36.6	27.2	31.2	29.4	13.7	24.1	25.4	36.7	30.9	12.3	19.6	41.8	16.5	35.7	31.7	20.3	36.3	16.3	13.1	8.8	31.8	21.3	9.0	14.0	11.1	46.6	14.4	12.8	43.8	23.3	22.0	28.3	20.0	32.8	29.3	20.6	37.8	13.3	11.7	34.7	34.1	27.4	41.5	25.3	7.8	18.5	19.9	16.0	17.3	24.7	18.9	35.3	24.8	26.7	56.4	21.5	51.6	14.4	7.2	17.0	11.3	14.2	25.7	18.4	14.3	13.8	13.6	20.2	11.9	14.3	11.1	1.6	18.8	29.0	13.0	10.9	16.0	13.4	17.8	23.7	27.4	15.3	15.3	18.7	19.0	16.7	18.0	14.9	23.9	46.0	71.4	61.6	53.0	2.8	20.4	20.1	13.6	34.9	58.9	54.4	14.9	44.4	5.6	27.4	17.0	0.0	39.8	56.2	34.7	37.8	12.8	19.8	34.6	42.9	28.8	17.8	23.1	8.1	27.3	24.1	23.6	30.7	23.4	21.7	31.2	17.5	20.1	15.2	68.2	32.3	49.2	36.7	73.9	71.6	49.2	39.9	41.2	60.5
NOC3L	"AD24, C10orf117, FAD24, FLJ12820"	ENSG00000173145	"NOC3 like DNA replication regulator"	Q8WTT2	10	94333226-94362959	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatogonia: 70.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063958, HPA067638, HPA070981"			Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA063958: AB_2685160, HPA067638: AB_2685876, HPA070981: AB_2686331"	"unprognostic (1.29e-1)"	"unprognostic (2.25e-1)"	"unprognostic (5.25e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.27e-3)"	"unprognostic (4.58e-2)"	"unprognostic (6.49e-3)"	"unprognostic (3.34e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.34e-1)"	"unprognostic (9.93e-2)"	"unprognostic (5.50e-2)"	"unprognostic (1.47e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.30e-1)"	16.7	13.2	9.2	11.2	14.5	3.7	14.4	10.8	12.7	13.5	8.9	6.0	8.4	6.7	14.1	8.5	14.3	12.1	7.3	8.8	9.3	6.6	11.0	15.0	9.7	14.9	16.4	7.7	15.4	7.8	12.5	18.2	11.0	14.5	12.5	8.2	6.3	9.7	8.9	18.8	11.6	8.4	9.8	16.6	19.8	8.1	14.1	13.1	12.8	15.7	13.6	16.0	16.1	10.6	13.7	4.3	0.5	4.1	7.5	5.8	3.1	17.9	9.8	6.7	21.5	7.0	11.4	7.9	14.4	11.4	19.8	23.0	16.7	12.7	19.5	10.6	7.2	10.2	13.0	19.0	8.6	32.1	13.3	14.2	13.2	8.2	10.7	14.0	20.9	6.0	6.5	8.5	20.8	21.0	12.9	8.8	7.3	20.5	9.9	19.4	6.0	13.1	15.6	14.1	10.5	10.9	5.9	15.3	10.7	11.7	5.6	4.8	11.9	10.3	5.2	15.9	7.8	13.4	8.1	8.5	12.7	12.8	11.5	24.1	9.4	18.8	27.1	11.6	20.3	9.4	0.0	2.4	0.5	4.3	3.9	5.4	13.7	4.4	5.4	4.3	12.6	5.8	5.1	0.1	7.5	4.1	3.8	4.0	3.1	9.2	14.5	10.8	12.7	9.3	6.6	16.4	7.7	14.5	13.1	17.9	10.7	18.7	20.6	21.1	20.3	20.0	10.2	28.1	47.8	21.0	7.9	18.3	21.6	16.6	2.2	24.1	2.0	0.0	11.8	11.5	13.4	12.0	28.8	9.2	11.3	12.7	5.2	13.5	14.5	3.6	17.0	13.1	11.8	25.2	6.0	21.0	12.3	2.9	23.3	18.0	20.6	12.9	21.8	59.0	70.2	19.1	12.7	13.8	8.6	13.5
NOL6	"bA311H10.1, FLJ21959, MGC14896, MGC14921, MGC20838, Nrap, UTP22"	ENSG00000165271	"Nucleolar protein 6"	Q9H6R4	9	33461441-33473930	"Predicted intracellular proteins, Predicted membrane proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055891, HPA061002"	Supported		Enhanced	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA055891: AB_2682959, HPA061002: AB_2684410"	"unprognostic (2.07e-2)"	"unprognostic (6.63e-2)"	"unprognostic (2.37e-1)"	"unprognostic (5.23e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.67e-1)"	"prognostic unfavorable (4.83e-5)"	"unprognostic (7.37e-3)"	"unprognostic (8.26e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.24e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (9.49e-4)"	"unprognostic (4.09e-1)"	15.3	14.9	13.3	17.7	19.7	21.0	14.9	16.8	30.8	16.0	11.4	14.6	9.0	10.3	15.3	11.9	21.1	12.8	18.2	13.1	12.4	10.6	13.8	41.6	13.5	15.8	10.1	11.4	20.5	20.5	22.7	18.2	15.4	19.2	17.5	14.8	12.5	15.5	15.5	23.4	23.5	11.3	17.0	7.3	17.6	13.0	19.0	7.8	13.8	13.2	19.7	20.9	12.4	14.5	4.2	7.1	0.3	8.4	3.9	6.0	3.4	15.6	22.6	8.6	19.5	13.5	9.3	14.8	17.5	13.1	20.5	17.2	24.9	5.8	27.3	8.0	19.6	9.0	11.0	25.0	25.1	21.7	17.3	10.4	14.0	26.3	13.8	13.3	31.9	20.6	10.3	20.8	27.1	26.2	8.5	13.4	10.1	22.8	10.5	16.2	13.8	17.8	32.1	31.2	17.5	20.6	15.4	8.5	14.2	15.8	18.8	10.2	14.1	14.6	18.9	6.2	9.6	7.6	18.6	14.9	12.6	17.0	15.8	30.4	10.0	14.0	23.1	11.2	16.9	14.4	0.0	4.0	0.3	5.4	8.4	6.0	4.2	4.1	5.2	7.1	3.6	5.1	4.8	0.2	3.9	7.9	3.8	4.0	3.4	13.3	19.7	16.8	30.8	12.4	10.6	10.1	11.4	19.2	7.8	3.0	14.6	4.5	5.1	17.7	4.5	5.5	7.6	4.0	11.4	3.5	5.9	3.4	3.3	6.7	17.3	6.0	2.3	0.0	3.4	4.8	4.1	6.5	3.5	6.7	4.4	3.2	9.8	3.7	1.2	17.9	5.5	2.7	5.0	1.8	4.1	4.2	4.9	0.0	5.6	2.1	3.5	0.0	5.1	2.3	6.1	22.6	2.5	5.0	6.8	7.4
NOM1	"C7orf3, PPP1R113, SGD1"	ENSG00000146909	"Nucleolar protein with MIF4G domain 1"	Q5C9Z4	7	156949723-156973182	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019866, HPA051624"	Approved		Enhanced	Nucleoli		NA	NA			Nucleoli		"HPA019866: AB_2670300, HPA051624: AB_2681556"	"unprognostic (1.24e-1)"	"unprognostic (7.47e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.30e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.46e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.01e-2)"	"unprognostic (3.35e-1)"	"unprognostic (6.30e-3)"	"unprognostic (1.49e-1)"	12.3	10.9	10.8	16.9	14.2	15.3	11.1	13.0	15.9	9.7	11.4	9.9	11.1	8.9	12.8	9.0	12.9	11.4	8.1	8.3	11.2	6.4	8.4	12.2	9.9	13.4	11.9	11.7	13.9	14.5	11.1	8.4	10.3	11.4	9.6	10.0	9.3	10.5	12.5	21.0	15.5	10.5	12.0	10.0	12.1	10.6	13.9	11.9	9.9	9.9	9.8	12.4	11.4	17.0	5.0	2.8	2.5	2.8	2.6	3.4	0.9	9.1	7.9	5.8	8.7	5.9	6.2	8.0	9.2	4.5	7.5	6.1	8.5	7.8	16.1	9.3	7.4	7.6	7.5	10.5	11.1	9.2	7.3	9.2	13.5	6.6	7.9	4.8	23.5	8.3	4.4	5.5	6.7	8.7	4.3	6.3	9.1	20.3	8.7	6.7	12.0	14.8	19.7	14.1	8.2	8.6	10.6	8.9	12.4	4.8	11.0	7.2	8.8	8.4	6.7	6.3	6.9	3.2	12.7	10.1	8.1	2.6	15.0	11.8	11.2	8.0	14.9	10.4	17.0	7.6	2.5	2.8	1.5	2.1	1.9	1.2	3.8	2.7	2.9	2.8	5.0	3.4	1.8	1.3	2.6	2.1	2.8	1.0	0.9	10.8	14.2	13.0	15.9	11.2	6.4	11.9	11.7	11.4	11.9	8.9	16.5	13.4	26.4	34.9	15.8	9.2	12.7	17.4	18.2	5.2	19.6	12.5	3.3	16.5	7.2	14.4	6.4	0.0	11.8	17.3	12.0	18.5	19.8	13.1	12.8	11.1	7.5	6.7	10.5	1.8	16.1	18.2	23.6	14.4	10.4	9.8	12.4	10.5	12.4	4.9	30.5	0.0	14.6	28.2	35.7	37.1	6.1	12.8	14.6	26.9
NOP14	"C4orf9, NOL14, RES4-25, UTP2"	ENSG00000087269	"NOP14 nucleolar protein"	P78316	4	2937933-2963385	"Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039596, HPA055652"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA039596: AB_2676590, HPA055652: AB_2682876"	"unprognostic (4.70e-2)"	"unprognostic (6.47e-2)"	"prognostic favorable (3.93e-5)"	"unprognostic (7.32e-2)"	"unprognostic (3.28e-1)"	"unprognostic (2.07e-2)"	"prognostic unfavorable (9.10e-4)"	"unprognostic (2.41e-2)"	"unprognostic (8.62e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.55e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.44e-1)"	"unprognostic (7.15e-2)"	"unprognostic (4.77e-2)"	17.3	16.8	9.8	22.4	13.2	19.0	16.2	21.1	15.2	12.0	12.6	9.0	12.6	12.0	14.3	11.7	19.0	12.1	14.7	14.8	8.9	7.1	13.6	34.0	12.9	20.8	10.0	8.7	20.7	26.8	13.9	15.5	12.8	10.6	12.3	12.8	11.1	14.7	14.6	38.6	21.4	13.1	12.4	9.8	18.0	15.1	9.8	11.4	17.9	15.4	16.3	20.9	18.1	18.9	5.2	4.9	1.3	3.8	4.4	8.4	3.0	16.3	13.9	8.3	17.1	11.2	12.7	14.5	15.1	10.8	15.8	13.0	18.1	17.3	46.3	10.7	12.2	11.5	11.3	22.8	19.6	17.0	8.8	21.8	36.8	13.2	16.4	14.8	39.9	16.1	12.8	17.7	17.8	16.3	7.8	13.2	14.3	33.3	16.5	11.8	11.7	42.1	30.1	21.6	15.1	22.8	27.3	12.6	15.4	7.9	26.4	17.2	10.1	12.5	9.3	11.8	7.9	17.8	15.8	16.4	13.2	7.7	16.1	27.7	12.4	19.9	40.0	13.8	29.6	13.7	1.3	3.2	0.6	4.8	3.8	8.4	3.4	5.8	7.0	4.0	5.2	7.0	5.2	0.5	4.4	2.5	4.9	3.8	3.0	9.8	13.2	21.1	15.2	8.9	7.1	10.0	8.7	10.6	11.4	17.9	22.5	10.4	13.9	23.0	9.0	18.2	15.3	17.4	35.2	1.8	13.7	12.7	10.0	12.9	1.7	14.3	3.6	0.0	20.6	13.2	7.6	9.5	19.7	23.1	9.9	19.1	8.6	9.2	3.2	2.1	11.5	11.3	0.0	15.4	9.7	6.0	16.8	8.6	9.2	10.1	7.1	12.9	13.3	9.2	20.6	28.4	9.6	12.5	13.4	14.8
NOP16	"HSPC111, HSPC185, LOC51491"	ENSG00000048162	"NOP16 nucleolar protein"	Q9Y3C1	5	176383938-176388975	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Basal keratinocytes: 179.6;Suprabasal keratinocytes: 179.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA036506, HPA058147"	Approved		Enhanced	Nucleoli		NA	NA			Nucleoli		"HPA036506: AB_10672223, HPA058147: AB_2683620"	"unprognostic (4.55e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.48e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.89e-1)"	"prognostic unfavorable (5.14e-4)"	"unprognostic (1.19e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (5.75e-6)"	"unprognostic (1.05e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.76e-1)"	17.1	12.8	11.0	15.3	12.7	13.2	13.5	6.1	10.4	8.5	13.3	4.9	8.4	12.0	9.5	8.1	23.2	9.6	9.9	18.2	8.0	8.2	18.2	34.3	8.7	15.0	11.0	8.8	10.9	16.2	5.8	7.2	9.5	14.8	9.1	11.8	3.2	8.8	7.7	50.2	15.6	9.5	8.7	6.8	14.7	11.2	12.2	9.5	9.4	11.3	29.3	17.1	11.1	12.2	26.8	30.3	2.7	26.6	24.1	22.6	13.7	17.6	27.0	6.7	28.6	9.9	10.4	26.1	14.7	8.7	21.3	18.5	37.0	17.8	29.5	20.1	10.9	21.6	16.7	31.5	48.6	14.9	37.5	25.7	15.2	19.9	31.3	20.0	31.1	18.0	10.8	21.9	19.5	24.2	7.0	15.5	14.5	29.7	15.1	15.3	51.4	23.7	42.9	23.7	27.0	34.3	19.9	9.5	31.3	19.8	15.1	20.2	17.0	8.6	35.0	19.5	6.8	15.6	22.8	14.0	16.3	16.7	15.2	36.6	19.4	23.0	32.7	12.7	42.6	14.0	2.1	16.8	2.7	17.4	26.6	22.6	25.1	19.6	18.7	24.9	26.8	21.5	22.5	1.7	24.1	13.0	30.3	13.6	13.7	11.0	12.7	6.1	10.4	8.0	8.2	11.0	8.8	14.8	9.5	6.0	18.7	26.1	87.2	179.6	3.6	28.3	30.6	17.4	51.2	1.8	3.9	42.2	31.5	52.0	5.5	36.6	15.8	0.0	45.6	43.9	34.5	39.0	25.5	35.6	34.5	0.0	20.1	9.2	8.5	3.1	18.1	22.4	54.0	27.1	25.0	3.4	46.9	8.6	13.8	56.7	2.9	6.5	76.9	28.6	31.6	179.5	32.0	17.3	40.3	81.4
NOP2	"NOL1, NOP120, NSUN1, p120"	ENSG00000111641	"NOP2 nucleolar protein"	P46087	12	6556863-6568691	"Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040119	Supported		Enhanced	Nucleoli		No	No			Nucleoli		"HPA040119: AB_10965321"	"unprognostic (2.88e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.15e-2)"	"unprognostic (8.74e-2)"	"unprognostic (6.47e-2)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (6.38e-2)"	"unprognostic (2.19e-2)"	"unprognostic (8.82e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.53e-1)"	"prognostic unfavorable (2.35e-10)"	"unprognostic (1.43e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.96e-3)"	16.5	12.7	14.8	21.7	17.1	30.9	15.3	14.8	14.9	10.8	12.8	6.9	7.3	14.0	15.2	11.4	19.5	15.0	11.2	12.8	11.9	8.7	12.8	31.2	14.0	25.9	14.7	8.9	14.5	21.5	12.1	15.1	12.3	13.8	17.4	14.7	9.0	21.3	9.4	32.6	19.1	15.7	14.7	8.9	23.1	13.4	19.4	13.2	24.7	16.8	18.5	27.2	11.5	17.1	12.6	16.5	3.3	11.5	11.9	20.3	10.9	16.3	26.4	7.2	24.7	9.2	7.9	39.2	14.9	9.6	17.7	15.3	32.2	16.7	35.1	4.1	7.3	18.6	20.3	27.6	16.5	17.2	41.4	25.9	34.4	25.2	18.6	12.4	33.8	19.8	8.0	16.3	21.4	33.3	7.8	11.9	18.8	24.1	5.6	14.0	20.3	18.1	29.4	60.3	21.9	14.8	25.9	21.1	17.2	12.9	22.7	5.5	11.0	23.4	25.5	12.3	29.8	4.2	16.2	11.2	12.2	16.3	15.8	34.3	7.8	11.4	52.4	11.2	19.4	21.1	1.4	8.2	0.9	14.8	11.5	20.3	12.6	14.1	16.6	16.5	10.1	17.3	17.6	3.3	11.9	10.0	14.5	9.7	10.9	14.8	17.1	14.8	14.9	11.9	8.7	14.7	8.9	13.8	13.2	11.9	5.0	12.3	13.4	21.2	5.5	5.6	5.1	2.7	1.2	3.5	2.0	10.0	1.7	10.0	16.0	8.0	2.9	0.0	10.3	10.4	8.5	9.5	7.0	6.6	10.6	6.4	6.9	9.8	9.2	6.6	8.6	8.1	8.5	9.0	7.6	2.5	10.6	5.8	4.6	1.0	2.8	12.9	12.0	10.7	19.5	18.6	6.1	7.2	11.2	11.5
NSA2	"FLJ94393, HCLG1, HUSSY-29, TINP1"	ENSG00000164346	"NSA2, ribosome biogenesis homolog"	O95478	5	74766991-74780113	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	"Ribosome biogenesis, rRNA processing"	Ribonucleoprotein		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA043487	Approved		Enhanced	Nucleoplasm,Nucleoli		No	No			"Nucleoplasm, Nucleoli"		"HPA043487: AB_2678507"	"unprognostic (4.79e-3)"	"unprognostic (1.92e-1)"	"unprognostic (5.49e-2)"	"unprognostic (7.80e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.07e-2)"	"unprognostic (6.14e-3)"	"unprognostic (4.24e-1)"	"unprognostic (2.15e-2)"	"unprognostic (9.14e-2)"	"unprognostic (8.66e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.92e-2)"	"unprognostic (3.98e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.44e-1)"	25.4	32.6	17.4	26.8	29.3	28.3	24.0	14.0	29.4	31.8	25.8	8.0	18.0	26.2	26.5	22.6	27.9	22.9	13.5	27.7	20.8	13.6	27.4	35.4	27.0	42.5	16.7	19.1	54.2	31.2	13.5	35.4	25.4	20.3	27.8	20.6	10.4	33.8	17.9	51.1	17.3	22.2	23.1	28.5	28.5	24.3	44.5	15.7	26.4	27.2	21.7	26.1	36.7	26.1	17.0	11.1	4.4	11.9	13.1	19.3	6.1	20.6	11.3	14.0	18.8	8.7	16.1	21.4	14.8	7.7	9.5	7.5	18.7	20.3	16.7	31.6	8.2	23.3	12.8	11.0	16.3	13.4	11.4	17.0	8.7	22.0	21.4	8.1	15.2	20.5	10.6	15.4	12.7	9.4	15.5	7.9	15.2	8.6	14.1	10.1	15.7	25.5	38.2	9.3	8.8	9.9	18.3	16.4	31.5	11.9	22.8	15.0	19.6	8.9	17.3	39.9	11.0	16.3	43.3	9.1	7.3	22.1	13.7	42.5	14.1	18.8	27.3	18.3	27.0	10.8	4.4	7.2	4.2	10.5	11.9	15.1	17.0	16.0	15.8	11.1	12.4	19.3	19.1	1.3	13.1	8.8	10.4	15.8	6.1	17.4	29.3	14.0	29.4	20.8	13.6	16.7	19.1	20.3	15.7	74.5	77.0	155.5	140.9	83.6	31.6	79.5	137.6	66.9	104.6	59.3	13.7	119.1	127.6	113.6	331.3	86.4	114.1	116.8	204.5	170.1	84.0	110.5	116.6	184.7	121.5	47.7	134.0	113.5	170.4	102.0	257.7	109.4	79.2	149.7	219.3	47.0	172.0	119.3	161.2	158.4	31.4	135.8	91.0	120.5	95.0	75.2	113.3	107.1	207.0	165.4
NSUN5	"FLJ10267, NOL1R, NSUN5A, p120(NOL1), WBSCR20, WBSCR20A, Ynl022cL"	ENSG00000130305	"NOP2/Sun RNA methyltransferase family member 5"	Q96P11	7	73302517-73308867	"Disease related genes, Predicted intracellular proteins"	"rRNA processing"	"Methyltransferase, RNA-binding, Transferase"	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020536, HPA045590, HPA046867"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA020536: AB_1858789, HPA045590: AB_2679376, HPA046867: AB_2679847"	"unprognostic (3.94e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.79e-2)"	"unprognostic (1.01e-3)"	"prognostic unfavorable (2.48e-4)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (3.96e-4)"	"unprognostic (3.54e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.58e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.85e-2)"	9.0	7.7	11.2	13.1	12.8	40.9	8.7	12.9	14.4	8.5	10.3	15.0	4.8	12.6	12.3	6.9	10.8	12.0	8.1	9.4	10.8	9.3	9.4	9.8	8.0	16.1	19.4	11.9	10.6	19.6	9.5	8.3	8.3	13.6	9.7	6.2	7.7	13.6	9.7	27.1	11.8	12.1	10.9	11.6	15.8	9.6	14.6	13.6	23.5	10.6	11.2	12.1	10.6	8.9	33.5	21.2	18.7	14.4	16.8	22.3	15.3	12.2	17.0	4.8	10.5	2.0	2.5	18.2	5.9	3.4	9.1	9.8	22.9	9.1	20.2	4.0	2.9	13.4	10.6	9.0	5.9	3.0	13.3	20.9	7.6	12.4	13.1	7.8	16.8	10.4	3.4	9.9	7.8	6.6	2.1	1.2	15.2	24.9	4.8	4.3	29.5	14.2	34.6	19.3	9.0	13.1	17.4	3.6	28.9	3.9	6.1	12.4	20.7	10.3	27.6	13.3	5.4	17.7	13.4	1.9	0.1	13.3	13.2	3.9	19.3	24.9	28.8	0.2	23.6	0.9	14.2	14.4	15.0	14.0	12.5	11.0	21.5	15.9	14.3	16.5	33.5	22.3	18.8	18.7	16.8	9.3	21.2	17.3	15.3	11.2	12.8	12.9	14.4	10.8	9.3	19.4	11.9	13.6	13.6	6.0	6.1	51.6	17.1	15.0	25.1	17.1	25.5	10.7	12.5	34.9	11.8	33.4	31.5	36.0	12.8	7.3	18.6	0.0	28.6	37.8	16.9	12.9	26.5	20.3	30.9	30.2	3.5	6.7	17.4	16.3	27.0	19.4	20.3	46.9	16.4	13.8	24.0	17.5	19.4	19.5	21.4	6.5	14.1	60.6	58.5	18.6	18.2	25.4	19.9	15.5
NUB1	"BS4, NUB1L, NYREN18"	ENSG00000013374	"Negative regulator of ubiquitin like proteins 1"	Q9Y5A7	7	151341699-151378449	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"monocytes: 930.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021220, HPA050722, HPA053648"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA021220: AB_2670630, HPA050722: AB_2681220, HPA053648: AB_2682217"	"unprognostic (7.04e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.22e-2)"	"prognostic unfavorable (8.70e-4)"	"unprognostic (1.42e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.10e-1)"	"unprognostic (8.76e-2)"	"unprognostic (2.69e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.64e-2)"	"unprognostic (5.83e-3)"	20.1	17.3	17.1	22.1	15.5	13.2	20.5	20.5	20.0	22.2	25.0	17.6	17.3	30.9	24.4	17.6	18.1	19.8	17.0	16.5	14.8	12.9	17.1	18.9	21.2	28.7	14.3	15.4	25.4	21.7	28.0	26.4	23.7	18.5	21.6	15.3	16.2	19.8	15.7	30.3	16.9	38.3	20.8	19.8	26.5	17.7	56.0	16.0	32.3	26.5	15.9	19.8	25.3	22.3	21.1	18.9	28.9	24.0	24.5	24.7	17.1	27.0	12.3	16.6	9.8	17.3	21.2	13.8	21.8	20.1	16.6	19.2	12.0	24.0	29.2	28.9	13.6	21.3	13.7	9.9	14.2	10.7	25.8	16.7	10.6	11.7	7.6	24.3	24.6	13.8	13.5	16.7	11.9	11.3	20.6	10.9	14.9	27.7	0.8	13.3	14.5	43.5	18.7	26.0	27.7	16.2	24.2	17.2	4.4	12.3	13.4	15.6	26.0	40.9	17.6	20.8	12.1	12.0	14.2	22.0	14.1	5.0	18.7	20.6	28.5	21.7	25.7	28.5	21.2	23.0	10.4	15.7	20.7	20.9	20.3	24.7	21.1	18.3	21.1	13.6	19.9	20.4	19.0	28.9	24.5	24.0	18.9	14.3	17.1	17.1	15.5	20.5	20.0	14.8	12.9	14.3	15.4	18.5	16.0	68.5	57.3	44.2	28.5	22.0	35.4	51.7	30.6	72.3	71.7	24.4	11.8	39.1	51.4	43.6	181.4	36.0	42.1	0.0	60.6	37.7	28.4	41.4	69.4	33.4	27.3	46.1	28.2	30.7	34.8	15.4	40.9	42.6	15.1	930.6	41.4	52.7	51.5	17.5	38.5	30.5	40.1	25.8	38.7	96.0	12.7	25.3	41.9	48.0	21.9	30.6
NUFIP1	NUFIP	ENSG00000083635	"NUFIP1, FMR1 interacting protein 1"	Q9UHK0	13	44939249-44989483	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Late spermatids: 47.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029958, HPA029959"	Approved		Enhanced	Nucleoplasm,Nucleoli		Yes	No			Nucleoplasm	Nucleoli	"HPA029958: AB_10598911, HPA029959: AB_10602308"	"unprognostic (2.01e-1)"	"unprognostic (5.32e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.98e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.91e-2)"	"unprognostic (9.74e-3)"	"unprognostic (4.52e-1)"	"unprognostic (3.95e-2)"	"unprognostic (3.73e-2)"	"unprognostic (4.04e-2)"	"unprognostic (4.89e-2)"	"unprognostic (3.31e-1)"	"unprognostic (5.24e-2)"	8.9	9.8	10.4	10.7	16.4	17.4	11.6	11.0	17.2	9.8	7.8	10.8	4.8	7.1	11.7	14.4	9.2	9.2	6.3	6.4	12.7	9.6	10.2	13.7	11.2	8.5	8.9	12.6	13.7	11.5	9.3	9.6	7.7	7.9	9.1	7.9	6.3	8.6	8.8	17.0	10.1	6.4	10.3	10.0	8.4	8.6	14.1	8.8	11.4	10.1	6.8	9.3	8.9	8.3	6.6	6.3	1.1	3.7	8.3	6.9	2.5	5.4	4.3	7.3	6.1	5.0	5.3	8.8	6.5	5.6	12.1	7.8	11.6	8.8	16.0	5.5	6.0	7.3	8.6	13.6	9.2	15.8	4.9	10.7	12.2	2.9	10.4	8.4	15.7	5.0	5.5	8.6	8.1	12.4	4.7	6.0	8.3	9.7	2.7	8.5	6.2	12.9	9.9	17.3	14.6	7.1	12.8	7.0	9.8	7.3	4.7	4.0	9.0	5.6	7.6	7.0	7.2	5.8	8.8	4.5	6.2	5.3	7.9	8.9	3.7	5.7	20.2	7.0	11.1	8.7	0.0	3.7	1.1	3.9	3.7	6.9	5.9	4.3	4.1	4.7	6.6	6.8	5.1	0.2	8.3	2.3	6.3	2.4	2.5	10.4	16.4	11.0	17.2	12.7	9.6	8.9	12.6	7.9	8.8	6.0	9.8	6.7	10.1	13.7	7.2	4.0	5.1	5.3	18.2	5.2	11.8	13.3	14.9	11.0	34.3	7.7	2.4	23.3	14.4	12.0	9.3	4.8	17.3	8.1	9.3	7.9	5.2	8.0	4.3	47.9	10.0	7.9	8.5	6.4	4.7	8.2	8.9	0.0	10.6	12.2	6.6	6.5	8.5	26.7	28.3	14.4	7.3	6.2	8.1	7.1
NVL	NVL2	ENSG00000143748	"Nuclear VCP-like"	O15381	1	224227334-224330387	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028207, HPA028219, HPA028224, HPA028654"	Supported		Enhanced	Nucleoli		NA	NA			Nucleoli		"HPA028207: AB_10601382, HPA028219: AB_2672526, HPA028224: AB_2672529, HPA028654: AB_2672714"	"unprognostic (1.50e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (5.77e-5)"	"prognostic favorable (2.95e-4)"	"unprognostic (4.43e-2)"	"unprognostic (7.14e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.42e-1)"	"prognostic unfavorable (4.10e-11)"	"unprognostic (1.67e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.37e-1)"	11.3	12.6	13.3	14.3	12.6	12.5	16.2	24.4	15.7	14.2	13.8	16.9	11.4	9.0	17.1	12.2	11.6	13.5	8.5	9.8	10.4	9.9	13.6	9.4	11.8	16.9	10.5	10.8	16.9	19.3	16.8	20.7	25.8	13.4	14.2	16.0	16.5	11.6	12.6	9.8	22.7	12.5	17.5	13.3	16.4	11.1	9.4	12.0	23.8	15.5	8.5	19.1	14.4	13.7	14.0	9.9	12.5	15.2	12.3	13.5	7.9	14.6	8.3	17.4	13.9	6.5	9.4	17.5	12.5	8.7	16.5	15.2	12.7	12.6	20.4	13.5	7.9	6.6	13.9	18.9	11.7	18.0	15.9	26.1	9.8	14.2	6.5	11.2	19.3	15.6	7.6	9.3	14.7	16.6	7.9	10.8	12.4	25.6	12.6	10.8	11.4	14.9	9.6	26.8	11.0	14.9	18.8	21.7	13.1	10.0	10.3	15.4	13.5	18.9	28.9	17.1	15.5	13.8	17.6	10.4	13.2	8.6	15.3	23.1	8.3	18.1	21.7	8.4	15.7	13.7	12.5	8.2	8.2	13.1	13.0	13.0	14.0	13.5	9.6	9.9	10.1	11.3	11.5	0.8	12.3	15.2	9.6	9.5	7.9	13.3	12.6	24.4	15.7	10.4	9.9	10.5	10.8	13.4	12.0	20.8	23.9	8.8	3.8	4.6	13.9	8.8	5.1	21.4	13.6	1.8	9.8	16.6	11.6	8.1	5.6	6.0	8.6	0.0	7.2	11.3	8.7	4.4	15.1	2.9	9.1	9.5	4.1	5.5	5.7	2.2	8.9	6.6	5.0	5.4	11.5	9.4	6.7	17.5	10.3	5.6	21.0	0.0	8.3	14.6	12.6	4.0	15.3	7.5	14.5	3.8
PARP1	"ADPRT, PARP, PPOL"	ENSG00000143799	"Poly(ADP-ribose) polymerase 1"	P09874	1	226360691-226408079	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"DNA-binding, Glycosyltransferase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Cytotrophoblasts: 400.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000147, CAB003839, CAB003840, HPA045168, CAB075726, CAB075727"	Supported	Supported	Enhanced	Nucleoplasm,Nucleoli		NA	NA		39000	Nucleoplasm	Nucleoli	"CAB000147: AB_430876, CAB003839: AB_365493, CAB003840: AB_562187, CAB075726: AB_2665732, CAB075727: AB_2665733, HPA045168: AB_2679240"	"unprognostic (2.02e-1)"	"unprognostic (9.40e-2)"	"unprognostic (7.44e-3)"	"unprognostic (1.32e-1)"	"unprognostic (4.29e-1)"	"unprognostic (9.22e-2)"	"prognostic unfavorable (3.40e-4)"	"unprognostic (2.20e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (1.35e-5)"	"unprognostic (2.38e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.64e-1)"	17.3	16.6	31.2	35.7	31.2	14.3	15.3	21.1	29.2	14.3	21.8	37.4	10.3	15.0	18.2	13.0	18.1	15.0	10.8	24.2	27.8	21.9	13.4	24.8	14.1	56.3	40.7	21.8	14.6	28.1	62.6	22.9	28.7	30.4	22.0	19.2	16.3	17.0	24.7	47.3	11.7	19.6	25.5	49.1	32.7	15.9	22.5	34.8	29.5	14.5	16.5	70.2	19.9	13.7	53.0	16.5	9.0	17.5	11.1	21.8	11.5	28.9	15.5	43.2	30.6	11.3	9.4	24.6	19.2	17.1	26.1	21.5	24.7	14.2	84.4	28.7	11.6	11.5	21.8	59.4	18.8	23.1	35.4	82.9	32.6	20.7	16.1	6.8	54.2	15.8	9.2	7.5	21.0	14.9	7.3	20.3	19.6	51.9	43.1	13.5	13.8	17.3	19.6	79.5	40.9	30.8	52.5	74.0	78.0	12.2	20.7	43.5	38.1	25.0	28.0	15.7	31.8	23.5	34.0	15.4	13.9	23.0	18.7	35.9	17.6	29.4	72.5	11.6	18.3	31.1	9.0	6.7	6.9	18.3	11.3	21.6	46.8	19.4	18.0	14.3	53.0	15.2	16.4	1.0	11.1	17.5	16.5	21.8	11.5	31.2	31.2	21.1	28.4	27.8	21.9	40.7	21.8	30.4	34.8	50.6	68.3	130.2	75.6	64.2	94.4	106.4	43.3	75.0	97.8	54.1	133.5	400.4	61.3	77.0	28.3	54.0	16.8	23.3	91.9	75.6	55.5	70.8	116.9	65.7	117.1	85.8	72.1	31.9	42.2	16.3	37.2	45.7	59.1	93.8	46.5	78.6	54.3	24.6	32.9	36.1	102.8	45.3	47.4	92.8	211.4	42.0	115.1	74.0	57.9	42.9
PELP1	MNAR	ENSG00000141456	"Proline, glutamate and leucine rich protein 1"	Q8IZL8	17	4669774-4704337	"Predicted intracellular proteins"	Transcription	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"monocytes: 107.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053966, HPA056028, HPA060760"	Supported		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA053966: AB_2682325, HPA056028: AB_2683013, HPA060760: AB_2684355"	"unprognostic (8.81e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.81e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (6.44e-4)"	"unprognostic (2.72e-1)"	"unprognostic (2.76e-1)"	"unprognostic (4.31e-2)"	"prognostic favorable (4.07e-5)"	"unprognostic (2.20e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.31e-2)"	"unprognostic (3.31e-1)"	"unprognostic (8.32e-2)"	"unprognostic (5.15e-2)"	14.0	12.3	19.8	13.8	22.0	10.5	10.9	22.9	28.0	12.6	11.8	25.5	8.4	12.9	14.3	9.8	17.4	17.3	11.4	18.2	19.9	18.8	9.6	10.6	11.2	17.2	20.2	18.6	21.0	18.9	18.2	17.0	12.4	18.3	13.8	8.6	13.8	16.5	14.7	38.2	17.2	11.6	12.2	18.7	13.6	12.4	21.3	18.1	17.0	14.5	12.3	13.3	11.2	10.6	3.8	3.5	5.8	3.4	3.8	4.5	1.9	15.9	35.0	13.9	21.9	10.8	8.0	31.2	11.6	8.1	16.1	17.3	34.1	11.8	38.5	17.9	9.1	11.4	24.6	25.8	18.1	9.2	19.9	36.8	17.1	17.6	27.5	14.0	13.8	23.1	9.8	11.3	19.8	16.7	8.3	11.9	20.8	20.6	16.9	8.8	21.9	26.0	16.3	22.8	15.5	11.8	27.5	12.3	18.9	11.2	12.1	14.0	18.7	19.9	14.7	14.9	13.9	17.7	9.4	12.0	12.5	17.7	18.9	22.3	9.1	15.6	16.0	14.1	14.3	16.0	0.9	2.4	5.8	3.1	3.1	3.1	2.6	3.0	2.4	2.4	3.8	3.3	4.5	1.4	3.8	3.4	3.5	2.0	1.9	19.8	22.0	22.9	28.0	19.9	18.8	20.2	18.6	18.3	18.1	20.8	29.6	16.3	12.9	13.2	23.9	19.8	5.1	20.1	19.4	8.7	15.7	24.8	1.7	13.2	47.9	13.2	6.2	0.0	12.6	23.5	14.1	12.3	29.0	9.0	14.7	33.4	12.1	4.9	4.5	17.5	8.6	13.8	10.1	107.4	16.1	12.5	11.1	12.4	18.0	4.1	16.6	6.5	9.9	21.4	71.6	14.3	17.7	13.1	18.8	10.6
PES1	"NOP7, PES"	ENSG00000100029	"Pescadillo ribosomal biogenesis factor 1"	O00541	22	30576625-30607083	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040210, HPA062439, HPA066670"	Supported		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	Yes			"Nucleoli, Nucleoli rim, Mitotic chromosome"	Nucleoplasm	"HPA040210: AB_2676885, HPA062439: AB_2684764, HPA066670: AB_2685700"	"unprognostic (1.82e-1)"	"unprognostic (5.88e-2)"	"unprognostic (5.59e-3)"	"unprognostic (4.83e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.23e-3)"	"prognostic unfavorable (1.84e-9)"	"unprognostic (3.29e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.79e-2)"	"unprognostic (2.46e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.65e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.42e-1)"	24.4	28.1	26.0	26.1	30.1	28.2	29.6	19.0	31.8	19.7	21.9	27.2	18.1	20.4	28.0	21.3	31.2	28.0	22.7	18.1	26.3	18.5	24.2	34.9	19.8	30.0	27.2	26.6	30.5	49.0	31.3	17.0	20.2	23.6	24.2	19.2	18.6	22.2	22.1	34.1	32.3	19.8	22.9	24.3	26.4	25.2	34.5	27.2	21.2	25.3	23.1	24.9	21.8	22.6	14.4	17.8	3.9	19.4	12.4	16.2	16.3	34.3	39.2	14.5	30.8	16.7	16.4	22.3	22.9	18.8	39.1	30.5	45.4	14.8	46.6	20.5	26.0	30.2	24.0	44.5	40.8	28.8	19.9	42.8	22.6	22.5	39.1	41.7	54.5	23.8	23.1	25.7	40.6	40.9	18.7	25.1	16.7	37.2	19.0	23.6	43.3	26.4	55.3	28.1	33.8	28.8	33.8	25.3	45.6	21.4	23.8	25.1	26.0	22.6	25.8	30.3	12.1	18.1	28.0	19.8	45.9	34.8	23.3	38.2	24.2	20.7	47.6	32.2	25.1	29.3	3.9	15.8	3.9	13.3	19.4	16.2	14.4	12.4	12.7	17.8	13.8	14.2	12.7	0.6	12.4	13.9	15.4	9.5	16.3	26.0	30.1	19.0	31.8	26.3	18.5	27.2	26.6	23.6	27.2	3.0	17.6	13.7	18.1	20.0	6.4	3.4	25.5	26.8	19.4	24.4	7.9	30.6	21.6	36.3	38.4	21.1	24.6	0.0	38.0	33.3	14.9	13.1	17.4	20.7	33.9	3.2	22.5	28.8	29.7	10.4	18.4	20.8	20.3	31.5	19.9	13.1	33.1	14.0	19.1	39.6	8.1	19.4	18.4	23.5	19.3	19.9	23.8	15.0	24.7	12.2
PIN4	"EPVH, PAR14, PAR17"	ENSG00000102309	"Peptidylprolyl cis/trans isomerase, NIMA-interacting 4"	Q9Y237	X	72181353-72302926	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"DNA-binding, Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 68.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054483, HPA064504"	Approved		Supported	"Nucleoplasm,Nucleoli,Mitotic chromosome"		Yes	No			"Nucleoplasm, Nucleoli"	"Mitotic chromosome"	"HPA054483: AB_2682503, HPA064504: AB_2685274"	"unprognostic (2.47e-1)"	"unprognostic (6.97e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.77e-2)"	"unprognostic (8.42e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.14e-2)"	"prognostic favorable (6.37e-4)"	"unprognostic (1.56e-1)"	"unprognostic (2.13e-2)"	"unprognostic (2.49e-1)"	"unprognostic (9.54e-2)"	"unprognostic (2.09e-3)"	"unprognostic (1.92e-1)"	"prognostic favorable (2.58e-4)"	"unprognostic (3.34e-3)"	"prognostic favorable (2.66e-4)"	14.4	11.3	15.0	8.0	14.7	6.1	18.8	10.7	16.2	9.7	9.7	8.4	6.7	9.5	11.6	19.3	8.9	8.7	30.7	11.2	15.2	12.2	15.6	23.2	7.9	7.9	12.9	11.0	12.7	8.1	8.0	9.2	9.8	10.0	10.4	11.1	6.6	30.7	37.1	68.7	7.3	9.6	9.2	12.4	16.7	9.3	4.7	6.9	9.7	12.9	40.1	9.1	7.8	9.2	28.9	26.8	23.4	23.6	22.4	33.4	22.7	15.4	18.1	19.0	12.9	13.0	10.9	10.1	10.6	12.2	13.0	13.4	9.1	11.5	4.6	31.0	10.9	17.6	11.0	16.8	18.6	16.1	11.7	37.8	7.9	21.6	23.9	7.2	12.5	6.7	7.3	10.3	14.2	4.9	14.7	13.2	14.2	13.3	20.6	9.7	18.7	10.9	21.1	13.5	17.6	16.4	10.9	15.1	13.7	16.5	10.8	12.2	21.7	12.4	5.8	10.9	14.6	9.0	11.5	13.2	5.9	9.1	16.2	7.7	7.1	7.6	7.7	17.0	12.6	6.4	21.9	23.3	23.4	26.8	23.6	26.4	28.9	28.3	25.5	22.8	26.4	29.3	29.4	9.7	22.4	21.8	26.8	33.4	22.7	15.0	14.7	10.7	16.2	15.2	12.2	12.9	11.0	10.0	6.9	62.5	35.0	52.8	54.1	38.4	26.9	74.7	81.5	84.3	51.2	113.4	7.9	137.4	154.2	102.6	10.6	70.5	117.6	23.3	102.2	92.0	70.9	50.1	55.5	238.7	95.4	27.0	88.9	80.4	73.2	6.2	69.0	61.7	57.3	68.5	76.9	55.6	124.5	101.7	76.4	218.0	33.7	84.1	78.3	14.4	39.1	40.9	100.9	62.3	82.1	54.0
RBM28	FLJ10377	ENSG00000106344	"RNA binding motif protein 28"	Q9NW13	7	128297685-128343908	"Disease related genes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 88.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019058, HPA026672, HPA031519"	Enhanced		Supported	Nucleoli		Yes	No			Nucleoli		"HPA019058: AB_1856118, HPA026672: AB_1856119, HPA031519: AB_2673920"	"unprognostic (2.34e-1)"	"unprognostic (1.87e-2)"	"unprognostic (6.43e-2)"	"prognostic unfavorable (2.94e-4)"	"unprognostic (2.19e-1)"	"unprognostic (2.13e-1)"	"prognostic unfavorable (2.72e-11)"	"unprognostic (6.83e-2)"	"prognostic unfavorable (6.44e-4)"	"unprognostic (7.20e-2)"	"unprognostic (4.01e-2)"	"unprognostic (3.97e-3)"	"unprognostic (1.45e-3)"	"unprognostic (7.15e-3)"	"unprognostic (3.05e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.04e-1)"	22.1	17.7	16.3	18.4	25.1	14.2	17.5	26.5	25.3	12.8	13.7	19.7	9.6	13.2	17.1	9.9	15.1	12.5	10.9	24.4	18.1	8.6	12.0	18.8	13.2	17.9	26.5	16.2	19.7	15.7	16.5	18.4	14.5	17.3	13.1	12.7	12.3	13.0	13.0	33.5	17.3	11.2	14.2	25.4	13.8	14.1	18.4	24.4	11.7	16.1	12.2	15.6	13.8	18.9	14.5	14.3	9.8	11.5	12.3	13.7	5.5	18.6	20.6	12.5	35.7	8.9	5.7	17.1	17.2	7.1	15.6	17.0	17.1	16.4	24.8	9.4	7.8	22.8	12.7	18.3	14.6	20.3	12.4	17.6	24.9	14.4	15.7	7.9	31.3	22.4	6.4	9.6	20.7	12.5	5.9	14.4	13.8	46.5	14.5	12.1	15.1	22.4	17.9	23.8	12.9	16.2	17.8	15.0	23.8	7.6	12.7	14.0	17.0	22.2	37.2	11.8	15.6	9.5	9.6	13.8	22.7	11.8	20.1	20.8	15.0	12.8	43.0	14.9	26.5	24.4	3.5	11.5	4.4	13.7	8.9	9.4	12.8	11.6	12.2	11.5	14.5	10.5	12.0	9.8	12.3	7.8	14.3	7.1	5.5	16.3	25.1	26.5	25.3	18.1	8.6	26.5	16.2	17.3	24.4	14.9	32.7	12.7	12.1	14.3	55.3	21.5	5.1	21.4	38.7	12.2	88.4	17.7	21.6	15.9	2.1	18.8	6.2	0.0	19.6	22.7	16.4	9.7	34.8	12.8	16.8	38.1	10.9	7.4	14.3	1.3	25.6	14.5	5.0	13.6	13.8	23.3	15.5	7.0	19.4	12.9	52.9	6.5	21.7	41.1	51.3	12.7	15.6	16.0	14.8	10.9
RNF169	KIAA1991	ENSG00000166439	"Ring finger protein 169"	Q8NCN4	11	74748868-74842413	"Enzymes, Predicted intracellular proteins"	"DNA damage, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038505, HPA046138, HPA047952"	Uncertain		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies,Cytosol"		NA	NA			"Nucleoplasm, Nuclear bodies"	"Nucleoli, Nucleoli rim, Cytosol"	"HPA038505: , HPA046138: AB_2679553, HPA047952: "	"unprognostic (1.71e-1)"	"unprognostic (4.18e-2)"	"unprognostic (4.34e-2)"	"unprognostic (3.72e-2)"	"unprognostic (3.86e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.68e-1)"	"unprognostic (6.47e-2)"	"prognostic unfavorable (8.04e-4)"	"unprognostic (2.76e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.34e-1)"	"unprognostic (9.55e-3)"	"unprognostic (1.21e-1)"	12.3	7.0	12.0	11.6	14.0	23.1	12.0	22.6	15.6	13.1	11.2	12.2	6.3	7.4	14.2	8.2	20.6	10.7	10.8	9.2	12.6	5.9	8.9	9.3	16.9	11.3	15.4	9.1	14.6	10.7	17.5	10.4	8.6	13.9	10.5	10.0	8.4	12.4	8.8	15.0	14.1	10.3	14.2	10.1	12.6	10.3	7.2	14.9	12.6	11.5	7.4	12.5	13.1	15.8	0.6	0.8	5.0	1.9	1.2	1.6	0.6	8.3	6.4	7.8	7.6	5.0	6.8	3.1	6.5	6.2	7.3	6.4	10.7	6.3	14.9	6.7	7.8	5.0	8.1	10.4	7.8	9.6	7.4	6.7	10.3	11.8	4.2	5.8	5.4	8.6	6.2	6.2	8.3	19.0	8.2	11.8	10.2	9.1	12.0	7.3	7.0	9.3	9.8	3.0	10.6	4.2	8.7	18.5	8.1	4.7	8.7	3.5	6.3	8.8	6.7	14.2	6.5	8.4	7.0	7.8	12.2	10.3	7.6	5.8	8.7	4.5	17.7	2.4	6.0	7.0	2.8	1.9	1.5	1.6	1.1	1.2	0.3	1.5	0.9	0.8	0.6	1.1	0.9	5.0	1.2	1.0	0.8	1.2	0.6	12.0	14.0	22.6	15.6	12.6	5.9	15.4	9.1	13.9	14.9	8.9	10.7	13.0	26.3	17.6	51.9	2.8	2.5	5.3	7.9	3.5	49.1	5.0	5.0	8.8	2.2	11.7	6.7	0.0	9.5	5.0	9.3	37.6	6.9	11.0	7.6	35.0	11.5	8.6	10.7	2.2	6.9	9.2	10.1	1.8	7.8	33.2	9.1	5.8	9.9	9.1	32.5	25.8	15.1	10.4	10.9	16.3	6.8	16.6	9.7	39.6
RPL13	"BBC1, D16S444E, L13"	ENSG00000167526	"Ribosomal protein L13"	P26373	16	89560657-89566828	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051702	Approved		Enhanced	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA		53000	"Nucleoli, Endoplasmic reticulum, Cytosol"		"HPA051702: AB_2681579"	"unprognostic (5.41e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.14e-2)"	"prognostic favorable (6.26e-4)"	"unprognostic (1.57e-2)"	"unprognostic (3.68e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.14e-1)"	"unprognostic (7.57e-2)"	"prognostic unfavorable (6.64e-4)"	"unprognostic (4.34e-2)"	"unprognostic (7.10e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.30e-2)"	82.5	56.0	46.7	105.0	38.4	112.7	150.9	37.7	44.0	114.5	114.9	31.3	76.9	65.5	118.4	85.4	144.0	98.4	101.6	85.2	38.6	32.1	60.8	118.3	90.4	385.1	38.8	37.4	231.3	255.8	36.5	57.5	66.0	27.0	136.2	44.4	43.0	267.3	87.6	197.4	137.7	66.7	90.2	44.8	104.7	71.1	106.5	24.6	135.0	102.4	129.6	98.6	109.3	156.8	277.8	163.1	26.9	96.9	120.7	299.0	355.4	67.5	75.1	53.4	86.5	96.1	160.2	111.9	42.7	92.6	89.3	36.3	113.4	104.8	95.0	88.2	72.4	35.5	94.0	63.4	112.3	44.6	26.6	176.0	32.3	41.9	150.3	205.8	39.2	39.5	194.0	239.4	57.2	144.3	145.7	93.0	120.4	98.7	54.2	68.5	211.6	107.4	308.2	109.2	133.6	79.9	160.2	56.6	133.5	108.4	56.8	75.3	110.2	59.1	77.3	128.1	35.2	152.0	233.4	54.2	57.7	62.3	50.8	58.5	82.2	77.2	96.9	75.3	138.7	60.5	26.9	96.9	15.3	129.1	74.9	239.2	252.5	234.3	176.5	116.8	277.8	299.0	230.2	10.7	120.7	56.7	163.1	163.7	355.4	46.7	38.4	37.7	44.0	38.6	32.1	38.8	37.4	27.0	24.6	1676.5	3076.1	8572.3	13242.6	11129.2	658.9	392.1	3263.7	1810.8	3433.9	1533.6	178.7	5497.3	3942.5	3304.0	3376.6	4985.3	2353.5	1588.5	9512.5	8594.0	5542.1	9230.0	2503.8	3991.9	4585.6	235.2	2827.6	3949.3	6200.5	9204.7	7634.3	6835.9	5176.0	5670.1	5289.2	713.9	6690.8	4380.2	3433.2	5399.2	577.3	2050.2	5882.2	1406.9	1082.9	14135.8	5156.1	7058.2	8155.8	12161.4
RPL19	"DKFZp779D216, FLJ27452, L19, MGC71997"	ENSG00000108298	"Ribosomal protein L19"	P84098	17	39200283-39204727	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	7	"SK-BR-3: 959.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043014, HPA051987"	Approved		Enhanced	Nucleoli,Cytosol		NA	NA		100000	"Nucleoli, Cytosol"		"HPA043014: AB_10965840, HPA051987: AB_2681682"	"unprognostic (4.07e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.18e-1)"	"unprognostic (4.46e-2)"	"unprognostic (4.25e-2)"	"unprognostic (6.40e-2)"	"unprognostic (9.70e-3)"	"unprognostic (1.50e-1)"	"unprognostic (5.46e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (6.87e-5)"	"unprognostic (1.33e-1)"	"unprognostic (2.20e-2)"	"unprognostic (2.48e-2)"	"unprognostic (8.60e-2)"	72.3	57.7	51.3	56.7	56.9	122.5	94.7	41.8	88.6	72.2	64.5	42.2	62.7	48.7	67.0	56.7	77.7	78.1	65.9	87.3	49.2	37.0	62.3	124.4	70.7	229.5	50.5	53.0	156.4	124.4	33.1	51.7	57.3	58.7	60.0	52.5	48.1	113.8	67.6	91.4	95.8	58.8	57.5	57.1	74.4	66.1	45.2	34.1	53.0	63.3	94.9	103.4	63.1	75.9	208.2	143.4	40.4	108.7	116.2	236.3	325.8	48.1	65.5	47.5	57.6	87.0	110.0	49.2	45.3	92.6	93.9	75.5	71.4	45.6	117.8	79.8	64.7	54.9	81.9	71.4	93.7	48.4	47.8	125.4	42.0	48.9	92.8	135.7	102.9	58.2	122.5	103.0	72.3	130.9	88.2	80.9	101.1	73.1	69.0	64.8	47.4	136.4	143.9	48.6	56.3	48.8	80.9	67.6	117.8	84.6	60.3	57.8	64.3	27.2	959.6	141.5	53.6	92.9	131.0	47.6	36.7	49.7	55.9	83.3	91.1	90.1	86.7	49.8	78.6	47.2	36.7	108.7	40.4	116.1	90.3	180.1	208.2	187.2	146.8	143.4	193.1	236.3	190.8	17.1	116.2	72.6	132.4	146.2	325.8	51.3	56.9	41.8	88.6	49.2	37.0	50.5	53.0	58.7	34.1	821.9	1155.8	5178.5	5153.7	4931.6	221.1	502.6	2265.0	995.7	1437.7	1080.0	88.4	3138.3	3070.4	2271.3	1107.8	2991.3	1604.9	1214.8	5434.8	4726.5	2858.0	4250.3	1510.1	1935.0	3620.1	125.5	1883.0	2240.5	3562.4	3346.4	3629.9	4014.1	3104.2	3202.1	2957.8	586.7	3801.6	2980.9	1917.8	3691.6	289.1	1506.9	3219.7	1098.4	764.8	5786.0	3261.3	3671.2	4220.8	5947.6
RPL27	L27	ENSG00000131469	"Ribosomal protein L27"	P61353	17	42998273-43002959	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Cancer-related genes, Diamond-Blackfan anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002649	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA		30000	Nucleoli	Nucleoplasm	"HPA002649: AB_1079840"	"unprognostic (8.53e-3)"	"unprognostic (7.15e-2)"	"unprognostic (3.97e-2)"	"unprognostic (2.81e-2)"	"unprognostic (4.99e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.91e-3)"	"unprognostic (7.32e-2)"	"unprognostic (9.17e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.12e-2)"	"unprognostic (3.86e-1)"	"prognostic unfavorable (7.80e-8)"	"unprognostic (1.10e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.14e-1)"	78.4	66.9	61.7	82.2	45.7	150.0	148.7	63.1	82.7	75.1	76.8	27.2	65.4	48.8	74.8	80.1	91.9	64.9	80.8	120.6	46.2	38.5	76.2	121.7	109.5	222.2	49.2	49.0	123.7	185.0	17.2	44.1	81.0	48.3	65.3	55.0	43.8	119.1	78.5	127.5	113.8	61.9	82.4	43.6	84.4	69.7	40.3	28.8	72.6	70.5	153.8	78.5	86.1	80.9	178.5	152.7	44.2	99.0	111.4	184.7	216.0	114.1	144.8	88.7	128.4	157.1	233.0	143.3	133.0	109.3	143.0	102.6	205.0	89.9	216.5	113.2	104.6	77.6	100.2	101.6	169.8	137.6	100.2	241.7	85.0	121.4	216.7	193.9	244.1	89.5	219.6	145.5	96.5	123.8	146.7	118.5	114.9	158.0	134.0	132.0	111.6	203.2	206.9	134.3	132.4	92.7	142.6	249.8	244.5	120.8	154.3	99.8	110.2	52.2	103.0	211.8	125.8	173.2	258.0	133.7	106.6	105.6	130.2	195.6	117.1	188.5	211.9	95.8	151.7	108.6	44.2	99.0	29.5	106.6	87.9	150.2	178.5	159.0	124.5	118.6	168.3	184.7	159.1	20.4	111.4	67.3	152.7	112.5	216.0	61.7	45.7	63.1	82.7	46.2	38.5	49.2	49.0	48.3	28.8	681.9	960.2	2744.7	1731.4	2247.5	123.8	670.7	1245.8	627.7	1104.4	492.0	84.4	1811.7	1268.3	1382.3	339.9	1526.1	906.3	700.8	2626.7	2977.9	1476.5	1638.9	947.9	1517.2	1848.2	62.0	876.6	1298.9	2145.4	659.2	2254.1	2398.0	1353.0	2460.8	1687.2	280.7	2397.9	1157.3	1202.8	1660.9	156.7	853.7	1593.4	457.6	394.4	2946.9	1827.2	1797.0	2037.9	2132.8
RPS3A	"MFTL, S3A"	ENSG00000145425	"Ribosomal protein S3A"	P61247	4	151099573-151104652	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	Differentiation	"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 440.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047100, HPA053454"	Approved		Enhanced	"Nucleoli,Endoplasmic reticulum,Cytosol"		No	No		63000	"Nucleoli, Endoplasmic reticulum, Cytosol"		"HPA047100: AB_2679931, HPA053454: AB_2682156"	"unprognostic (6.24e-3)"	"unprognostic (3.45e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.79e-2)"	"unprognostic (5.46e-2)"	"prognostic unfavorable (6.56e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.41e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.81e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.39e-1)"	71.7	46.9	48.4	69.2	47.7	124.7	160.3	40.4	43.5	114.1	98.4	30.4	61.9	45.0	75.3	84.4	142.8	73.3	53.9	51.1	36.8	33.3	72.8	94.2	79.4	102.5	42.6	43.5	179.5	143.8	18.1	49.3	70.5	38.0	113.3	62.4	39.0	113.8	48.5	116.8	97.1	73.5	62.0	43.1	94.2	64.2	61.9	30.7	120.4	126.8	111.6	90.6	111.4	86.3	211.6	187.7	44.3	92.8	142.9	282.7	440.7	80.5	59.3	113.1	111.1	145.6	285.0	115.5	85.9	132.7	121.8	75.4	114.6	117.8	365.6	43.0	93.6	43.0	53.5	114.6	143.5	115.8	80.5	110.9	78.9	73.3	132.3	168.6	187.3	81.9	211.3	296.1	74.9	199.3	172.0	144.4	137.0	126.9	191.5	144.6	120.4	202.3	222.6	106.1	129.0	45.9	148.2	110.4	122.3	141.0	97.9	108.8	107.7	38.6	141.4	189.2	83.4	94.6	227.8	87.6	59.6	78.9	65.7	94.5	148.9	239.5	223.9	76.5	136.8	70.6	44.3	92.8	27.2	120.6	74.5	203.9	211.6	203.1	157.9	156.5	185.7	282.7	226.9	15.1	142.9	62.1	187.7	145.5	440.7	48.4	47.7	40.4	43.5	36.8	33.3	42.6	43.5	38.0	30.7	902.2	1351.4	4981.2	6887.5	5470.3	389.5	334.4	1689.1	1088.1	1918.8	783.4	113.9	3954.4	3630.9	1946.8	1331.3	2405.0	1231.3	1425.0	3246.4	6519.9	2822.1	4092.8	1400.9	1318.9	2985.4	154.1	2072.9	2006.5	3842.5	3230.8	4100.5	4536.3	3092.4	3236.3	3439.0	634.6	3016.2	2304.0	2436.9	3691.6	432.9	1739.7	3595.7	655.4	688.2	5905.5	3840.1	4239.4	5672.4	6561.2
RRP1	"D21S2056E, NNP-1, Nop52, RRP1A"	ENSG00000160214	"Ribosomal RNA processing 1"	P56182	21	43789513-43805293	"Predicted intracellular proteins"	"rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016818, HPA018166"	Approved		Enhanced	"Nucleoli,Mitotic chromosome"		Yes	No			"Nucleoli, Mitotic chromosome"		"HPA016818: AB_1854561, HPA018166: AB_1854562"	"unprognostic (5.38e-2)"	"unprognostic (3.48e-1)"	"unprognostic (3.43e-1)"	"unprognostic (2.53e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.13e-2)"	"unprognostic (7.69e-3)"	"unprognostic (1.26e-1)"	"unprognostic (7.63e-3)"	"unprognostic (9.42e-2)"	"unprognostic (6.94e-2)"	"unprognostic (5.25e-2)"	"prognostic unfavorable (6.29e-5)"	"unprognostic (1.13e-1)"	"unprognostic (9.21e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.88e-1)"	12.0	10.6	12.1	12.8	15.6	9.7	9.4	11.4	20.0	8.6	8.9	18.0	6.0	10.6	10.0	9.1	19.8	10.9	9.3	8.5	14.3	11.3	8.3	16.6	7.3	15.1	16.3	14.4	14.8	16.6	9.4	7.6	10.3	14.9	9.4	6.7	9.9	14.7	9.8	15.6	20.1	9.7	7.4	11.5	11.1	11.9	13.8	15.6	10.5	9.6	11.4	14.7	8.9	9.8	10.9	8.8	1.5	4.3	10.4	12.3	6.0	16.3	8.8	6.0	10.1	3.3	3.8	11.7	8.4	4.9	11.7	8.3	23.1	9.7	15.8	7.0	4.5	10.8	8.4	11.2	8.1	5.3	7.8	22.0	22.5	8.1	14.0	6.9	14.2	8.1	5.0	7.7	11.7	9.2	3.0	6.2	14.9	29.4	11.9	5.4	19.3	12.3	19.5	20.3	11.3	13.2	22.8	4.9	29.1	6.0	9.1	14.4	8.6	8.7	9.4	11.0	1.7	9.8	9.8	7.0	7.8	8.9	8.2	14.4	14.9	12.8	16.4	11.9	23.8	10.1	0.1	4.3	1.5	9.7	4.0	12.3	9.6	10.1	9.9	8.8	10.9	11.2	7.4	0.9	10.4	1.9	7.5	5.8	6.0	12.1	15.6	11.4	20.0	14.3	11.3	16.3	14.4	14.9	15.6	14.9	20.8	16.0	24.4	64.2	17.6	4.5	7.6	20.1	39.8	7.0	19.6	27.0	6.6	26.5	3.5	19.1	9.1	23.3	28.6	31.6	22.6	15.8	20.7	13.5	29.5	7.9	20.1	12.9	6.7	2.4	17.8	19.7	40.5	19.8	15.3	9.9	31.9	5.8	19.4	17.0	17.4	32.3	24.7	22.6	29.6	61.4	25.4	13.1	25.2	35.2
RRP12	KIAA0690	ENSG00000052749	"Ribosomal RNA processing 12 homolog"	Q5JTH9	10	97356358-97426076	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 62.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 19.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049945, HPA074403"			Supported	"Nucleoli,Vesicles,Plasma membrane,Cytosol"		No	No			Nucleoli	"Vesicles, Plasma membrane, Cytosol"	"HPA049945: AB_2680965, HPA074403: "	"unprognostic (2.79e-1)"	"unprognostic (7.65e-2)"	"unprognostic (5.87e-3)"	"unprognostic (1.10e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (3.12e-8)"	"unprognostic (2.64e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.82e-1)"	"prognostic unfavorable (2.54e-5)"	"unprognostic (2.58e-2)"	"unprognostic (3.32e-1)"	"unprognostic (4.81e-2)"	"unprognostic (6.99e-3)"	7.1	8.4	5.9	7.4	11.9	62.6	4.6	3.8	15.7	4.1	4.0	5.4	2.9	5.2	6.4	3.9	7.1	6.4	6.4	8.4	4.4	7.2	4.4	9.3	5.6	6.0	5.9	6.1	6.0	16.4	9.6	10.6	3.9	9.6	5.5	3.6	4.1	6.6	3.9	31.7	8.2	3.8	5.3	3.2	7.1	5.3	13.9	6.1	4.6	4.9	7.2	5.4	4.2	4.3	3.4	4.3	19.3	11.1	1.2	2.4	3.7	15.9	21.4	5.7	12.3	4.4	5.2	12.5	10.1	6.1	10.5	8.2	23.2	14.8	17.6	13.2	6.4	9.4	20.6	15.6	11.7	7.1	9.6	18.7	13.6	8.0	18.0	7.3	21.1	17.9	5.4	16.6	25.8	23.9	11.9	5.9	9.9	19.4	11.8	5.9	20.8	14.3	13.6	24.5	8.5	14.5	15.7	7.8	17.4	7.3	8.9	7.7	16.4	8.1	7.8	10.1	4.6	18.8	11.0	7.7	7.1	12.2	15.8	31.9	24.2	21.0	20.7	10.1	27.2	7.5	0.2	7.3	4.6	2.0	9.3	2.4	2.9	1.2	1.6	4.3	3.4	1.9	2.1	19.3	1.2	11.1	3.6	0.8	3.7	5.9	11.9	3.8	15.7	4.4	7.2	5.9	6.1	9.6	6.1	32.8	39.8	13.7	10.9	20.8	6.2	9.5	7.6	25.4	34.2	14.0	39.3	4.4	0.0	9.1	5.6	6.7	3.9	0.0	7.4	5.9	7.6	10.1	39.4	6.8	10.4	4.8	20.6	4.9	10.8	3.6	3.4	8.4	6.8	1.0	7.2	2.2	7.8	5.1	2.5	6.8	12.3	0.0	6.1	9.9	18.4	17.1	7.7	4.4	7.8	12.4
RRP1B	"KIAA0179, Nnp1, PPP1R136, RRP1"	ENSG00000160208	"Ribosomal RNA processing 1B"	Q14684	21	43659548-43696079	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Cone photoreceptor cells: 123.7;Early spermatids: 195.5;Late spermatids: 173.7;Rod photoreceptor cells: 138.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA017893, HPA020324"	Supported		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Nucleoli, Nucleoli rim, Mitotic chromosome"	Nucleoplasm	"HPA017893: AB_1852274, HPA020324: AB_1852276"	"unprognostic (1.03e-1)"	"unprognostic (1.37e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.03e-2)"	"unprognostic (7.19e-2)"	"unprognostic (1.98e-2)"	"unprognostic (5.55e-3)"	"unprognostic (1.08e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (2.95e-9)"	"unprognostic (1.45e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.05e-2)"	"unprognostic (4.24e-2)"	12.7	10.3	10.7	20.0	13.7	7.6	14.5	13.9	12.5	13.1	11.1	11.5	9.4	9.5	16.1	9.2	15.7	14.0	12.2	8.4	9.5	8.6	7.5	17.7	10.4	22.8	13.1	7.5	20.0	20.6	11.8	11.4	8.4	10.3	11.3	10.9	15.0	13.9	12.8	21.6	14.1	11.1	12.9	9.9	16.9	11.8	32.5	12.6	25.6	9.6	12.6	20.5	13.5	14.1	6.0	3.2	2.1	2.7	5.8	9.8	5.3	16.9	10.0	10.7	16.1	7.0	7.5	8.8	8.9	6.4	9.9	8.2	22.7	7.4	33.2	5.9	7.0	11.5	7.6	26.4	15.4	11.8	11.1	21.0	19.6	11.6	14.2	9.7	30.5	7.8	7.7	9.9	11.9	13.8	6.1	11.0	14.4	30.6	9.8	8.7	8.8	24.2	9.3	36.5	11.0	11.2	32.0	10.8	23.2	7.2	8.1	21.3	11.4	16.8	12.4	12.4	4.1	8.1	9.6	9.8	3.1	9.7	8.1	16.2	13.3	16.9	39.7	9.7	33.0	10.0	2.1	2.6	0.7	7.2	2.7	8.5	6.0	9.1	8.6	3.2	5.3	8.6	9.8	0.1	5.8	2.3	2.6	7.0	5.3	10.7	13.7	13.9	12.5	9.5	8.6	13.1	7.5	10.3	12.6	29.8	16.0	22.1	12.1	20.3	28.9	10.4	12.7	21.4	28.4	5.2	123.7	6.5	1.7	12.9	195.5	15.9	4.7	0.0	13.7	13.6	13.6	12.0	33.7	16.6	16.5	23.8	5.2	11.1	11.9	173.7	20.8	11.6	8.5	11.8	8.5	14.7	16.6	0.0	25.1	9.5	138.2	0.0	16.0	24.0	34.2	27.7	3.7	27.3	13.8	12.2
RRP36	"C6orf153, dJ20C7.4"	ENSG00000124541	"Ribosomal RNA processing 36"	Q96EU6	6	43021645-43034156	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA029904, HPA029905"	Uncertain		Enhanced	Nucleoplasm,Nucleoli		Yes	No			"Nucleoplasm, Nucleoli"		"HPA029904: AB_10611817, HPA029905: AB_2673244"	"unprognostic (1.76e-1)"	"unprognostic (4.47e-1)"	"unprognostic (3.78e-2)"	"unprognostic (1.46e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (5.95e-4)"	"unprognostic (2.61e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.38e-1)"	"prognostic unfavorable (2.48e-5)"	"unprognostic (3.53e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.09e-2)"	25.0	29.7	21.0	24.9	27.2	23.3	57.7	18.0	42.1	21.3	22.4	16.0	24.9	19.4	23.8	24.7	31.9	20.6	20.1	31.3	22.7	21.4	25.2	32.7	24.1	46.5	21.1	28.0	17.3	37.4	37.0	28.8	23.4	27.3	24.6	23.8	19.5	23.5	36.4	61.9	28.4	21.4	28.3	28.5	29.4	25.7	23.9	15.8	25.0	22.6	30.9	31.8	23.7	28.2	6.5	9.7	4.0	4.6	3.1	7.7	1.2	39.4	22.3	22.2	32.4	24.0	22.5	18.7	31.3	28.4	40.2	39.5	40.5	17.3	18.3	25.6	32.6	29.5	21.2	37.1	38.0	44.5	23.1	37.8	29.4	24.8	43.2	27.9	24.4	22.9	22.7	23.3	48.0	20.6	14.4	32.6	16.6	35.5	20.0	37.2	41.6	29.3	26.7	24.6	70.7	23.2	27.7	21.9	21.1	24.6	37.4	28.5	25.0	23.1	21.2	35.8	21.8	29.2	30.1	26.2	37.2	28.3	24.4	49.1	18.8	28.2	48.9	16.2	30.9	34.5	3.9	3.6	3.1	5.9	4.6	4.7	6.5	4.2	7.0	3.7	2.6	3.9	7.7	4.0	3.1	3.6	9.7	2.1	1.2	21.0	27.2	18.0	42.1	22.7	21.4	21.1	28.0	27.3	15.8	0.0	14.1	20.6	9.5	11.8	15.3	13.7	28.1	8.1	12.5	19.2	15.7	25.9	11.6	31.6	8.6	11.3	10.5	0.0	38.9	36.9	13.2	13.1	5.8	34.3	25.3	17.5	13.4	22.1	14.3	18.5	10.9	13.4	13.5	28.9	11.3	25.1	32.5	7.0	17.7	16.1	17.2	6.5	12.0	7.6	10.2	16.3	28.1	10.0	12.8	12.1
RSL24D1	"C15orf15, HRP-L30-iso, L30, RPL24, RPL24L"	ENSG00000137876	"Ribosomal L24 domain containing 1"	Q9UHA3	15	55180806-55197067	"Predicted intracellular proteins, Ribosomal proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA062724, HPA063392"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Nucleoplasm, Nucleoli, Nucleoli rim"		"HPA062724: AB_2684850, HPA063392: AB_2685002"	"unprognostic (3.40e-2)"	"unprognostic (3.00e-1)"	"unprognostic (3.83e-1)"	"unprognostic (7.28e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.07e-3)"	"unprognostic (6.71e-3)"	"unprognostic (1.15e-1)"	"unprognostic (6.56e-3)"	"unprognostic (1.34e-1)"	"unprognostic (6.19e-3)"	"unprognostic (7.22e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.44e-1)"	"unprognostic (4.54e-2)"	"unprognostic (4.95e-1)"	"unprognostic (2.41e-1)"	27.7	24.3	26.7	23.4	28.8	76.1	47.8	35.7	29.9	40.6	32.2	10.0	25.6	18.1	34.5	26.6	34.2	26.4	21.4	25.3	25.1	25.3	24.3	26.7	27.0	35.8	25.4	25.8	54.7	37.8	15.0	23.2	22.4	24.1	44.3	20.5	11.2	25.8	21.3	47.2	19.3	21.1	50.4	27.5	28.6	28.8	24.2	20.6	39.5	43.1	36.9	27.4	61.9	49.6	29.1	27.0	11.4	24.1	22.7	45.1	47.7	16.1	16.4	18.1	23.7	14.2	26.8	14.7	17.1	19.2	14.4	18.4	15.7	9.9	50.4	15.5	12.3	14.1	19.8	23.8	19.8	19.4	24.5	14.8	25.8	13.2	19.5	32.8	48.5	16.9	22.7	42.0	14.4	41.9	23.3	17.8	37.9	48.6	36.6	16.7	16.5	26.5	42.8	22.3	33.1	14.8	21.2	22.7	75.9	21.6	15.0	25.7	30.8	7.9	22.3	55.4	15.0	21.4	71.8	12.4	11.9	13.9	13.8	24.4	35.3	53.9	50.1	18.5	48.1	19.9	11.4	23.8	11.4	19.6	23.4	31.1	29.1	29.5	24.3	27.0	22.5	45.1	34.0	6.0	22.7	24.1	21.1	32.4	47.7	26.7	28.8	35.7	29.9	25.1	25.3	25.4	25.8	24.1	20.6	92.3	65.6	256.3	349.8	515.7	83.5	63.5	89.2	77.6	80.8	80.3	21.6	138.6	242.1	170.0	67.8	119.6	46.1	70.0	234.1	222.4	198.3	186.8	150.0	57.1	128.0	14.3	134.4	79.8	196.0	28.6	188.4	183.5	269.9	194.8	102.0	68.6	201.1	134.0	140.4	191.4	51.1	155.2	258.6	71.0	148.8	456.4	145.9	187.5	118.2	292.9
SETD7	"KIAA1717, KMT7, SET7, SET7/9, Set9"	ENSG00000145391	"SET domain containing lysine methyltransferase 7"	Q8WTS6	4	139495941-139606699	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Hepatocytes: 64.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058111	Enhanced		Enhanced	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Nucleoli, Nucleoli rim"	"Mitotic chromosome"	"HPA058111: AB_2683607"	"prognostic unfavorable (8.28e-4)"	"unprognostic (7.07e-2)"	"unprognostic (4.04e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.92e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.71e-2)"	"unprognostic (9.10e-2)"	"unprognostic (6.44e-2)"	"unprognostic (7.75e-2)"	"unprognostic (1.37e-1)"	"unprognostic (6.16e-3)"	"unprognostic (1.17e-1)"	"unprognostic (6.92e-2)"	"unprognostic (6.56e-3)"	26.1	13.2	12.0	9.6	12.3	5.7	26.3	10.2	16.2	27.9	17.7	17.9	11.0	4.8	23.8	12.0	18.3	13.8	16.9	25.2	13.0	10.0	7.2	30.7	12.1	6.9	18.0	10.1	13.3	13.8	26.8	9.3	12.0	15.4	22.8	10.2	12.4	13.7	13.9	56.4	14.2	9.9	33.3	19.0	11.8	17.7	10.6	16.5	2.9	10.3	15.2	9.9	24.2	30.1	2.3	6.8	1.8	5.6	0.5	5.6	1.6	9.0	11.7	4.5	2.6	26.5	22.9	9.9	21.5	22.4	11.0	9.3	6.9	12.4	21.1	8.5	36.2	7.6	4.6	14.9	17.0	17.9	10.4	10.5	2.9	15.3	0.2	13.1	10.1	4.5	19.8	19.9	17.5	18.7	14.0	13.9	9.0	1.7	32.9	14.0	15.1	6.6	1.5	2.2	13.3	7.7	6.2	15.5	12.1	10.7	8.3	17.4	5.8	14.3	21.3	5.1	4.5	8.4	9.2	22.5	19.5	13.9	23.2	17.8	28.4	27.2	13.4	22.5	10.2	9.3	1.0	5.6	0.5	0.6	3.2	4.1	1.8	1.8	1.8	6.8	2.3	0.8	0.5	1.8	0.5	4.8	3.5	5.6	1.6	12.0	12.3	10.2	16.2	13.0	10.0	18.0	10.1	15.4	16.5	6.0	13.1	3.4	10.9	15.2	6.6	35.4	17.8	4.0	6.8	8.7	11.8	21.9	0.0	20.5	0.9	24.7	1.8	23.3	18.1	14.4	19.2	35.1	2.3	64.4	18.3	7.9	1.2	36.8	29.7	3.5	21.3	18.3	10.1	7.2	11.2	13.3	21.5	0.0	26.5	3.9	12.6	19.4	21.0	3.2	1.9	19.3	38.6	5.0	9.9	14.2
SNAPC1	"PTFgamma, SNAP43"	ENSG00000023608	"Small nuclear RNA activating complex polypeptide 1"	Q16533	14	61762357-61796428	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 120.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"GAMG: 41.4;hTERT-HME1: 41.6;U-2 OS: 55.1;U-251 MG: 38.0"					"Low region specificity"	"Detected in all"			"HPA067076, HPA072276"			Enhanced	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA067076: AB_2732757, HPA072276: AB_2732199"	"unprognostic (7.40e-2)"	"unprognostic (5.04e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.94e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.68e-3)"	"unprognostic (1.88e-1)"	"unprognostic (4.01e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.47e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.26e-1)"	9.9	12.3	7.5	8.6	10.3	7.0	8.4	12.1	8.0	14.4	6.8	5.6	11.6	4.9	10.3	15.8	9.2	8.7	10.4	11.2	7.8	7.6	8.7	7.0	10.5	9.7	11.8	5.4	12.1	5.0	8.8	27.2	11.3	14.2	10.3	4.2	5.7	7.2	19.8	5.6	8.7	5.2	6.9	14.5	9.5	5.4	24.9	9.4	9.1	9.8	8.2	8.9	17.4	14.3	12.0	9.3	7.5	7.0	9.6	13.1	5.1	14.6	2.8	2.8	6.0	3.2	3.7	3.4	12.4	8.3	14.3	8.5	1.0	3.0	3.0	16.6	5.2	41.4	4.6	2.8	3.7	23.6	3.3	2.0	1.8	1.5	2.0	8.4	1.9	4.0	3.5	2.5	12.0	41.6	5.6	5.4	4.2	2.0	2.8	13.6	1.8	4.6	3.0	2.7	1.6	9.5	3.5	7.5	1.1	11.7	2.3	2.0	4.9	8.2	1.4	9.8	3.7	2.9	3.0	8.3	15.8	55.1	10.2	38.0	1.8	1.9	2.7	10.7	2.4	9.3	7.5	7.0	5.8	6.4	5.9	8.3	12.0	8.1	5.5	7.0	12.0	13.1	8.5	7.1	9.6	4.9	9.3	8.7	5.1	7.5	10.3	12.1	8.0	7.8	7.6	11.8	5.4	14.2	9.4	32.8	16.5	17.9	48.3	84.6	10.6	18.8	5.1	57.6	28.4	27.9	2.0	14.9	6.6	20.7	35.6	28.5	4.0	0.0	14.0	21.4	31.0	23.1	40.5	5.8	15.6	7.9	4.1	27.6	12.6	8.2	20.4	19.5	16.9	13.6	4.5	42.6	16.7	0.0	19.1	8.2	11.7	19.4	30.3	120.2	67.0	56.3	4.7	15.2	6.4	22.2
SPATS2L	"DNAPTP6, SGNP"	ENSG00000196141	"Spermatogenesis associated serine rich 2 like"	Q9NUQ6	2	200305881-200482263	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 76.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055427, HPA066310"	Uncertain		Enhanced	Nucleoli,Cytosol		NA	NA			"Nucleoli, Cytosol"		"HPA055427: AB_2682813, HPA066310: AB_2685655"	"unprognostic (1.13e-1)"	"unprognostic (1.74e-1)"	"unprognostic (9.35e-2)"	"unprognostic (1.78e-2)"	"unprognostic (4.39e-3)"	"unprognostic (3.58e-2)"	"unprognostic (2.17e-3)"	"unprognostic (3.44e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (7.43e-4)"	"unprognostic (3.95e-1)"	"unprognostic (7.84e-3)"	"unprognostic (3.71e-2)"	"unprognostic (5.67e-2)"	"unprognostic (6.01e-2)"	"unprognostic (2.99e-1)"	25.0	13.5	22.4	14.3	20.1	4.2	46.1	15.7	25.7	33.1	34.5	14.5	27.2	34.3	20.4	20.7	28.0	34.8	46.9	46.4	18.4	18.8	37.7	44.9	22.4	14.7	21.9	20.9	30.0	24.3	17.1	24.7	26.9	20.3	27.3	34.6	14.9	63.4	28.8	26.5	15.6	44.6	20.6	23.4	22.1	42.2	11.5	16.7	14.3	21.6	17.5	12.3	25.4	46.5	2.2	9.8	22.9	3.3	4.2	17.0	1.6	27.3	15.8	18.6	2.3	12.5	16.0	6.9	49.0	16.4	31.9	23.9	42.6	30.1	0.1	11.3	31.1	17.4	27.1	5.6	28.6	21.0	16.4	7.8	0.2	14.4	51.1	22.5	4.7	2.1	19.6	28.5	21.3	20.4	22.7	12.4	3.4	6.3	19.7	42.4	8.4	0.7	1.3	4.5	48.8	36.4	0.1	66.3	1.9	76.9	22.4	0.5	5.3	12.7	7.1	19.9	27.6	3.8	6.5	20.5	21.2	21.4	6.6	27.9	5.8	5.6	0.3	18.1	2.2	29.8	22.9	3.1	4.2	3.6	3.3	8.3	1.6	3.9	3.6	9.8	2.2	1.7	2.0	3.1	4.2	2.5	7.6	17.0	1.6	22.4	20.1	15.7	25.7	18.4	18.8	21.9	20.9	20.3	16.7	80.4	19.2	18.1	208.3	80.9	13.9	110.0	359.2	145.9	56.9	164.0	11.8	13.7	94.5	137.6	58.2	54.0	166.5	0.0	128.0	30.2	94.6	270.0	56.4	183.0	67.0	57.2	52.9	86.5	88.0	14.5	153.4	70.0	121.4	18.0	201.8	6.1	152.6	164.9	133.7	331.2	48.9	77.6	97.1	16.5	78.7	68.1	8.2	19.2	64.2	162.6
SPTY2D1	"DKFZp686I068, FLJ39441, Spt2"	ENSG00000179119	"SPT2 chromatin protein domain containing 1"	Q68D10	11	18606401-18634791	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039372, HPA040177, HPA047957"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA039372: AB_2676472, HPA040177: , HPA047957: AB_2680224"	"unprognostic (8.43e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.62e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.51e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.48e-1)"	"prognostic unfavorable (2.59e-4)"	"unprognostic (2.03e-1)"	"prognostic favorable (2.07e-4)"	"unprognostic (1.33e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.33e-1)"	14.0	12.7	6.2	9.7	9.2	33.6	11.9	10.9	10.9	13.7	10.9	6.9	9.9	8.3	11.9	8.6	15.5	12.5	12.2	9.9	5.8	6.5	14.9	25.1	9.7	8.7	6.0	6.8	16.7	16.9	13.6	14.0	15.3	8.5	12.5	9.7	7.9	13.3	13.9	16.3	12.5	13.7	9.3	7.6	15.0	11.0	7.1	5.5	17.7	12.8	8.0	13.3	12.5	11.8	2.7	3.4	7.8	5.7	7.3	8.7	3.3	8.2	8.1	6.5	9.1	10.9	11.4	10.0	12.2	13.4	10.2	12.3	7.2	3.6	18.5	6.9	11.5	8.0	8.6	10.8	9.6	14.7	9.7	10.1	7.4	4.9	6.6	10.5	15.6	14.8	9.4	10.0	6.5	13.3	7.4	11.2	11.1	10.3	29.5	11.3	8.9	10.4	6.2	5.9	16.2	9.1	9.6	18.1	7.9	10.7	11.9	6.3	8.9	10.9	12.7	8.5	8.9	7.9	6.7	9.8	10.0	8.5	19.4	7.4	10.3	12.7	14.5	11.9	8.7	8.4	7.8	4.1	5.8	5.7	5.7	8.7	2.6	5.6	5.7	3.4	2.7	5.2	5.6	6.0	7.3	5.4	2.9	6.0	3.3	6.2	9.2	10.9	10.9	5.8	6.5	6.0	6.8	8.5	5.5	23.8	45.0	23.8	18.6	49.6	12.8	23.6	12.7	61.6	34.2	26.2	9.8	12.3	14.9	21.5	1.6	21.9	22.7	0.0	21.7	19.7	31.0	20.1	56.6	25.6	14.3	11.1	42.5	21.5	27.0	1.7	17.5	31.7	15.1	13.6	24.2	13.8	21.6	22.1	13.1	12.6	11.2	32.3	23.0	10.7	14.2	58.1	23.0	35.5	18.6	29.3
SURF2		ENSG00000148291	"Surfeit 2"	Q15527	9	133356552-133361169	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 50.1"	"Cell type enhanced"	"Detected in many"	13	"Early spermatids: 358.5;Late spermatids: 675.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 43.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044340, HPA052213, HPA059710"	Approved		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim"		No	No			"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA044340: AB_2678900, HPA052213: AB_2681763, HPA059710: "	"unprognostic (1.53e-1)"	"unprognostic (6.10e-3)"	"unprognostic (1.24e-3)"	"unprognostic (2.25e-2)"	"unprognostic (2.50e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.46e-3)"	"unprognostic (8.28e-2)"	"unprognostic (1.07e-3)"	"unprognostic (1.09e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.86e-1)"	8.3	9.2	15.8	9.0	13.2	8.2	10.7	13.1	14.5	5.7	8.8	7.4	10.8	13.2	6.4	12.0	11.0	10.7	11.2	8.9	13.4	11.0	14.3	12.0	6.5	12.1	13.1	8.7	9.0	17.5	7.1	11.3	5.9	10.3	7.7	5.7	7.7	14.2	8.8	11.5	14.8	11.4	6.9	9.4	8.6	9.3	50.1	6.6	10.6	10.1	14.9	9.8	6.5	8.3	17.5	15.6	13.1	16.2	13.2	26.9	14.1	7.2	12.5	5.3	6.5	3.8	3.0	11.1	3.7	3.3	5.9	3.1	17.1	6.0	7.2	5.4	2.4	5.1	19.9	8.3	9.0	2.7	6.9	11.5	5.7	14.3	6.3	7.7	9.3	4.3	3.6	10.7	8.4	12.4	2.1	2.7	8.9	9.0	5.0	4.0	43.6	9.6	6.2	16.6	17.4	24.2	10.7	7.9	16.9	5.0	8.3	19.7	9.9	8.2	13.8	11.0	3.4	14.7	4.4	5.1	9.0	9.1	9.2	13.1	6.2	12.3	7.8	5.7	5.6	9.0	13.1	16.2	12.0	17.8	16.2	23.1	15.6	21.9	20.2	13.8	17.5	20.8	19.7	7.1	13.2	11.6	15.6	26.9	14.1	15.8	13.2	13.1	14.5	13.4	11.0	13.1	8.7	10.3	6.6	11.9	7.8	21.6	25.7	74.8	17.9	12.4	45.9	48.2	17.0	21.0	2.0	33.0	89.5	56.4	358.5	19.4	48.7	0.0	70.1	21.0	22.4	21.1	9.2	21.5	25.8	12.7	35.1	20.3	25.9	675.3	24.2	22.4	40.5	27.9	17.1	13.2	50.2	28.1	23.0	64.0	18.9	64.7	32.0	140.5	86.5	77.0	21.4	26.1	23.8	17.8
SURF6	"FLJ30322, RRP14"	ENSG00000148296	"Surfeit 6"	O75683	9	133328774-133336398	"Plasma proteins, Predicted intracellular proteins"		"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023608, HPA074622"	Approved		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Nucleoli, Nucleoli rim"	"Nucleoplasm, Mitotic chromosome"	"HPA023608: AB_1857671, HPA074622: AB_2686703"	"unprognostic (5.27e-3)"	"unprognostic (8.67e-3)"	"unprognostic (5.41e-3)"	"unprognostic (3.69e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.20e-1)"	"unprognostic (1.26e-3)"	"unprognostic (3.60e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.37e-2)"	"unprognostic (6.18e-3)"	"unprognostic (9.32e-3)"	"prognostic favorable (7.31e-5)"	"unprognostic (1.50e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.66e-1)"	14.8	16.8	19.9	15.0	22.7	16.2	15.7	16.4	25.8	13.9	16.2	14.0	11.9	21.7	18.6	10.9	17.4	18.5	15.9	13.9	19.1	17.9	14.5	16.2	12.6	17.6	19.6	22.9	27.4	23.1	16.5	11.8	12.5	24.6	15.8	13.1	11.6	18.3	19.5	47.3	17.8	22.3	18.0	23.6	18.8	13.6	16.5	19.8	8.6	14.4	11.1	13.5	15.3	19.1	7.7	8.9	3.9	4.7	4.6	8.5	3.6	4.1	6.4	5.0	7.4	3.1	2.9	8.3	6.5	3.9	5.8	3.7	10.1	7.1	11.9	5.1	3.6	4.3	12.5	6.4	6.9	2.2	7.9	7.2	8.2	7.4	6.0	5.6	13.8	7.1	4.1	6.1	6.1	5.7	5.3	3.0	11.7	17.8	6.5	5.2	10.7	11.2	11.4	14.5	16.8	11.7	11.8	6.9	12.1	5.1	4.0	10.5	8.9	6.4	10.5	5.7	3.2	9.2	7.8	6.2	13.4	7.1	6.7	8.9	4.8	6.8	15.5	5.0	9.5	7.8	3.9	4.7	1.9	6.8	4.4	7.0	7.1	6.2	6.1	4.9	7.7	8.5	7.0	1.3	4.6	3.7	8.9	5.0	3.6	19.9	22.7	16.4	25.8	19.1	17.9	19.6	22.9	24.6	19.8	41.7	23.5	25.1	10.6	21.1	24.6	26.3	30.6	17.4	35.2	21.0	5.9	26.9	18.3	29.0	1.1	20.3	37.7	0.0	16.8	19.1	14.3	11.8	24.3	29.2	18.5	20.6	32.3	12.9	11.1	2.4	25.6	14.2	6.8	21.6	37.2	16.4	23.6	28.1	26.2	11.9	20.1	0.0	17.0	18.9	21.0	24.1	15.9	16.6	47.0	10.5
TAF13	"TAF2K, TAFII18"	ENSG00000197780	"TATA-box binding protein associated factor 13"	Q15543	1	109062486-109076002	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044492	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA044492: AB_10962871"	"unprognostic (8.54e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.33e-2)"	"prognostic unfavorable (8.74e-6)"	"unprognostic (1.73e-2)"	"unprognostic (2.18e-1)"	"prognostic favorable (2.42e-5)"	"unprognostic (1.85e-1)"	"unprognostic (6.78e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.91e-1)"	"unprognostic (7.61e-3)"	"unprognostic (7.22e-3)"	23.5	13.4	24.6	14.3	23.4	27.7	14.7	14.0	33.7	18.0	16.6	19.5	15.3	10.0	13.9	14.7	22.1	9.9	18.0	19.2	25.3	26.9	22.3	21.0	11.5	8.6	32.2	22.6	6.6	15.9	14.6	21.2	21.0	35.8	16.9	18.2	7.7	14.5	11.7	40.9	13.0	12.8	22.2	36.1	7.7	14.0	10.3	20.7	4.1	18.2	16.6	14.8	16.4	11.0	1.3	3.0	7.9	4.6	0.5	2.3	0.8	20.6	5.4	8.3	12.1	24.0	22.5	13.8	49.1	20.8	20.0	20.3	8.6	4.7	7.9	18.8	32.6	11.9	8.7	14.6	17.7	30.2	13.5	3.3	7.9	13.2	8.9	19.0	13.9	12.1	20.0	21.3	33.5	18.3	10.8	17.1	7.3	15.1	7.7	27.0	11.9	7.3	3.8	16.6	9.6	11.3	5.7	15.0	3.1	23.6	18.0	8.7	10.8	24.1	15.6	17.7	15.5	5.3	9.9	22.3	33.1	12.6	23.3	26.8	9.4	23.7	10.6	35.2	7.4	49.1	2.6	4.6	3.7	1.7	3.3	1.5	1.2	1.1	1.7	1.5	1.3	1.1	1.6	7.9	0.5	2.8	3.0	2.3	0.8	24.6	23.4	14.0	33.7	25.3	26.9	32.2	22.6	35.8	20.7	17.9	21.1	8.2	9.3	62.4	4.5	57.2	10.2	16.0	26.1	7.0	0.0	15.5	11.6	14.4	29.0	19.7	31.6	23.3	18.1	26.6	20.6	18.8	13.9	35.8	16.4	6.4	30.6	24.5	29.7	2.9	8.6	18.4	13.5	12.6	26.1	10.8	24.9	20.1	12.0	26.2	7.5	6.5	26.2	9.8	15.7	72.0	45.9	7.7	10.5	25.9
TBL3	"SAZD, UTP13"	ENSG00000183751	"Transducin beta like 3"	Q12788	16	1972037-1982933	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 84.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042562, HPA055695"	Enhanced	Supported	Enhanced	Nucleoli		NA	NA			Nucleoli		"HPA042562: AB_10964911, HPA055695: AB_2682888"	"unprognostic (1.96e-1)"	"unprognostic (5.49e-3)"	"unprognostic (8.49e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.67e-1)"	"unprognostic (2.65e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.78e-2)"	"unprognostic (8.03e-2)"	"unprognostic (2.14e-2)"	"unprognostic (8.32e-2)"	"prognostic favorable (7.33e-4)"	"unprognostic (3.65e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.77e-1)"	8.9	7.9	6.0	9.5	8.3	6.0	5.8	16.3	9.6	6.2	6.8	8.8	6.8	7.7	7.1	6.3	9.4	5.4	6.0	7.5	6.6	6.1	7.2	8.7	6.9	7.2	7.0	7.3	7.7	8.9	10.5	5.5	7.3	5.7	5.7	3.6	5.6	10.5	6.0	18.2	9.5	7.8	5.9	4.8	6.7	9.5	20.5	6.5	9.5	7.2	11.5	9.3	5.1	5.4	8.5	11.2	5.8	12.0	14.8	12.1	8.5	5.6	10.9	3.0	5.9	3.0	2.4	9.8	5.2	3.4	4.5	3.7	13.9	10.8	7.5	12.2	3.9	4.1	15.2	4.8	6.0	2.4	5.5	6.9	4.7	5.5	5.2	3.4	8.1	4.5	2.4	4.6	5.6	3.3	3.6	5.6	4.6	9.5	5.5	2.6	9.0	10.3	4.5	7.1	5.0	4.4	18.1	5.5	12.5	2.2	2.1	7.0	5.4	4.7	12.1	4.4	3.1	9.1	5.5	8.7	6.2	7.4	5.5	10.0	10.1	4.4	11.8	3.6	5.2	7.1	4.8	10.2	5.8	12.1	12.0	10.7	7.5	8.9	11.8	11.2	8.5	11.4	8.6	2.5	14.8	11.7	5.7	9.6	8.5	6.0	8.3	16.3	9.6	6.6	6.1	7.0	7.3	5.7	6.5	3.0	9.8	7.5	13.4	11.6	12.1	14.3	7.6	4.0	10.3	17.4	7.9	22.6	6.6	21.3	84.6	9.2	22.2	0.0	19.4	20.7	8.2	12.3	14.9	12.4	17.7	9.5	13.3	8.6	9.7	53.2	13.8	9.8	6.8	29.7	13.7	16.1	19.6	20.1	10.3	13.0	8.7	25.8	9.9	14.4	17.7	15.9	18.8	10.9	15.4	12.4
THUMPD3	DKFZP434F091	ENSG00000134077	"THUMP domain containing 3"	Q9BV44	3	9362842-9386791	"Predicted intracellular proteins"		"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 224.3;Spermatocytes: 126.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036170, HPA036171"	Approved		Enhanced	Nucleoli,Cytosol		No	No			Cytosol	Nucleoli	"HPA036170: AB_10671836, HPA036171: AB_2674985"	"unprognostic (2.13e-2)"	"unprognostic (8.30e-2)"	"unprognostic (1.74e-3)"	"unprognostic (4.25e-2)"	"unprognostic (2.66e-2)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (1.25e-7)"	"unprognostic (6.54e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.00e-1)"	"unprognostic (4.19e-2)"	"prognostic favorable (1.03e-4)"	"unprognostic (1.41e-1)"	"unprognostic (4.53e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.59e-2)"	17.4	17.2	13.3	12.9	14.8	22.2	14.2	13.4	19.6	15.2	14.4	13.8	12.5	12.8	14.0	15.8	16.5	12.3	10.9	19.3	12.3	13.9	20.7	23.9	11.1	13.5	18.3	11.0	14.3	14.8	22.2	27.8	14.4	23.2	15.9	15.1	14.0	16.1	14.9	29.4	13.4	14.9	12.3	15.8	14.5	12.5	42.8	14.8	22.3	18.2	17.5	13.2	16.2	11.7	13.9	15.4	12.5	19.3	11.7	22.3	10.1	12.8	17.5	12.2	6.4	16.1	15.6	49.2	15.7	12.9	16.0	12.2	13.1	13.6	13.2	12.3	14.2	25.6	8.5	22.3	16.0	16.3	14.7	13.0	16.5	17.7	11.4	15.8	21.0	12.0	12.5	18.2	18.9	19.7	13.0	10.5	21.5	25.9	19.2	21.1	18.2	24.8	9.0	23.5	14.4	17.0	15.8	21.0	18.8	10.5	19.5	5.1	16.5	13.0	9.4	13.9	13.2	15.1	13.6	7.4	15.4	13.3	18.5	17.2	24.6	57.2	42.5	18.7	19.7	22.0	10.6	13.2	12.5	16.2	17.4	21.1	12.3	14.1	16.8	15.0	13.9	22.3	16.8	2.7	11.7	19.3	15.4	13.2	10.1	13.3	14.8	13.4	19.6	12.3	13.9	18.3	11.0	23.2	14.8	23.8	17.9	6.7	21.7	9.5	20.8	43.1	20.4	16.0	29.6	21.0	15.7	29.0	44.7	33.1	224.3	13.1	8.7	0.0	25.5	25.1	18.7	25.5	26.7	23.1	24.1	36.5	2.9	11.6	15.1	105.0	19.0	17.7	11.8	17.2	15.2	28.6	27.1	3.5	24.4	25.2	34.6	6.5	13.4	126.9	51.4	11.3	23.0	15.2	18.8	18.0
TMA16	"C4orf43, FLJ11184"	ENSG00000198498	"Translation machinery associated 16 homolog"	Q96EY4	4	163494442-163520539	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041571, HPA052688"	Uncertain		Enhanced	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA041571: AB_10794381, HPA052688: AB_2681916"	"unprognostic (6.02e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.00e-1)"	"unprognostic (2.92e-3)"	"prognostic unfavorable (2.70e-5)"	"prognostic unfavorable (4.40e-4)"	"unprognostic (2.30e-3)"	"unprognostic (1.33e-2)"	"unprognostic (1.17e-3)"	"unprognostic (2.69e-2)"	"prognostic unfavorable (7.70e-4)"	"unprognostic (6.98e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.56e-2)"	16.1	13.1	7.1	25.3	9.6	10.2	16.0	8.9	11.5	17.5	11.5	8.9	11.8	9.4	18.5	17.7	16.1	12.8	13.5	12.0	8.7	7.4	13.5	16.8	10.2	22.1	7.6	8.8	16.0	19.3	7.2	12.4	12.6	9.9	11.6	11.0	8.8	16.9	12.2	17.2	15.1	9.8	13.1	11.1	21.1	13.0	30.0	8.5	28.2	10.6	15.0	18.3	15.6	13.5	21.4	28.2	3.3	21.9	13.5	14.0	7.4	15.7	8.3	13.4	12.2	5.6	9.6	13.8	18.5	9.3	10.1	8.6	8.0	21.6	35.0	7.7	9.8	8.3	8.0	15.6	13.2	12.8	18.0	13.4	48.8	7.9	12.7	12.4	38.5	15.2	6.2	12.0	8.5	10.7	8.4	11.0	11.3	17.1	25.7	11.0	14.2	23.1	20.0	14.9	8.6	12.2	22.1	12.7	22.1	8.0	7.8	7.8	11.5	11.7	15.7	13.8	8.9	9.4	15.0	19.3	8.1	15.3	7.7	19.5	18.7	24.0	40.7	16.0	20.5	24.2	3.3	14.5	1.3	7.7	21.9	11.4	21.4	14.0	9.9	16.5	19.9	13.2	11.1	0.5	13.5	17.7	28.2	11.5	7.4	7.1	9.6	8.9	11.5	8.7	7.4	7.6	8.8	9.9	8.5	20.8	28.2	49.6	29.7	29.2	13.2	32.7	50.9	14.7	27.3	31.4	3.9	47.8	54.7	39.8	141.5	25.9	10.6	23.3	60.9	76.4	30.6	17.5	27.8	47.0	32.6	14.3	29.3	38.6	33.4	132.5	51.5	37.8	25.3	35.1	34.4	14.7	45.8	28.1	30.1	37.2	13.4	38.8	30.6	59.7	38.5	34.6	25.5	21.7	37.6	23.0
UBE2M	"hUbc12, UBC12"	ENSG00000130725	"Ubiquitin conjugating enzyme E2 M"	P61081	19	58555712-58558960	"Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 134.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004993, HPA054551, HPA057800"	Approved		Enhanced	"Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol"		Yes	No			Nucleoplasm	"Nucleoli, Nuclear bodies, Cytosol"	"CAB004993: AB_436983, HPA054551: AB_2682520, HPA057800: AB_2683531"	"unprognostic (1.42e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.17e-3)"	"unprognostic (3.90e-3)"	"unprognostic (4.86e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.81e-1)"	"unprognostic (8.63e-3)"	"unprognostic (1.76e-1)"	"unprognostic (5.85e-2)"	"unprognostic (8.42e-3)"	18.1	26.0	51.8	16.3	38.9	32.1	13.6	28.4	52.4	15.2	20.4	17.0	20.5	17.8	17.3	19.6	24.9	19.3	17.4	43.2	35.1	33.9	19.6	19.1	16.5	18.1	32.1	30.5	19.4	20.2	25.9	22.8	32.0	26.4	18.4	16.7	15.0	20.9	22.6	61.9	19.2	15.9	19.2	19.8	18.5	17.9	31.8	16.1	32.7	22.2	21.2	19.9	18.2	23.5	3.8	7.6	10.9	4.3	1.8	3.8	2.1	21.5	39.3	19.9	18.9	10.6	12.7	14.5	22.5	19.8	16.3	14.1	23.7	16.8	22.7	17.0	15.9	32.7	14.1	22.1	22.2	12.3	25.8	134.3	33.0	25.3	15.4	26.0	29.8	26.2	13.6	17.4	24.8	29.5	17.9	19.6	21.5	16.0	28.7	21.6	22.1	23.8	27.1	12.6	25.2	34.4	22.2	16.6	29.2	18.8	27.2	35.1	28.7	19.5	23.9	21.0	7.6	14.3	27.4	14.6	51.1	10.4	16.0	39.8	34.8	52.5	24.3	32.5	26.5	33.3	6.8	4.3	4.1	3.5	2.8	2.7	3.4	3.8	3.7	3.1	3.8	3.7	2.5	10.9	1.8	2.7	7.6	3.1	2.1	51.8	38.9	28.4	52.4	35.1	33.9	32.1	30.5	26.4	16.1	6.0	15.4	10.4	28.7	35.8	101.5	34.7	17.8	12.0	6.8	17.4	19.6	18.8	6.6	15.3	18.8	19.0	45.1	23.3	26.0	17.2	20.9	42.6	19.6	28.7	30.5	103.3	39.5	20.3	27.6	27.8	16.1	18.1	33.7	11.8	28.6	85.9	31.9	25.4	13.1	25.9	58.3	25.8	25.5	26.4	7.9	49.7	43.8	15.2	31.9	47.5
URB2	"KIAA0133, NET10, NPA2"	ENSG00000135763	"URB2 ribosome biogenesis 2 homolog (S. cerevisiae)"	Q14146	1	229626234-229660199	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 27.5;Rod photoreceptor cells: 17.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008902, HPA046788"	Uncertain		Enhanced	Nucleoli		NA	NA			Nucleoli		"HPA008902: AB_2213805, HPA046788: AB_2679807"	"unprognostic (1.26e-1)"	"unprognostic (4.03e-3)"	"unprognostic (2.16e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.48e-1)"	"unprognostic (5.53e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.62e-3)"	"unprognostic (7.81e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.45e-1)"	9.8	6.2	7.0	7.2	7.8	7.6	6.5	5.8	11.0	4.7	5.0	9.5	2.9	4.3	7.4	3.8	8.0	6.9	5.2	4.9	5.3	3.7	4.3	10.4	4.9	12.0	8.2	7.7	7.2	13.7	6.5	9.9	6.5	8.0	5.0	4.9	6.4	5.8	3.8	14.0	5.8	5.3	6.6	5.8	8.4	5.8	15.6	7.2	10.3	4.6	6.2	9.0	5.5	4.8	2.7	2.7	0.5	3.9	1.9	5.6	2.9	7.3	11.1	7.2	9.6	4.6	3.8	22.1	5.9	3.6	9.1	6.9	11.0	5.8	15.2	6.8	4.1	4.8	10.2	17.8	7.2	8.4	7.4	17.0	9.5	9.3	6.4	4.3	13.8	8.2	3.7	5.3	9.0	7.1	2.3	4.3	9.0	20.0	7.1	5.6	5.8	15.4	6.8	24.2	13.1	7.4	17.3	10.3	15.2	4.1	9.3	10.8	13.3	6.9	7.3	5.8	2.6	8.2	7.9	4.7	7.5	9.5	9.5	16.7	7.9	7.6	22.9	4.0	10.4	13.6	0.2	1.9	0.5	3.0	3.9	5.6	2.0	2.8	3.6	2.7	2.7	4.3	3.3	0.2	1.9	1.3	1.6	3.1	2.9	7.0	7.8	5.8	11.0	5.3	3.7	8.2	7.7	8.0	7.2	0.0	0.6	1.9	4.7	9.0	6.8	2.4	2.5	0.0	2.3	5.2	27.5	4.2	0.0	2.3	0.3	5.5	0.9	0.0	2.4	8.6	2.7	4.3	0.0	2.9	2.5	3.2	6.3	4.3	1.8	0.8	2.0	2.4	5.0	2.8	1.8	2.7	2.3	0.0	3.2	1.6	17.2	0.0	3.0	5.2	2.9	8.0	2.7	0.0	3.0	3.1
USP36	"FLJ12851, KIAA1453"	ENSG00000055483	"Ubiquitin specific peptidase 36"	Q9P275	17	78787381-78841441	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012082, HPA012395, HPA052860"	Uncertain	Supported	Enhanced	"Nucleoli,Nucleoli rim,Nuclear speckles"		NA	NA			"Nucleoli, Nucleoli rim"	"Nuclear speckles"	"HPA012082: AB_1858682, HPA012395: , HPA052860: AB_2681974"	"unprognostic (1.94e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (5.18e-5)"	"unprognostic (9.35e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.50e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.03e-3)"	"unprognostic (1.78e-1)"	26.3	23.4	12.9	21.3	16.0	36.5	28.1	28.3	17.4	17.2	16.4	25.4	19.2	12.3	25.1	22.2	14.6	18.0	21.9	17.4	10.4	11.2	15.9	16.4	20.0	17.2	17.5	16.0	41.3	33.6	19.6	30.0	23.4	14.6	21.0	15.1	20.4	21.8	45.5	19.5	29.3	15.1	25.2	14.5	18.2	17.3	20.8	13.7	12.8	19.3	11.2	22.2	24.6	18.1	6.7	12.4	8.9	5.3	5.6	8.8	2.5	16.0	19.4	5.7	10.6	12.3	13.7	11.0	13.2	13.4	12.7	8.6	18.8	8.1	20.5	6.7	11.7	13.8	11.8	13.4	9.8	22.8	4.9	20.3	18.7	28.3	19.6	12.7	20.5	10.3	11.9	16.3	18.1	40.6	9.8	11.0	9.3	14.9	21.7	10.4	12.3	18.6	20.8	8.8	12.0	15.6	14.4	12.6	13.8	8.0	17.0	16.9	10.3	9.5	44.3	24.0	13.0	11.4	13.1	9.3	30.1	14.0	17.5	23.3	16.1	6.3	25.3	11.8	16.0	9.4	8.9	3.9	3.1	7.6	5.3	8.8	6.4	7.2	6.4	2.3	6.7	8.0	7.7	5.7	5.6	3.3	12.4	4.8	2.5	12.9	16.0	28.3	17.4	10.4	11.2	17.5	16.0	14.6	13.7	11.9	41.5	16.3	21.0	45.9	31.4	13.5	15.3	12.0	26.1	14.0	31.4	6.9	5.0	8.7	12.1	20.4	6.8	0.0	8.3	8.9	25.9	22.8	19.7	12.4	34.2	25.4	17.7	12.3	20.6	6.1	10.9	34.8	28.7	10.8	13.6	17.3	10.7	8.6	11.7	4.1	32.5	6.5	22.7	14.2	10.6	37.9	10.8	30.5	14.0	20.4
UTP6	"C17orf40, HCA66"	ENSG00000108651	"UTP6, small subunit processome component"	Q9NYH9	17	31860899-31901765	"Predicted intracellular proteins"	"rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025936, HPA055806"	Supported		Enhanced	"Nucleoli,Mitotic chromosome"		Yes	No			Nucleoli	"Mitotic chromosome"	"HPA025936: AB_1845588, HPA055806: AB_2682930"	"unprognostic (1.55e-1)"	"unprognostic (1.07e-1)"	"unprognostic (5.61e-3)"	"unprognostic (2.54e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.11e-2)"	"prognostic unfavorable (1.86e-5)"	"unprognostic (5.68e-2)"	"unprognostic (9.78e-3)"	"unprognostic (5.50e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (1.16e-6)"	"unprognostic (1.63e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.96e-2)"	"unprognostic (4.76e-2)"	19.3	17.9	18.7	16.9	19.3	19.0	26.4	28.7	19.3	17.7	19.5	18.0	12.5	10.8	23.4	30.4	15.7	13.3	10.7	13.0	19.5	17.0	16.7	20.7	15.4	23.3	16.2	16.1	19.5	17.0	14.1	26.0	21.4	16.2	19.9	15.9	15.0	15.9	15.0	17.0	25.3	15.2	17.0	18.8	23.1	16.4	18.5	19.1	23.2	17.1	18.5	28.1	16.0	15.5	15.4	19.7	13.1	10.9	5.7	8.0	7.0	8.5	5.6	7.9	4.5	8.2	5.4	9.6	7.4	4.2	11.3	8.7	20.1	4.5	12.9	9.3	6.8	10.9	11.2	11.1	9.2	10.4	3.3	16.8	8.0	12.6	18.2	9.0	12.3	8.3	8.3	9.2	11.0	8.1	10.2	7.2	8.5	14.1	7.4	9.0	7.0	11.4	32.8	10.4	10.6	8.8	12.0	11.3	12.6	11.6	7.9	5.2	7.9	7.8	5.6	12.4	12.8	13.6	23.0	7.5	17.0	12.8	8.9	14.8	8.3	14.8	18.7	11.6	8.5	9.1	10.6	10.8	6.7	7.6	10.9	7.3	12.7	8.0	8.0	13.6	15.4	7.1	8.0	13.1	5.7	9.7	19.7	7.7	7.0	18.7	19.3	28.7	19.3	19.5	17.0	16.2	16.1	16.2	19.1	17.9	22.4	27.9	22.9	22.9	16.2	12.5	7.6	30.8	30.7	5.2	7.9	36.3	8.3	22.3	20.6	18.0	9.1	0.0	20.7	41.1	23.1	22.0	35.7	14.4	32.5	11.1	5.2	12.9	20.5	3.6	17.3	29.1	8.5	44.1	14.6	17.8	22.2	7.0	15.9	15.0	16.0	6.5	23.1	62.6	62.6	22.7	32.0	13.3	15.3	27.6
WDR3	"DIP2, FLJ12796, UTP12"	ENSG00000065183	"WD repeat domain 3"	Q9UNX4	1	117929720-117966542	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatogonia: 60.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027509, HPA054354, HPA072915"			Enhanced	Nucleoplasm,Nucleoli		No	No			Nucleoli	Nucleoplasm	"HPA027509: AB_10601808, HPA054354: AB_2682459, HPA072915: "	"unprognostic (6.77e-2)"	"unprognostic (4.53e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.46e-3)"	"unprognostic (1.91e-2)"	"unprognostic (3.57e-2)"	"prognostic unfavorable (7.33e-5)"	"unprognostic (1.29e-1)"	"unprognostic (9.52e-2)"	"unprognostic (6.04e-2)"	"prognostic unfavorable (8.82e-4)"	"unprognostic (8.90e-3)"	"unprognostic (7.47e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.93e-1)"	"unprognostic (8.65e-2)"	12.5	13.5	7.7	10.6	10.7	3.3	12.2	8.4	9.7	10.5	7.7	6.8	9.7	7.3	12.6	6.5	13.3	10.5	4.6	8.7	7.1	6.4	8.5	14.8	7.3	15.5	6.9	6.2	12.1	21.4	16.3	14.8	8.4	8.3	8.4	10.8	6.6	9.8	8.1	25.4	10.5	6.8	11.7	6.2	8.5	9.3	14.9	6.9	15.2	11.1	9.5	15.2	10.2	9.1	8.7	11.9	0.5	6.6	7.9	12.4	6.3	15.2	9.7	9.7	14.8	10.6	8.7	11.2	10.7	7.0	12.5	11.0	10.2	5.1	18.1	14.7	7.9	8.0	10.3	24.1	12.3	19.9	14.9	12.5	17.0	10.4	8.2	8.7	31.8	9.0	8.5	8.9	15.8	24.0	7.4	11.9	12.8	20.7	8.9	10.9	8.8	15.1	7.3	35.0	13.4	15.6	14.5	33.7	13.8	6.2	10.2	15.0	13.7	12.2	15.1	17.3	14.1	6.0	13.3	10.5	9.4	15.0	17.1	23.9	13.1	15.3	28.4	13.8	20.6	24.2	0.1	6.0	0.5	8.8	6.1	11.4	8.7	8.0	10.3	11.9	7.9	12.4	11.3	0.5	7.9	6.6	6.6	10.7	6.3	7.7	10.7	8.4	9.7	7.1	6.4	6.9	6.2	8.3	6.9	8.9	11.0	9.2	10.8	18.5	9.6	14.0	5.1	25.4	33.0	7.0	5.9	9.2	8.3	8.4	28.6	11.7	2.7	0.0	11.8	7.5	9.5	8.9	15.1	25.5	7.2	14.3	3.5	11.6	6.3	34.2	11.5	7.4	10.1	2.8	5.1	6.5	10.6	3.5	11.0	6.0	6.4	12.9	14.6	25.9	60.1	19.6	4.2	5.7	9.4	7.7
WDR55	"FLJ20195, FLJ21702"	ENSG00000120314	"WD repeat domain 55"	Q9H6Y2	5	140664676-140674124	"Predicted intracellular proteins"	"rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043470, HPA048143, HPA075133"	Uncertain		Enhanced	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA043470: AB_2678495, HPA048143: AB_2680282, HPA075133: "	"prognostic unfavorable (1.51e-4)"	"unprognostic (1.35e-1)"	"unprognostic (7.77e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.35e-1)"	"prognostic unfavorable (8.88e-6)"	"unprognostic (9.96e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.05e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.19e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.70e-1)"	"unprognostic (2.51e-2)"	17.9	12.4	7.6	17.8	8.8	18.1	12.9	13.0	12.7	9.5	16.6	11.4	16.9	14.9	12.0	11.0	18.8	10.9	20.2	9.6	7.7	9.1	15.3	29.9	12.7	15.0	12.6	8.5	12.0	16.2	11.4	13.2	13.9	10.6	12.8	17.5	8.9	16.7	14.8	18.2	15.8	20.8	11.1	8.9	18.8	14.9	8.0	8.5	12.5	12.0	14.0	21.4	13.5	11.0	10.4	11.3	10.4	18.9	11.3	14.3	10.2	7.9	10.9	5.3	21.3	8.3	6.7	14.9	7.9	9.8	8.5	9.7	18.7	10.9	7.5	10.7	10.3	15.3	9.9	7.2	13.9	6.6	6.9	5.9	8.5	9.0	7.6	8.0	8.9	16.1	7.9	8.1	11.6	6.2	5.8	9.0	8.4	5.9	5.9	9.3	11.3	8.2	8.0	5.6	11.4	9.6	7.0	7.7	7.0	10.1	12.0	5.2	7.0	10.9	31.9	12.1	6.8	22.6	9.6	8.0	11.1	5.8	12.7	10.7	9.8	7.6	5.9	14.3	11.9	6.5	6.9	11.7	8.6	13.9	18.9	14.3	10.4	12.9	11.8	11.3	8.8	10.5	10.7	10.4	11.3	15.4	8.4	14.1	10.2	7.6	8.8	13.0	12.7	7.7	9.1	12.6	8.5	10.6	8.5	8.9	18.4	22.6	8.8	12.9	12.9	4.5	5.1	17.4	18.2	17.4	11.8	19.4	18.3	17.5	20.3	9.5	24.1	0.0	24.4	36.3	12.9	11.7	19.6	13.5	18.9	22.3	14.3	8.6	12.4	6.8	8.9	18.9	8.5	26.2	17.8	5.6	23.0	28.1	7.1	15.6	7.8	12.9	12.3	7.1	9.6	11.7	19.5	20.0	19.8	12.9
XRN2		ENSG00000088930	"5'-3' exoribonuclease 2"	Q9H0D6	20	21303304-21389827	"Predicted intracellular proteins"	"mRNA processing, Transcription, Transcription regulation, Transcription termination"	"DNA-binding, Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047118, HPA050485"	Supported		Enhanced	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA047118: AB_2679941, HPA050485: AB_2681141"	"unprognostic (9.38e-2)"	"unprognostic (4.70e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (3.54e-5)"	"unprognostic (7.26e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.99e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.31e-1)"	42.9	35.1	12.5	24.5	17.7	38.3	30.4	18.0	16.4	26.8	22.8	18.6	23.3	14.4	38.6	25.2	22.1	30.6	21.8	19.3	13.7	10.3	31.4	35.3	27.5	33.4	17.4	12.1	32.1	26.4	30.0	35.3	26.5	15.9	25.7	20.1	19.1	27.6	25.0	36.8	23.0	21.6	24.1	18.6	40.9	23.2	27.4	18.3	41.1	31.3	20.4	30.6	33.1	21.7	16.0	30.6	35.0	33.9	21.7	24.6	23.8	27.4	32.7	36.1	27.6	27.0	33.3	35.8	25.3	33.1	33.8	39.5	21.8	31.6	27.1	15.1	26.5	46.1	32.7	40.6	42.6	43.5	12.2	20.5	35.0	12.3	41.1	23.8	31.4	30.5	31.5	21.6	37.2	32.7	30.2	29.0	26.1	28.0	23.3	31.3	21.5	46.2	20.8	28.1	26.8	22.1	34.0	61.4	23.1	28.8	29.2	28.0	36.4	29.5	36.4	27.1	29.2	20.4	37.5	26.7	34.0	25.5	7.7	31.9	20.6	26.4	29.1	13.1	14.7	25.6	15.1	33.9	23.8	18.6	27.2	24.6	16.0	20.4	20.2	30.6	15.1	21.8	21.0	35.0	21.7	32.7	13.2	24.0	23.8	12.5	17.7	18.0	16.4	13.7	10.3	17.4	12.1	15.9	18.3	56.6	105.5	63.6	78.1	56.4	39.0	48.7	53.5	108.4	109.2	38.4	39.3	93.9	23.2	104.4	113.2	77.5	32.5	0.0	104.1	85.7	61.2	59.6	79.9	61.8	93.6	47.7	57.1	43.0	136.4	16.3	53.5	87.6	57.3	76.7	45.4	69.3	88.3	45.9	52.3	62.6	44.7	58.2	72.1	99.1	113.5	58.7	88.0	62.3	54.7	73.2
ZCCHC7	"AIR1, FLJ22611"	ENSG00000147905	"Zinc finger CCHC-type containing 7"	Q8N3Z6	9	37120539-37358149	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"REH: 48.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020600, HPA021088, HPA029522"	Uncertain		Enhanced	Nucleoli,Cytosol		NA	NA			"Nucleoli, Cytosol"		"HPA020600: AB_1858985, HPA021088: AB_1858986, HPA029522: AB_10601029"	"unprognostic (1.19e-3)"	"unprognostic (1.21e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.36e-1)"	"unprognostic (7.21e-3)"	"unprognostic (2.78e-1)"	"unprognostic (4.27e-3)"	"unprognostic (3.18e-2)"	"unprognostic (8.00e-3)"	"unprognostic (1.29e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.83e-1)"	"unprognostic (4.58e-2)"	"unprognostic (8.23e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.04e-2)"	"unprognostic (5.49e-2)"	15.2	12.7	9.9	28.4	11.3	16.2	16.8	16.5	12.1	16.1	13.4	10.2	20.0	11.3	19.2	14.9	11.5	13.1	12.4	10.2	10.1	10.3	10.0	11.1	10.9	27.5	11.8	8.4	21.9	19.8	8.6	30.7	10.2	11.2	13.5	14.2	9.8	14.3	19.2	9.9	12.7	13.9	14.0	11.8	18.4	11.8	14.3	12.4	19.9	16.1	12.3	29.3	19.2	12.9	29.7	7.5	10.9	8.5	10.1	11.4	5.2	7.4	5.0	7.0	7.5	7.3	11.4	6.5	7.3	8.5	5.7	7.8	5.0	3.6	26.4	4.0	5.7	6.7	3.1	6.7	6.9	8.2	12.1	4.7	7.5	8.2	4.3	11.4	12.9	7.5	7.8	10.8	5.9	23.3	10.9	6.5	9.8	20.6	9.2	5.1	3.5	9.9	7.2	7.4	8.1	7.5	48.0	4.7	6.7	7.1	2.9	7.9	5.7	5.2	6.3	6.7	7.2	4.5	8.4	5.8	4.2	5.3	6.0	4.4	3.1	5.8	31.5	6.8	8.4	7.7	4.7	4.4	10.9	7.8	5.0	7.7	18.1	8.9	8.8	4.0	29.7	11.4	10.4	8.8	10.1	8.5	7.5	7.4	5.2	9.9	11.3	16.5	12.1	10.1	10.3	11.8	8.4	11.2	12.4	32.8	14.4	78.3	25.6	25.1	15.3	9.3	5.1	24.1	20.5	5.2	9.8	13.5	23.2	14.0	40.8	19.1	9.7	0.0	13.7	21.8	25.2	22.7	23.1	10.6	14.4	11.1	18.3	15.4	13.0	15.6	25.0	16.4	15.1	9.0	19.9	18.5	12.5	14.4	18.4	15.4	23.6	6.5	21.7	45.1	42.1	28.5	15.6	27.7	19.5	19.2
ZNF444	"EZF2, FLJ11137, ZSCAN17"	ENSG00000167685	"Zinc finger protein 444"	Q8N0Y2	19	56132599-56160893	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 51.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056895, HPA065203"	Approved		Enhanced	Nucleoplasm,Nucleoli		Yes	No			Nucleoplasm	Nucleoli	"HPA056895: AB_2683267, HPA065203: AB_2685431"	"unprognostic (1.58e-1)"	"unprognostic (3.34e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.57e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (2.61e-4)"	"unprognostic (4.70e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.32e-1)"	"prognostic favorable (1.87e-4)"	9.4	13.4	15.0	7.1	21.0	3.7	8.3	14.9	20.1	9.0	14.8	12.8	14.3	13.6	10.5	9.9	6.6	11.9	11.2	10.5	13.5	13.3	9.9	37.4	10.9	6.1	12.3	11.0	12.5	25.3	8.5	12.2	12.5	8.0	14.3	5.3	10.4	14.1	25.6	17.2	11.5	11.3	7.5	10.3	8.6	17.2	9.2	10.4	28.1	16.6	2.8	8.2	10.4	6.8	4.3	3.5	3.5	1.7	3.7	7.1	1.8	4.7	9.1	8.4	7.3	3.6	3.7	5.5	6.1	4.0	5.2	5.7	10.0	5.4	8.4	5.4	3.5	2.6	4.4	5.2	4.1	2.2	7.3	51.5	8.2	6.1	18.0	5.9	3.6	7.7	4.3	3.8	4.2	3.3	7.9	4.6	10.5	10.6	3.7	3.6	6.2	11.8	10.3	9.1	9.5	16.7	13.8	5.4	4.4	5.7	4.4	9.0	12.4	3.1	10.3	4.5	4.8	10.2	6.7	6.0	9.4	8.1	2.0	6.6	9.1	7.7	6.3	5.9	5.0	6.1	3.1	1.7	3.5	4.1	1.4	4.5	2.0	6.9	6.9	2.1	4.3	7.1	4.6	0.2	3.7	1.0	3.5	4.2	1.8	15.0	21.0	14.9	20.1	13.5	13.3	12.3	11.0	8.0	10.4	3.0	14.9	10.2	14.2	2.7	16.7	11.4	33.1	13.4	9.1	10.4	7.9	16.2	8.3	23.1	26.9	15.8	12.8	0.0	19.3	7.9	9.2	13.8	10.3	34.7	9.4	19.1	28.2	19.6	5.3	28.6	11.2	3.9	15.1	19.8	24.4	16.6	21.0	10.5	11.3	18.8	13.6	25.8	13.2	10.4	19.8	4.5	10.4	13.1	19.3	8.9
ZNF554	FLJ34817	ENSG00000172006	"Zinc finger protein 554"	Q86TJ5	19	2819874-2835773	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 2: 15.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA060247, HPA063358"	Uncertain		Enhanced	Nucleoplasm,Nucleoli		No	No			Nucleoplasm	Nucleoli	"HPA060247: AB_2684230, HPA063358: AB_2684995"	"unprognostic (3.81e-1)"	"unprognostic (1.89e-3)"	"unprognostic (1.84e-1)"	"unprognostic (3.58e-3)"	"unprognostic (5.05e-2)"	"unprognostic (7.36e-5)"	"unprognostic (1.65e-1)"	"prognostic favorable (9.31e-4)"	"unprognostic (1.82e-1)"	"unprognostic (3.37e-3)"	"prognostic favorable (4.69e-4)"	"unprognostic (1.57e-1)"	"prognostic favorable (1.99e-5)"	"unprognostic (1.75e-1)"	"unprognostic (9.91e-3)"	"unprognostic (1.79e-2)"	"prognostic favorable (5.00e-4)"	4.1	4.4	7.9	2.0	9.1	1.9	5.1	12.2	14.1	6.0	4.6	7.7	5.6	6.1	6.8	4.5	4.0	6.4	5.6	7.3	8.2	8.4	6.6	8.6	5.0	3.9	6.2	6.9	8.2	5.0	9.8	8.4	25.9	6.0	5.7	4.3	7.7	7.6	5.4	8.9	7.4	4.7	5.6	4.2	3.7	4.2	4.0	6.5	5.1	7.9	4.7	6.0	4.5	4.1	2.3	3.6	0.6	0.6	1.8	1.8	0.7	3.7	0.1	3.3	3.6	2.3	3.0	4.2	2.4	2.6	5.0	2.3	0.3	1.0	3.5	2.3	1.9	3.8	1.8	0.3	1.9	0.7	0.0	1.7	1.0	1.2	1.5	1.8	0.5	0.8	2.4	4.4	1.4	2.0	3.0	0.4	4.4	3.6	2.0	1.6	0.7	1.7	0.4	1.6	1.2	1.1	1.9	2.2	0.9	3.2	3.0	3.0	5.4	2.7	0.5	4.0	4.2	1.4	1.8	0.0	0.4	1.0	1.4	0.9	6.6	7.3	0.7	1.9	1.7	1.0	0.2	0.3	0.6	0.4	0.1	1.5	0.8	0.7	0.9	0.0	2.3	1.8	0.3	0.2	1.8	0.6	3.6	0.3	0.7	7.9	9.1	12.2	11.2	8.2	8.4	6.2	6.9	6.0	6.5	11.9	15.1	0.9	2.6	1.1	4.1	2.8	2.5	8.1	6.8	0.0	7.9	1.9	3.3	2.0	0.4	2.5	3.8	0.0	1.2	1.0	2.0	2.5	0.0	1.9	1.3	3.2	3.5	2.5	1.0	0.2	2.8	2.0	0.0	1.0	1.7	4.6	1.7	0.0	2.5	2.1	4.7	0.0	1.5	4.4	10.4	1.3	7.3	4.5	2.2	1.5
ZNF593	ZT86	ENSG00000142684	"Zinc finger protein 593"	O00488	1	26169871-26170873	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 59.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA054363, HPA059387"	Supported		Enhanced	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA054363: AB_2682462, HPA059387: AB_2684001"	"unprognostic (1.23e-2)"	"unprognostic (8.97e-2)"	"unprognostic (7.13e-2)"	"unprognostic (7.42e-2)"	"unprognostic (9.37e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.63e-2)"	"unprognostic (8.96e-2)"	"unprognostic (5.06e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.79e-2)"	11.7	11.5	9.4	10.7	9.4	15.7	18.3	7.2	12.1	9.0	11.7	7.0	12.1	11.4	8.7	9.0	10.9	8.4	11.3	14.5	8.9	10.0	13.5	30.8	7.7	16.8	10.0	7.0	11.6	36.2	9.7	9.3	12.7	10.9	10.4	5.8	5.9	15.9	12.0	59.3	9.8	11.0	6.5	7.3	13.0	15.2	9.3	8.3	5.4	15.1	17.2	9.2	10.6	10.1	23.5	26.8	0.7	25.0	16.1	21.7	14.1	20.1	11.1	3.8	13.4	3.7	4.9	20.2	9.0	4.6	10.5	10.1	17.0	12.2	23.6	16.6	5.6	8.4	13.2	12.9	11.7	3.8	14.1	41.4	16.0	9.1	25.7	16.1	22.1	14.1	8.8	11.5	11.6	12.2	4.4	8.8	5.8	24.0	9.1	6.2	15.4	9.0	41.1	15.1	19.5	39.5	11.3	6.7	23.8	7.5	8.9	10.1	11.0	10.9	27.4	34.2	3.3	11.3	12.5	9.1	10.1	11.9	21.1	16.8	18.0	18.2	25.5	11.8	45.9	12.9	0.1	15.7	0.2	14.2	25.0	13.3	23.5	20.1	14.0	21.7	22.7	15.0	14.3	0.7	16.1	25.0	26.8	21.7	14.1	9.4	9.4	7.2	12.1	8.9	10.0	10.0	7.0	10.9	8.3	11.9	63.0	48.3	137.4	152.1	16.6	5.9	58.6	21.4	40.9	57.6	2.0	93.3	87.9	89.4	5.0	36.0	55.3	23.3	126.2	135.2	54.6	99.4	51.7	184.5	69.6	3.2	105.3	38.6	55.7	10.0	30.0	42.5	47.2	47.7	71.1	18.5	122.6	60.4	21.9	148.8	11.7	12.9	55.6	33.0	56.3	147.0	186.2	28.8	68.1	152.9
ZNF692	"AREBP, FLJ20531, Zfp692"	ENSG00000171163	"Zinc finger protein 692"	Q9BU19	1	248850006-248859144	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059337, HPA062792"	Uncertain		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA059337: AB_2683984, HPA062792: AB_2684869"	"unprognostic (4.86e-2)"	"unprognostic (9.51e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.90e-1)"	"unprognostic (6.72e-3)"	"unprognostic (2.85e-3)"	"unprognostic (5.66e-3)"	"unprognostic (1.25e-1)"	"unprognostic (4.50e-2)"	"prognostic favorable (4.09e-4)"	"unprognostic (5.65e-3)"	"prognostic unfavorable (7.72e-9)"	"unprognostic (5.32e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.59e-1)"	"prognostic favorable (8.35e-5)"	5.6	8.7	15.3	7.9	25.0	11.1	10.7	27.7	22.3	11.6	8.1	16.5	17.8	8.3	13.6	15.1	9.7	13.1	9.4	7.4	20.1	11.6	9.7	8.6	6.9	9.8	30.4	14.3	17.2	12.2	18.4	13.8	8.1	21.2	14.9	7.0	7.7	21.9	11.1	11.5	19.6	8.9	9.2	18.3	10.0	8.7	22.9	25.7	6.6	11.3	9.2	7.8	9.1	8.8	4.6	4.4	4.8	2.1	10.6	6.4	2.8	4.8	5.1	4.3	10.7	3.7	1.9	18.7	4.1	1.4	4.7	3.0	5.8	7.0	6.0	8.5	2.0	1.9	7.0	6.5	6.2	3.4	8.9	4.4	7.1	10.9	1.6	2.8	7.9	5.7	2.4	8.0	4.8	12.8	4.7	4.3	8.0	14.6	4.4	2.1	3.4	4.0	16.3	8.8	12.4	11.1	13.7	2.8	12.0	9.0	3.6	8.5	6.3	4.5	7.8	8.4	1.7	9.5	13.0	3.0	2.1	3.5	2.3	5.6	12.4	7.8	3.8	4.6	10.5	3.5	0.0	2.1	1.9	5.7	1.6	4.9	4.6	4.5	6.0	4.4	3.8	6.4	4.6	4.8	10.6	1.4	3.5	4.7	2.8	15.3	25.0	27.7	22.3	20.1	11.6	30.4	14.3	21.2	25.7	8.9	7.5	8.0	10.6	8.5	14.0	3.0	10.2	8.1	2.3	10.4	21.6	10.2	5.0	6.3	8.0	6.3	8.8	23.3	3.4	9.1	6.6	13.7	5.7	5.9	5.7	11.1	7.9	1.8	6.9	5.8	9.5	5.4	15.1	6.4	9.4	8.4	6.1	5.8	6.7	3.1	13.8	0.0	4.9	31.1	15.6	6.9	5.1	10.2	11.7	8.5
ZNF771	DSC43	ENSG00000179965	"Zinc finger protein 771"	Q7L3S4	16	30407297-30431108	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 27.0;REH: 17.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030730, HPA046672, HPA059398"	Uncertain		Enhanced	Nucleoplasm,Nucleoli		No	No			"Nucleoplasm, Nucleoli"		"HPA030730: AB_2673583, HPA046672: AB_2679745, HPA059398: AB_2684002"	"unprognostic (8.21e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.21e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.95e-2)"	"unprognostic (3.12e-5)"	"unprognostic (3.53e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.57e-1)"	"unprognostic (9.99e-3)"	6.6	6.7	15.3	5.0	14.5	4.0	5.3	10.7	18.3	6.6	6.1	4.9	6.6	4.5	10.4	7.2	4.6	7.5	6.1	4.6	13.4	10.6	9.2	8.6	4.1	3.3	8.8	16.9	10.8	7.3	8.1	6.2	2.4	8.8	10.1	5.4	4.0	4.9	12.3	18.2	6.1	4.3	9.6	5.1	3.6	4.8	3.7	8.1	1.9	5.4	3.5	4.2	6.8	5.6	6.6	3.7	1.9	2.5	1.8	6.2	2.7	3.1	3.6	5.0	4.1	7.2	3.0	3.8	4.7	2.3	3.0	3.1	1.6	1.6	3.8	8.0	2.3	3.7	2.4	5.2	2.1	3.1	1.3	27.0	3.2	2.4	4.8	3.7	1.6	3.8	4.6	1.6	3.7	2.3	3.1	3.0	4.0	7.7	2.3	2.5	5.7	3.8	5.2	4.0	1.9	2.9	17.3	3.7	2.4	1.7	1.3	7.9	5.0	2.5	2.2	3.0	2.7	2.9	1.8	2.7	5.0	6.0	2.9	3.3	3.5	3.7	1.9	3.3	3.5	3.2	1.0	1.1	0.7	3.6	2.5	4.9	2.7	4.3	4.2	2.8	6.6	6.2	3.7	1.9	1.8	0.5	3.7	4.4	2.7	15.3	14.5	10.7	18.3	13.4	10.6	8.8	16.9	8.8	8.1	3.0	0.3	2.2	10.4	4.5	11.2	6.3	15.3	0.0	1.2	5.2	9.8	4.8	28.2	6.4	1.3	5.8	5.3	0.0	3.7	2.6	9.4	8.8	1.1	16.3	2.9	11.1	4.1	14.7	0.6	1.5	23.3	2.8	5.0	1.0	8.1	15.1	3.6	4.2	28.0	23.6	7.1	12.9	8.9	1.1	1.6	5.8	3.0	3.9	9.8	3.4